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This publication is a compendium of NIOSH research and recommendations on asbestos. It
updates and supersedes the NIOSH document Asbestos Publications dated June 1992.
This publication is divided into three Parts:
• Part I consists of full or partial text of selected NIOSH documents on asbestos. These 
documents provide an overview of NIOSH research on the health hazards of asbestos 
and NIOSH recommendations on workplace exposure to asbestos.
• Part II contains a comprehensive bibliography of NIOSH documents on asbestos. It is 
divided into two sections: (A) NIOSH-authored documents (which include numbered 
publications, testimony, journal articles, and miscellaneous reports) and (B) NIOSH- 
funded documents (which include grant and contract reports). Each document citation 
includes the title and year of publication and bibliographic or ordering information (see 
below).
• Part III contains summary asbestos information from other Federal agencies.
All documents listed in Part II may be obtained in one of the following ways:
1. Single copies of any document cited as being “Available from NIOSH” may be 
obtained free of charge as long as supplies last from:
NIOSH Publications (C-13)
4676 Columbia Parkway 
Cincinnati, OH 45226-1998 
Telephone: 1-800-356-4674 
Fax: (513) 533-8573 
E-mail: pubstaft@cdc.gov
2. Copies of any document cited with a “GPO NO” may be ordered from the 
Superintendent of Documents, U.S. Government Printing Office (GPO) using the GPO 
order form on page 215. The GPO prices listed are for printed copy in the U.S. only. 
For other countries, add 25%.
3. Copies of any document cited with an “NTIS NO” may be ordered from the 
National Technical Information Service (NTIS) using the NTIS order form on page 
217. The NTIS prices listed are for printed copy in the U.S., Canada, and Mexico and
are subject to change without notice. Prices for other countries are double those 
shown. Microfiche copies are also available from NTIS; prices for microfiche should 
be confirmed with NTIS before ordering.
4. Copies of journal articles, book chapters, and proceedings may be obtained from 
public or university libraries using the bibliographic information shown in the citation.
PARTI
FULL OR PARTIAL TEXT OF SELECTED 
NIOSH REFERENCES ON ASBESTOS





This guideline summarizes pertinent information about as­
bestos for workers, employers, and occupational safety and 
health professionals who may need such information to con­
duct effective occupational safety and health programs. Recom­
mendations may be superseded by new developments in these 
fields; therefore, readers are advised to regard these recom­
mendations as general guidelines.
SUBSTANCE IDENTIFICATION
Data in the following section are presented for various forms 







If unspecified, data apply to all forms.







• Synonyms: (1) Asbestos fiber, serpentine, amphibole;
(2) Canadian chrysotile, white asbestos, serpentine;





• Identifiers: (1) CAS 1332-21-4; RTECS 06475000; DOT 
2212 (blue) 2590 (white);
(2) CAS 12001-29-5; RTECS CI6478500; DOT 2590;
(3) CAS 12172-73-5; RTECS 06477000; DOT Not assigned;
(4) CAS 12001-28-4, RTECS CI6479000; DOT 2212;
(5) CAS 14567-73-8; RTECS CI6560000; DOT Not assigned;
(6) CAS 17068-78-9; RTECS CI6478000; DOT Not assigned;
(7) CAS 13768-00-8; RTECS CI6476000; DOT Not assigned
• Appearance and odor: A fiber or filament, asbestos may 
have a “fluffy” appearance. Colors may vary from white, gray, 
blue, brown, green or yellow. Positive identification requires 
microscopic examination.
CHEMICAL AND PHYSICAL PROPERTIES
• Physical data
1. Molecular weight: (2) 277.13; (5) 185.03
2. Specific gravity (water = I): 2.5-3.0
3. Noncombustible solid
• Warning properties
Evaluation of warning properties for respirator selection: 
Vfaming properties are not considered in recommending respi­
rators for use with carcinogens.
EXPOSURE LIMITS
Only asbestos fibers greater than 5 micrometers (¿i)m in length 
are considered for the following exposure limits. The current 
Occupational Safety and Health Administration (OSHA) per­
missible exposure limit (PEL) for asbestos is O i fiber per cu­
bic centimeter (cc) of air as a time-weighted average (TWA) 
concentration over an 8-hour workshift with an action level of
0.1 fiber/cc as an hour TWA. The National Institute for Oc­
cupational Safety and Health (NIOSH) recommends that as­
bestos be controlled and handled as a potential human 
carcinogen in the workplace and that exposure be minimized 
to the lowest feasible limit. The NIOSH recommended ex­
posure limit (REL) is 0.1 fiber/cc (in 40-liter air sample) as 
a TWA concentration for up to an 8-hour workshift, 40-hour 
workweek. The American Conference of Governmental Indus­
trial Hygienists (ACGIH) has designated asbestos as an A1 sub­
stance (suspected human carcinogen, with an assigned 
threshold limit value/ TLV®) of 2 fibers/cc for chrysotile, 0.5 
fiber/cc for amosite, &2 fiber/cc for crocidolite, and 2 fibers/cc 
for other forms, as a TWA for a normal 8-hour workday and 
a 40-hour workweek (Table I).
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• Fibers greater than 5 pm in length.
t  (Ca): NIOSH recommends treating as a potential human car­
cinogen.
§ (Ala): Human carcinogen with an assigned TLV®.
HEALTH HAZARD INFORMATION
• Routes of exposure
Asbestos may cause adverse health effects following exposure 
via inhalation or ingestion.
• Summary of toxicology
1. Effects on animals: Single intrapleural injections of asbestos 
in rats, rabbits, and hamsters produced mesothelioma (cancer 
of the chest or abdominal linings). In rats, chronic inhalation 
or oral administration of asbestos produced cancers of the 
lungs, stomach, kidneys, liver, or mammary glands. All forms 
of asbestos were found to be carcinogenic in treated animals.
2. Effects cm humans: Exposure to asbestos has been found to 
significantly increase the risks of contracting asbestosis, lung 
cancer, and mesothelioma.
• Signs and symptoms of exposure
1. Short-term (acute): Exposure to asbestos can cause short­
ness of breath, chest or abdominal pain, and irritation of the 
skin and mucous membranes.
2. Long-term (chronic): Exposure to asbestos can cause 
reduced pulmonary function, breathing difficulty, dry cough, 
broadening and thickening of the rads of the fingers, and bluish 
discoloration of the skin and mucous membranes.
RECOMMENDED MEDICAL PRACTICES
• Medical surveillance program
Workers with potential exposures to chemical hazards should 
be monitored in a systematic program of medical surveillance 
intended to prevent or control occupational injury and disease. 
The program should include education of employers and work­
ers about work-related hazards, placement of workers in jobs 
that do not jeopardize their safety and health, earliest possi­
ble detection of adverse health effects, and referral of workers 
for diagnostic confirmation and treatment. The occurrence of 
disease (a “sentinel health event,” SHE) or other work-related 
adverse health effects should prompt immediate evaluation of 
primary preventive measures (e.g., industrial hygiene monitor­
ing, engineering controls, and personal protective equipment). 
A medical surveillance program is intended to supplement, not 
replace, such measures.
A medical surveillance program should include systematic col­
lection and epidemiologic analysis of relevant environmental
and biologic mo: .toring, medical screening, and morbidity and 
mortality data, his analysis may provide information about 
the relatedness ' adverse health effects and occupational ex­
posure that caí ot be discerned from results in individual 
workers. Sensit /ity, specificity, and predictive values of bio­
logic monitoring and medical screening tests should be evalu­
ated on an industry-wide basis prior to application in any given 
worker group. Intrinsic to a surveillance program is the dis­
semination of summary data to those who need to know, in­
cluding employers, occupational health professionals, 
potentially exposed workers, and regulatory and public health 
agencies.
•  Preplacement medical evaluation
Prior to placing a worker in a job with a potential for exposure 
to asbestos, the physician should evaluate and document the 
worker’s baseline health status with thorough medical, environ­
mental, and occupational histories, a physical examination, and 
physiologic and laboratory tests appropriate for the anticipat­
ed occupational risks. These should concentrate on die func­
tion and integrity of the respiratory system using die principles 
and methods recommended by NIOSH and the American 
Thoracic Society (ATS).
A preplacement medical evaluation is recommended in order 
to detect and assess preexisting or concurrent conditions which 
may be aggravated or result in increased risk when a worker 
is exposed to asbestos at or below the NIOSH REL. The ex­
amining physician should consider die probable frequency, in­
tensity, and duration of exposure, as well as the nature and 
degree of die condition, in placing such a worker. Such con­
ditions, which should not be regarded as absolute contraindi­
cations to job placement, include cigarette smoking, 
preexisting asbestos-related disease, and significant breathing 
impairment due to preexisting chronic lung diseases. In addi­
tion to the medical interview and physical examination, the 
means to identify these conditions may include the methods 
recommended by NIOSH and ATS.
• ftriodic medical screening and/or biologic monitoring 
Occupational health interviews and physical examinations 
should be performed at regular intervals. Additional examina­
tions may be necessary should a worker develop symptoms that 
may be attributed to exposure to asbestos. The interviews, ex­
aminations, and appropriate medical screening and/or biologic 
monitoring tests should be directed at identifying an excessive 
decrease or adverse trend in the physiologic function of die 
respiratory system as compared to the baseline status of the in­
dividual worker or to the expected values for a suitable refer­
ence population. The following tests should be used and 
interpreted according to standardized procedures and evalua­
tion criteria recommended by NIOSH and ATS: standardized 
questionnaires, tests of lung function, and chest X-rays.
• Medical practices recommended at the time of job trans­
fer or termination
The medical, environmental, and occupational history inter­
views, the physical examination, and selected physiologic and 
laboratory tests which were conducted at die time of placement 
should be repeated at the time of job transfer or termination. 
Any changes in the worker’s health status should be compared 
to those expected for a suitable reference population. Because
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occupational exposure to asbestos may cause diseases of 
prolonged induction-latency, the need for medical surveillance 
may extend well beyond termination of employment.
• Sentinel health events
Delayed-onset SHE's include: Scarring of the lungs (asbesto- 
sis) and its lining (pleural fibrosis) and cancer of the lungs 
(bronchogenic lung cancer) and its lining (mesothelioma).
MONITORING AND MEASUREMENT 
PROCEDURES
• TWA exposure evaluation
Measurements to determine worker exposure to asbestos 
should be taken so that the TWA exposure is based on a single 
entire workshift sample or an appropriate number of consecu­
tive samples collected during the entire workshift. Under cer­
tain conditions, it may be appropriate to collect several 
short-term interval samples (up to 30 minutes each) to deter­
mine the average exposure level. Air samples should be taken 
in the worker’s breathing zone (air that most nearly represents 
that inhaled by the worker).
• Method
Sampling and analysis fix’ airborne asbestos may be performed 
by collecting asbestos fibers with membrane filters and analyz­
ing by phase contrast microscopy A detailed sampling and ana­
lytical method for asbestos may be found in the NIOSH Manual 
o f Analytical Methods (method number 7400).
PERSONAL PROTECTIVE EQUIPMENT
Chemical protective clothing (CPC) should be selected after 
utilizing available performance data, consulting with the 
manufacturer, and then evaluating the clothing under actual use 
conditions.
Workers should be provided with and required to use CPC, 
gloves, and other appropriate protective clothing necessary to 
prevent skin contact with asbestos.
SANITATION
Clothing which is contaminated with asbestos should be re­
moved at the end of the work period and placed in nonreusa- 
ble, impermeable containers for storage, transport, and 
disposal until it can be discarded or until provision is made for 
the removal of asbestos from the clothing. These containers 
should be marked “Asbestos-Contaminated Clothing" in easy* 
to-read letters. If the clothing is to be laundered or cleaned, 
the person performing the operation should be informed of as­
bestos’s hazardous properties. Reusable clothing and equip­
ment should be checked for residual contamination before reuse 
or storage.
A change room with showers, washing facilities, and lockers 
that permit separation of street and work clothes should be 
provided.
Workers should be required to shower following a workshift 
and prior to putting on street clothes. Clean work clothes should 
be provided daily.
Skin that becomes contaminated with asbestos should be 
promptly washed with soap and water.
The storage, preparation, dispensing, or consumption of food 
or beverages, the storage or application of cosmetics, the 
storage or smoking of tobacco or other smoking materials, or 
the storage or use of products for chewing should be prohibit­
ed in work areas.
Workers who handle asbestos should wash their feces, hands, 
and forearms thoroughly with soap and water before eating, 
smoking, or using toilet facilities.
COMMON OPERATIONS AND CONTROLS
Common operations in which exposure to asbestos may occur 
and control methods which may be effective in each case are 
listed in Tfcble 2.




During the production of as­
bestos or the manufacture of 
products containing as­
bestos
During the demolition of 
buildings
Process enclosure, wet pro­
cess (when possible), per­
sonal protective equipment
Process enclosure, local ex­
haust ventilation, wet pro­
cess (when possible), 
personal protective equip­
ment
Water spray, personal pro­
tective equipment
EMERGENCY FIRST AID PROCEDURES
In the event of an emergency, remove the victim from further 
exposure, send for medical assistance, and initiate emergen­
cy procedures.
• Eye exposure
Where there is any possibility of a worker’s eyes being exposed 
to asbestos, an eye wash fountain should be provided within 
the immediate work area for emergency use.
If asbestos gets into the eyes, flush diem immediately with large 
amounts of water for 15 minutes, lifting the lower and upper 
lids occasionally. Get medical attention as soon as possible. 
Contact tenses should not be worn when working with this sub­
stance.
• Skin exposure
If asbestos gets on the skin, wash it immediately with soap and 
water.
• Rescue
If a worker has been incapacitated, move the affected worker 
from the hazardous exposure. Put into effect the established 
emergency rescue procedures. Do not become a casualty. Un­
derstand the facility’s emergency rescue procedures and know 
the locations of rescue equipment before the need arises.
SPILLS AND LEAKS
Workers not wearing protective equipment and clothing should 
be restricted from areas of spills or leaks until cleanup has been 
completed.
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If asbestos is spilled or leaked, the following steps should be 
taken:
Asbestos dust may be collected by vacuuming with an appropri­
ate high-efficiency nitration system or by using wet methods 
and placed in an appropriate container.
WASTE REMOVAL AND DISPOSAL
U.S. Environmental Protection Agency, Department of Trans­
portation, and/or state and local regulations shall be followed 
to assure that removal, transport, and disposal are in accord­
ance with existing regulations.
RESPIRATORY PROTECTION
It must be stressed that the use of respirators is the least 
preferred method of controlling worker exposure and should 
not normally be used as the only means of preventing or 
minimizing exposure during routine operations. However, 
there are some exceptions for which respirators may be used 
to control exposure: when engineering and work practice con­
trols are not technically feasible, when engineering controls 
are in die process of being installed, or during emergencies and 
certain maintenance operations including those requiring 
confined-space entry (Table 3).
In addition to respirator selection, a complete respiratory pro­
tection program should be instituted which as a minimum com­
plies with the requirements found in the OSHA Safety and 
Health Standards 29 CFR 1910.134. A respiratory protection 
program should include as a minimum an evaluation of the 
worker’s ability to perform the work while wearing a respira­
tor, the regular training of personnel, fit testing, periodic en­
vironmental monitoring, maintenance, inspection, and 
cleaning. The implementation of an adequate respiratory pro­
tection program, including selection of the correct respirators, 
requires that a knowledgeable person be in charge of the pro­
gram and that the program be evaluated regularly.
Only respirators that have been approved by the Mine Safety 
and Health Administration (MSHA, formerly Mining Enforce­
ment and Safety Administration) and by NIOSH should be 
used. Remember! Air-purifying respirators will not pro­
tect from oxygen-deficient atmospheres.
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Ihble 3.—Respiratory protection for asbestos
Condition Minimum respiratory protection*
Any detectable concentration Any self-contained breathing apparatus with a full facepiece and operated in a pressure-
demand or other positive pressure mode
Any supplied-air respirator with a full facepiece and operated in a pressure-demand or 
other positive pressure mode in combination with an auxiliary self-contained breathing 
apparatus operated in a pressure-demand or other positive pressure mode
Any self-contained breathing apparatus with a full facepiece and operated in a pressure- 
demand or other positive pressure mode
Any supplied-air respirator with a full facepiece and operated in a pressure-demand or 
other positive pressure mode in combination with an auxiliary self-contained breathing 
apparatus operated in a pressure-demand or other positive pressure mode
Any self-contained breathing apparatus with a full facepiece and operated in a pressure- 
demand or other positive pressure mode
Any air-purifying full facepiece respirator with a high-efficiency particulate filter
Any appropriate escape-type self-contained breathing apparatus 
Only NIOSH/MSHA-approved equipment should be used.
Planned or emergency entry into 
environments containing unknown 
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I .  INTRODUCTION
When the asbestos criteria document vas first published in 1972, the 
National Institute for Occupational Safety and Health (NIOSH) recommended a 
standard of 2.0 asbestos fibers/cubic centimeter (cc) of air based on a 
count of fibers greater than 5 micrometers (/an) in length. This standard 
was recouaended with the stated belief that it would "prevent" asbestosis 
and with the open recognition that It would not "prevent" asbestos-induced 
neoplasms. Furthermore, data were presented which supported the fact that 
technology was available to achieve that standard and that the criteria 
would be subject to review and revision as necessary. Since the time that 
the asbestos criteria were published In 1972, sufficient additional data 
regarding asbestos-related disease have been developed to warrant 
réévaluation.
On June 7, 1972, the Occupational Safety and Health Administration
(OSHA) promulgated a standard for occupational exposure to asbestos 
containing an 8-hour time-weighted average (TWA) concentration exposure 
limit of 5 fibers longer than 5 fim/cc of air, with a celling limitation 
against any exposure in excess of 10 such flbers/cc. The standard further 
provided that the 8-hour TWA was to be reduced to 2 flbers/cc on July 1, 
1976.
As the result of a court case, OSHA decided that to achieve the most 
feasible occupational health protection, a reexamination of the standard's 
general premises and general structure was necessary* To this end, on 
October 9, 1975, OSHA announced a proposed rule-making to lower the 
exposure limit to an 8-hour TWA concentration of 0.5 asbestos fibers longer
Chan 5 jim/cc of air with a ceiling concentration of 5 fibers/cc of air 
determined by a sampling period of up to IS minutes. On December 2, 1975,
OSHA requested N10SH to reevaluate the information available on the health 
effects of occupational exposure to asbestos fibers and to advise OSHA on 
the results of this study.
This document contains an updated review of the available information 
on the health effects of exposure to asbestos. In addition, NIOSH's 
proposal for a new numerical exposure limit is included.
* John F. Fink lea, M.D.
Director, National Institute for 
Occupational Safety and Health
V. BASIS FOR THE RECOMMENDED STANDARD
The first modem approach to the setting of an asbestos standard was proposed by 
the British Occupational Hygiene Society (BOHS 1968) in terms of fiber concentration. 
In 1968, a subcommittee of the Society evaluated data on 290 men at work in an 
asbestos factory. These data were provided by company sources. All the men had been 
employed after January 1933, following implementation of dust control measures 
mandated by the Factory Inspectorate in 1931. Estimates of the fiber exposure of these 
workmen were also provided by the company. Of the 290 individuals, 8 were stated to 
have x-ray evidence of asbestos disease and 16 had rales. Noteworthy in the 1968 data 
was the preponderance of individuals who had been employed less than 20 years. Only 
118 of the 290 persons had worked for longer than 20 years and a scant 13 has been 
employed for 30 or more years.
After a review of these data, the BOHS proposed a standard which was adopted 
with minor modifications by the British government in 1969, and implemented in May 
1970. All fibers between 5 and 100 microns in length were counted by light microscopy. 
The standard required no action to be taken below 2 fibers/cc. Between 2 fibers/cc and 
12 fibers/cc, control measures commensurate with the exposure circumstances (time and 
frequency of worker exposure) were prescribed; above 12 fibers/cc, full application of 
control measures, including respiratory protection, was mandatory. The BOHS predicted 
that the risk of being affected, to the extent of having the earliest clinical signs of 
asbestos exposure (rales), would be less than 1% for an accumulated exposure of 100
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fiber-years/cc (2 fibers/cc for 50 years, 4 fibers/cc for 25, etc.). Data (Lewinsohn, 1972) 
from the same factory which formed the basis for the BOHS standard demonstrate that a 
greater prevalence of abnormalities now exist (Table V-l). These data, in addition to 
demonstrating a dose-response relationship for radiographically detected abnormalities 
consistent with asbestosis, further showed a 17% prevalence of abnormal radiographic 
findings (6% consistent with asbestosis) in individuals employed since 1950.
Weill et al (1975), when considering lung function and irregular small opacities, 
reported that there was little evidence of a dose-response relationship below 100 mppcf- 
years. They further concluded that a concentration of 5 fibers/cc could be cautiously 
considered as "safe". Ayer and Berg (1976), however, reported data which suggest that 
the BOHS standard, of an average cumulative exposure of 100 fiber-years/cc, for 
chrysotile asbestos may prevent significant decreases in pulmonary function only when 
combined with periodic spirometry and further reduction of exposure for affected 
workers. Holmes (1973) has since stated that the data upon which the BOHS standard 
was based were inadequate to set a standard to prevent asbestosis. The BOHS- 
recommended standard of 2 fibers/cc was based on data related only to asbestosis and 
the Society clearly cautioned that, since a quantitative relationship between asbestos 
exposure and cancer risk was not known, it was not possible at that time to specify an air 
concentration which was known to be free of increased cancer risk. (BOHS 1968)
Howard et al (1976), in a follow-up examination of the textile workers previously 
studied by Doll (1955) and Knox et al (1965, 1968) for cancer, and by Lewinsohn (1972) 
for asbestosis, reported a statistically significant increase in the risk of developing lung 
cancer (1.8 times the expected) among those first entering scheduled areas from 1933 to
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1950. In the same study, they also reported an excess of deaths due to lung cancer (1.9 
times the expected) after 15 or more years from initial exposure among those who 
started work subsequent to 1950, a period of improved industrial engineering control 
technology and regulation.
In a study of miners exposed to amphibole fibers (amosite) in the cummingtonite- 
grunerite ore series, with airborne concentrations of less than 2.0 fibers/cc (average 
concentration, 0.25 fibers/cc) and 94% of the fibers shorter than 5 fim in length, Gillam 
et al (1976) have demonstrated threefold increases in the risks of mortality from both 
malignant and nonmalignant respiratory diseases.
Newhouse (1969, 1973) and Newhouse et al (1972) have shown that the cancer 
risk to factory workers following mixed exposure to chrysotile, amosite, and croddolite is 
dose-related. The women reported to have heavier exposures (as judged by their 
occupations) showed a sixfold excess of cancer following only 15 years* latency, whereas 
those with moderate or low exposures required 25 years’ latency to demonstrate an 
excess. The rate of mesothelioma increased with both the severity and the length of 
exposure. However, even with as little as two years of asbestos exposure, six 
mesotheliomas occurred among female employees.
McDonald (1973) stated that the risk of developing lung cancer was essentially 
confined to persons with a dust index above 200 mppcf-years, and Enterline et al (1973) 
showed no direct dose-response for respiratory cancer below 125 mppcf-years. In a 
review of these two papers, Schneiderman (1974) concluded that, instead of being 
consistent with a threshold level at which no cancer risk exists, these data did not 
provide evidence for a threshold or for a "safe“ level of exposure. He pointed out that in
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the paper by Enterline et al (1973) there is no dose group for which the Standardized 
Mortality Ratio (SMR) is below 100 (100 = normal), but that the 95% confidence limits 
on the SMR’s included 100 for two of the three dose groups below 125 mppcf-years.
One of the dose groups (25-62.4) had a statistically significant excess mortality from lung 
cancer, whereas for the other two this mortality rate was insignificantly elevated above 
the expected values. Regarding McDonald’s paper, Schneiderman stated that it is hard 
to determine what is excess since no expected numbers for each group were given upon 
which to base this comparison.
Among amosite workers with employment of 3 months or less, Selikoff (1976) 
reported excess cancer risks of 3.87, 1.68, and 1.65 times those expected for cancer of the 
lung, colon and rectum, and all sites, respectively.
Anderson et al (1976) have reported a significant excess of radiographic 
abnormalities of the chest characteristic of asbestos exposure (pleural and/or 
parenchymal) 25-30 years after the onset of household contamination. These 
abnormalities were observed in 35% of 326 otherwise healthy workers who had 
household contacts with amosite asbestos. In addition, four pleural mesotheliomas were 
found in this group.
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VI. THE RECOMMENDED STANDARD
Available studies provide conclusive evidence that exposure to asbestos fibers 
causes cancer and asbestosis in man. Lung cancers and asbestosis have occurred 
following exposure to chrysostile, crocidolite, amosite, and anthophyllite. Mesotheliomas, 
lung and gastrointestinal cancers have been shown to be excessive in occupationally 
exposed persons, while mesotheliomas have developed also in individuals living in the 
neighborhood of asbestos factories and near crocidolite deposits, and in persons living 
with asbestos workers. Asbestosis has been identified among persons living near 
anthophyllite deposits.
likewise, all commercial forms of asbestos are carcinogenic in rats, producing 
lung carcinomas and mesotheliomas following their inhalation, and mesotheliomas after 
intrapleural or ip injection. Mesotheliomas and lung cancers were induced following 
even 1 day’s exposure by inhalation.
The size and shape of the fibers are important factors; fibers less than 0.5 ptm in 
diameter are most active in producing tumors. Other fibers of a similar size, including 
glass fibers, can also produce mesotheliomas following intrapleural or ip injection.
There are data that show that the lower the exposure, the lower the risk of 
developing cancer. Excessive cancer risks have been demonstrated at all fiber 
concentrations studied to date. Evaluation of all available human data provides no 
evidence for a threshold or for a "safe" level of asbestos exposure.
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In view of the above, the standard should be set at the lowest level detectable by 
available analytical techniques, an approach consistent with NIOSH’s most recent 
recommendations for other carcinogens (ie, arsenic and vinyl chloride). Such a standard 
should also prevent the development of asbestosis.
Since phase contrast microscopy is the only generally available and practical 
analytical technique at the present time, this level is defined as 100,000 fibers > 5 fim in 
length/m3 (0.1 fibers/cc), on an 8-hour-TWA basis with peak concentrations not 
exceeding 500,000 fibers >5 /im in length/m3 (0.5 fibers/cc) based on a 15-minute 
sample period. Sampling and analytical techniques should be performed as specified by 
NIOSH publication USPHS/NIOSH Membrane Filter Method for Evaluating Airborne 
Asbestos Fibers - T.R. 84 (1976).
This recommended standard of 100,000 fibers >5 ¡xm in length/m3 is intended to 
(1) protect against the noncarcinogenic effects of asbestos, (2) materially reduce the risk 
of asbestos-induced cancer (only a ban can assure protection against carcinogenic effects 
of asbestos) and (3) be measured by techniques that are valid, reproducible, and 
available to industry and official agencies.
However, some difficulties arise in that specific work practices and innovative 
engineering control or process changes are needed. But because of the well-documented 
human carcinogenicity from all forms of asbestos, these difficulties should not be cited as 
cause for permitting continued exposure to asbestos at concentrations above 100,000 
fibers >5 fim in length/m3.
19
This standard was not designed for the population-at-large, and any extrapolation 
beyond general occupational exposures is not warranted. The standard was designed 
only for the processing, manufacturing, and use of asbestos and asbestos-containing 
products as applicable under the Occupational Safety and Health Act of 1970.
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MEMORANDUM FOR: Dr. Eula Bingham
Assistant Secretary for 
Occupational Safety and Health
Dr. Anthony Robbins 
Director, National Institute for 
Occupational Safety and Health
Asbestos Work Group
The Updated Scientific 
Information on Asbestos and 
Recommended Occupational 
Standard for Asbestos Exposure
In the fall of 1979, a NIOSH/OSHA committee was formed 
at the direction of Dr. Eula Bingham, Assistant Secretary of 
Labor for Occupational Safety and Health, and Dr. Anthony 
Robbins, Director of the National Institute for Occupational 
Safety and Health (NIOSH), to review the scientific informa­
tion concerning asbestos-related disease and assess the adequa­
cy of the current OSHA occupational health standard of 
* 2,000,000 fibers per cubic meter greater than 5 jun in length 
(2Mf/m3). Since the 1972 promulgation of this 2,000,000 f/m3 
standard, OSHA, in 1975, proposed lowering the standard to
500,000 f/m3; NIOSH, in 1976, recommended lowering the stan­
dard to 100,000 f/m3; and the British Advisory Committee on 
Asbestos, in 1979, recommended lowering its occupational ex­
posure standards. The NIOSH/OSHA committee has reviewed 
the most recent scientific information, including documents 
concerning the above developments and the 1977 International 
Agency for Research on Cancer (IARC) review of the carcino­
genicity hazards of asbestos, and presents the following major 
conclusions and recommendations. A detailed updating of sig­
nificant scientific literature since the 1976 NIOSH Criteria 
Document and the 1977 IARC Monograph is attached.
*Effective January 19» 1989, the OSHA Permissible 
Exposure Limit (PEL) was changed to 0.2 f/cc. 
Federal Register, Vol. 54, No. 12, pp. 2332-2983.
FROM:
SUBJECT:
1. Definition o f Asbestos. Having considered the many factors 
involved in specifying which substances should be regulated as 
asbestos, the committee recommends the following definition:
Asbestos is defined to be chrysotile, cro- 
cidolite, and fibrous cummingtonite-grun- 
erite including amosite, fibrous tremolite, 
fibrous actinolite, and fibrous anthophyl- 
lite. The fibrosity of the above minerals is 
ascertained on a microscopic level with fi­
bers defined to be particles with an aspect 
ratio of 3 to 1 or larger.
2. Sampling and Analysis o f A irbome Asbestos. The committee 
concludes that the membrane filter-phase contrast microscopy 
method represents the only technique available that can rea­
sonably be used for routine monitoring of occupational ex­
posures and sampling for compliance purposes. However, the 
committee recognizes the lack of specificity of this method for 
fiber identification» and recommends the use of supplementary 
methods such as electron microscopy for fiber identification in 
cases of mixed fiber exposures. In recommending the primary 
use of light microscopy, the committee also wants to stress the 
inability of this method to detect short asbestos fibers to which 
workers are exposed. The toxicity of asbestos fibers shorter 
than the 5-micrometer detection limit of light microscopy can­
not be dismissed on the basis of current scientific information.
3. Biologic Effects o f Exposure to Asbestos. Animal studies 
demonstrate that all commercial forms and several non­
commercial forms of asbestos produce pulmonary fibrosis, 
mesothelioma, and lung neoplasms. Chrysotile is as likely as 
crocidolite and other amphiboles to induce mesotheliomas after 
intrapleural injection, and also as likely to induce lung neo­
plasms after inhalation exposures.
Human occupational exposures to all commercial asbestos 
fiber types, both individually and in various combinations, 
have been associated with high rates of asbestosis, lung cancer, 
and mesothelioma. While significant excesses of cancer of 
several other sites have been observed in exposed workers, 
presently available information is insufficient to determine the 
role of specific fiber types.
On the basis of available information, the committee con­
cludes that there is no scientific basis for differentiating be­
tween asbestos fiber types for regulatory purposes. Accordingly, 
the committee recommends that a single occupational health 
standard be established and applied to all asbestos fiber types.
Available data show that the lower the exposure, the lower 
the risk of developing asbestosis and cancer. Excessive cancer 
risks, however, have been demonstrated at all fiber concentra­
tions studied to date. Evaluation of all available human data 
provides no evidence for a threshold or for a "safe” level of 
asbestos exposure. Accordingly, the committee recommends 
that, to the extent uses of asbestos cannot be eliminated or less 
toxic materials substituted for asbestos, worker exposures to 
asbestos must be controlled to the maximum extent possible.
4. Inadequacy o f Current 2,000,000’Fiber Occupational Stan­
dard. The committee concluded that a variety of factors demon­
strates that the current 2,000,000-fiber standard is grossly in­
adequate to protect American workers from asbestos-related 
disease. First, the 2,000,000-fiber standard was designed in 
1969 by the British Occupational Hygiene Society (BOHS) for 
the limited purpose of minimizing asbestosis. Disease preva­
lence data from the BOHS study population collected subse­
quent to 1969 strongly suggest that this standard is insufficient 
to prevent a large incidence of asbestosis. Second, all levels of 
asbestos exposure studied to date have demonstrated asbestos- 
related disease, and a linear relationship appears to best de­
scribe the shape of the dose-response curve. These considera­
tions led the committee to conclude that there is no level of 
exposure below which clinical effects do not occur. Third, the 
absence of a threshold is further indicated by the dramatic 
evidence of asbestos-related disease in members of asbestos- 
worker households and in persons living near asbestos-con- 
taminated areas. These household and community contacts 
involved low level and/or intermittent casual exposure to as­
bestos. Studies of duration of exposure suggest that even at 
very short exposure periods (1 day to 3 months) significant 
disease can occur.
Although various models can be and have been fashioned 
to postulate possible dose-response relationships involving as­
bestos, the committee believes that the limited current data 
preclude the creation of any one empirical curve to describe the 
exact dose-response relationship. Over the last three decades, 
measurement techniques for asbestos have changed in several 
crucial respects, and there have been no suitable methods avail­
able to date to compare the results of prior techniques to current 
methods.
In addition, no adequate epidemiological information is 
available on the disease experience of workers exposed below 
the current standard and followed for a sufficient period to 
identify long latent effects. Consequently, the committee can­
not present a precise dose-response relationship for the variety 
of asbestos-related diseases. However, the committee firmly be­
lieves that compelling evidence demonstrates that prevention 
of asbestos-related diseases requires that an occupational stan­
dard minimize all asbestos exposures, and definitely be set far 
below the current 2,000,000-fiber standard.
5. Recommended Occupational Standard for Asbestos Expo­
sure. Given the inadequacy of the current 2,000,000-fiber stan­
dard, the committee urges that a new occupational standard be 
promulgated which is designed to eliminate non-essential as­
bestos exposures, and which requires the substitution of less 
hazardous and suitable alternatives where they exist. Where 
asbestos exposures cannot be eliminated, they must be con­
trolled to the lowest level possible. A significant consideration 
in establishing a permissible exposure limit should be the low­
est level of exposure detectable using currently available ana­
lytical techniques. At present this level would be 100,000 fibers 
greater than 5 p.m in length per cubic meter averaged over an 
8-hour workday. Regardless of the choice of a permissible ex­
posure limit, the best engineering controls and work practices 
should be instituted, and protective clothing and hygiene facil­
ities should be provided and their use required of all workers 
exposed to asbestos. Respirators are not a suitable substitute 
for these control measures. The committee also reiterates its 
judgment that even where exposure is controlled to levels below
100,000 fibers, there is no scientific basis for concluding that all 
asbestos-related cancers would be prevented.
6. Medical Surveillance Program. Appropriate medical surveil­
lance is crucial to detect and minimize the progression of some 
asbestos-related diseases. Considerable emphasis should be 
placed on baseline medical examinations for all workers poten­
tially exposed or who have been exposed to asbestos at any 
level. These examinations should include the following: (1) a 
14" x 17" postero-anterior chest X-ray; (2) spirometry including 
forced vital capacity (FVC) and forced expiratory volume in one 
second (FEVO; (3) a physical examination of the chest includ­
ing auscultation for the presence or absence of rales, rhonchi,
and wheezing; (4) an assessment of the presence or absence of 
finger clubbing; and (5) a history of respiratory symptoms and 
conditions including tobacco smoking.
An occupational history should include a history of expo­
sure to asbestos and exposure to other substances of real or 
potential medical significance. Performance criteria for these 
procedures, including the periodicity of subsequent medical 
surveillance, should be developed by NIOSH in consultation 
with OSHA and professional societies and organizations con­
cerned with the diagnosis and prevention of respiratory dis­
eases. The committee does not recommend comprehensive an­
nual medical examinations as presently required. Sputum cy­
tology should be evaluated in the development of an improved 
medical surveillance program. The committee believes that 
sputum cytology may prove to be a valuable supplement to 
X-ray evaluation.
It is also crucial that all required medical surveillance be 
promptly evaluated and the results reported to the employee. 
Furthermore, the standard should provide for periodic report­
ing of aggregate medical information concerning an employer's 
entire workforce. Results at a minimum should be displayed in 
a non-identifiable, aggregate format so that the employer, em­
ployees, and OSHA can see the prevalence of abnormalities 
possibly associated with asbestos-related disease, and also see 
how this prevalence has changed over time.
The committee recognizes that OSHA's recent lead stan­
dard contains a multiple physician review mechanism whereby 
workers can get independent medical evaluations by physicians 
of their choice. The lead standard also contains a medical re­
moval protection program whereby workers can obtain special 
health protection where necessary, accompanied by appropriate 
economic protection. The committee feels that these programs 
are relevant to asbestos workers and should be considered as 
part of a new occupational asbestos standard.
Medical records generated due to the standard's medical 
surveillance program should be maintained for at least 40 years 
or for 20 years after termination of employment, whichever is 
longer.
7. Other Recommendations. The committee further recom­
mends the following: (1) Due to the widespread current and past 
uses of asbestos products in the maritime and construction in­
dustries, it is vital that any new asbestos standard address 
these industry sectors as well as other workplaces with employ­
ees exposed to asbestos. Regulation of these industries should 
be structured around the principle that where work must be 
done using asbestos, only those employees needed to do this 
work should be present, and only for the minimum period of 
time needed to complete this work.
(2) Due to the sampling and analytical difficulties concern­
ing asbestos, manufacturers of asbestos-containing products 
such as construction materials should perform detailed moni­
toring of exposures which could result from all foreseeable uses 
of their products, including misuse. This monitoring should 
include electron microscopy to identify fiber type mix and ex­
posures to fibers less than 5 jim in length. This monitoring data 
should accompany these products downstream so the users not 
only know that asbestos exposures may occur, but also know 
the nature of potential exposures. This monitoring data could, 
if appropriate, avoid the need for small employers who use 
asbestos-containing products to have to conduct monitoring on 
their own.
(3) Due to the fact that other agencies regulate occupa­
tional exposures to asbestos (such as the Mine Safety and 
Health Administration), these agencies should be urged to 
participate in the development of a new standard and adopt 
this new standard.
(4) Because cigarette smoking enhances the carcinogenic 
effect of asbestos exposure on the lung, particular emphasis 
should be placed on this in any educational program developed 
under a new standard.
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INTRODUCTION
Occupational exposure to asbestos minerals 
constitutes a major health hazard in the United 
States and in most industrialized nations of the 
world. Because of their unique properties such 
as resistance to heat and chemical attack, asbes­
tos minerals have long been used by man. Fin­
nish potters are known to have used soils con­
taining anthophyllite asbestos dating from 2500
B.C. (103). Use of asbestos in lamp wick was 
described by Theophrastus, Strabo, and Plutarch. 
Herodotus (456 B.C.) described cremation clothes 
made of woven asbestos. Marco Polo described 
tablecloths of asbestos seen during his journeys 
(66).
Despite early uses, large scale use of asbes­
tos came with industrialization and particularly 
the steam engine which required heat resistant 
materials for packings and seals. The first as­
bestos textile mill in the United States began pro­
duction in about 1896. Today, commercial uses 
of asbestos are countless and nearly every manu­
facturing sector may be involved with produc­
tion or use of asbestos-containing products.
The term “asbestos” is applied to a group 
of naturally occurring fibrous silicate minerals. 
Although many minerals are fibrous in nature, 
only six are regulated by Occupational Safety and 
Health Administration (OSHA) standards. These 
minerals fall into two major mineralogical sub­
divisions: chrysotile, which belongs to 
the serpentines; and the amphiboles, including 
crocidolite, asbestiform actinolite, asbestiform 
tremolite, amosite, and anthophyllite. Only am­
osite, chrysotile, and crocidolite are of economic 
importance. Chrysotile is basically a sheet silicate 
mineral rolled into itself to form a hollow tube. 
This tube constitutes the basic fibril of chrysotile.
All amphibole asbestos types are similar in crys­
tal structure: they consist of double chains of 
linked silicon oxygen tetrahedra between which 
metallic ions are sandwiched (128). Chemical 
composition and trace metal contamination (Cr, 
Co, Mn, Ni associated with chrysotile) of as­
bestos fibers may vary considerably between 
deposits from different mining regions (43).
More than 90% of all asbestos used in the 
United States is of the chrysotile variety. Total 
U.S. consumption of asbestos in 1977 was
610,000 metric tons, down from peak comsump- 
tion of 795,000 metric tons in 1973 (12). By con­
trast, only 93,000 metric tons were produced in 
U.S. mines and mills; Canada furnished 95 Vo of 
all imported raw asbestos fiber. U.S. asbestos 
consumption by end use for 1978 is shown in 
Table II-9. Asbestos cement products constitute 
the major use of asbestos followed closely by 
floor products or materials used in the construc­
tion industry. Materials containing asbestos have 
been extensively used in construction and ship­
building for purposes of fireproofing and for 
decoration. These have often been applied by 
spray application.
DEFINITION
Asbestosis is the name of the pneumo­
coniosis produced by the inhalation of asbestos 
fibers. It is characterized by diffuse interstitial 
fibrosis of the lung parenchyma, often accom­
panied by thickening of the visceral pleura and 
sometimes calcification of the pleura. Clinical 
findings include dyspnea on exertion, non-pro­
ductive cough, rales at the lung bases, bronchi, 
and in advanced cases, finger clubbing. Lung 
function measurements usually demonstrate a 
restrictive impairment with reduced diffusing 
capacity.
Table II-9
U.S. ESTIMATED ASBESTOS CONSUMPTION IN 1978 BY END USE CATEGORY
Product
Consumption (Metric Tons)
Chrysotile Crocidolite Amosite Anthophyllite
Asbestos cement pipe 119,800 23,300 2,700
Asbestos cement sheet 28,400 800
Flooring products 122,400
Roofing products 58,200 100
Packing and Gaskets 23,200 100
Thermal insulation 14,300
Electrical insulation 3,200
Friction products 81,000 600





Total 552,100 24,700 3,500 2,700
Source: (12)
CAUSATIVE AGENTS
Asbestosis is perhaps the most widely stud- 
ied of the known occupational hazards; however, 
its mechanisms are still not fully understood. 
Both clinical and epidemiological data have con­
clusively shown that asbestos is associated with 
asbestosis and respiratory cancer in man. Animal 
bioassay data fully support these findings and 
suggest that pathological responses to asbestos 
may be more related to physical characteristics 
of the fibers than to chemical composition. 
Animal data have shown a wide variety of fibrous 
minerals and small diameter glass fibers to be 
capable of producing tumors upon pleural injec­
tion or implantation (110X111X139). Interstitial 
fibrosis has also been produced in animals in- 
tratracheally injected with small diameter glass 
fibers (63).
POPULATION AT RISK
Asbestos has over 3,000 commercial uses 
and is ubiquitous in the general environment. 
Because of the mineral's resistance to thermal 
and chemical degradation, exposures may take 
place starting from initial mining of the fibers 
through manufacture, use, and eventual burial 
of asbestos containing waste.
Mining and milling of asbestos in the United 
States is not extensive: fewer than a thousand 
workers are employed (148). However, amphibole
minerals and, to a lesser extent, serpentines, are 
sometimes found as contaminants of other types 
of ore bodies, such as talc, vermiculite, crushed 
stone aggregates, and in ores from various metal 
mining operations (19X64X115) (140). There have 
been no systematic studies of mining operations 
in the United States to identify specific ores con­
taining asbestos as contaminants and the degree 
to which workers are exposed.
Estimates of the number of workers exposed 
to asbestos in primary manufacturing of asbestos 
products are given in Table 11-10. In the primary 
manufacturing sector approximately 18,000 work­
ers are estimated to be potentially exposed; how­
ever, this number could be as high as 37,000 (17). 
A large variety of asbestos products and materials 
produced in primary manufacturing are fabricated 
and processed with other materials in secondary 
industries to produce the more than 3,000 end prod­
ucts containing asbestos. The secondary fabrica­
tion and processing industry is very large and has 
been estimated to employ more than 300,000 work­
ers (17).
By far the largest number of workers with 
potential asbestos exposures may be found in in­
dustries which utilize asbestos products such as 
the construction industry, the automobile ser­
vicing industry (including remanufacturing of
32
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Manufacturing Sector Exposed Workers
Asbestos cement pipe 1,755
Asbestos cement sheet 980
Friction materials 5,605
Floor coverings 3,500
Asbestos paper products 2,120
Packing and gaskets 1,125




asbestos containing parts), and the shipbuilding 
and repair industry. In the construction industry, 
including those doing demolition and repair, an 
estimated 180,000 to 408,000 workers are poten­
tially exposed to asbestos. The automobile serv­
icing industry includes brake and clutch servicing 
garages, rebuilding and refacing friction com­
ponents, and repackaging of friction products. 
Within this sector, 2 million workers are poten­
tially exposed to asbestos (17). Approximately 
3,800 workers are potentially exposed to asbestos 
in shipbuilding and repair.
A total of 2.3 to 2.5 million workers are 
estimated to be currently (potentially) exposed 
to asbestos. However, because of the long laten­
cy (20 to 30 years) required before asbestos re­
lated diseases become clinically manifest, past 
asbestos workers must also be considered at risk. 
These estimates are especially difficult to develop 
and are subject to controversy (29). Nonetheless, 
large numbers of previous asbestos workers are 
now completing their latency period and are at 




The first well documented case of asbestosis 
was reported by H. Montague Murray in 1906, 
although there were several anecdotal reports 
prior to this time (66)(95). Murray documented
a case of pulmonary fibrosis at autopsy in a 
worker engaged in the production of asbestos 
textiles. This worker reported that he was the sole 
survivor of 10 men who started with him in the 
carding room; the others had died.
Following the report by Murray, Pancoast 
et al. (1917) reported 17 cases of pulmonary Fi­
brosis in a Pennsylvania plant (105). In 1924, 
Cooke published another detailed autopsy report 
of a 33-year-old woman suffering from asbestosis 
(14). Necropsy findings included pulmonary fi­
brosis, pleural thickening, pleural calcification, 
and heart enlargement. Further cases were report­
ed by Mills in 1930, Donnelly (1933), Lynch and 
Smith (1931), Seiler and Gilmour (1931), Wood 
and Gloyne (1930), Oliver (1927), Simson (1928), 
Stewart (1928), and Pancoast and Pendergrass 
(1926) (21)(70)(88)(104)(106)(120)(134)(141)(164). 
By 1930, more than 75 asbestosis cases had been 
reported in the literature.
Early case reports stimulated concern and 
in 1928 the first detailed epidemiologic study of 
asbestos workers was undertaken by the Ministry 
of Labour in Great Britain. Results were pub­
lished by Merewether and Price in 1930 (84). This 
was a cross-sectional chest x-ray study of 363 
workers engaged in production of asbestos tex­
tiles. Of this group, 95 (26.2%) were found to 
have pulmonary fibrosis and the prevalence of 
fibrosis with 20 or more years employment was 
over 80%.
In the United States, Donnelly (1936) report­
ed a cross-sectional chest x-ray study of 151 
asbestos workers which found a pulmonary fi­
brosis prevalence of 59% among workers em­
ployed 4 years of more (22). Schull (1936) report­
ed chest x-ray studies of 100 workers dismissed 
from North Carolina asbestos plants due to dis­
ability and found a 55% prevalence of moderate 
or advanced asbestosis (131).
In 1937 the U.S. Public Health Service 
undertook the first detailed epidemiologic study 
of asbestos workers in the United States with 
results published by Dreessen et al. in 1938 (23). 
A total of 511 employees were studied in this 
cross-sectional study and worker exposures were 
estimated by the impinger method. A relation­
ship was found between extent of asbestos ex­
posure and clinical symptoms of asbestosis al­
though many workers had only short periods of 
exposure at the time of the study. This study re­
sulted in a recommended occupational exposure
limit of 5 million particles per cubic foot of air 
(mppcf) in the United States.
Lung Cancer and Mesothelioma
The first indication that asbestos might be 
a human carcinogen came in 1935. Lynch and 
Smith (in the United States) and Gloyne (in 
England) independently reported three cases of 
lung cancer detected during autopsy studies of 
asbestos workers (34)(71). All three workers had 
died of asbestosis. Other case reports followed 
by Egbert and Geiger in 1936, Gloyne in 1936, 
and Nordmann in 1938 (26X33X102). In the 1947 
annual report of the Chief Inspector of Factories 
in England, Merewether stated that of 365 
asbestosis deaths, 65 (17.8%) also had cancer of 
the lung at autopsy (83). This compared to a 
prevalence of lung cancer of only 1.3% for cases 
certified at death as having silicosis.
Despite early suggestions, the first detailed 
epidemiologic study to conclusively demonstrate 
an association between asbestos exposure and 
lung cancer was not published until 1955 by Doll 
(20). Doll studied the mortality experience of a 
cohort of 113 asbestos textile workers employed 
more than 20 years. Among this group, 11 lung 
cancer deaths were observed compared to only 
0.8 expected—based on the mortality experience 
of England and Wales.
Asbestos exposure is associated with meso- 
thelial tumors of pleural and peritoneal tissues. 
Lee and Selikoff have reviewed early reports 
associating asbestos exposures and mesothelioma 
(66). The first cases were reported in 1946 by 
Wyers (165). However, conclusive evidence of 
an association between asbestos exposure and 
mesothelioma was not available until 1960 when 
Wagner et al. reported 33 pleural mesotheliomas 
in the crocidolite mining area of South Africa 
(152).
Mortality
Epidemiologic studies have repeatedly dem­
onstrated an association between asbestos expo­
sure and increased mortality due to asbestosis, 
lung cancer, pleural and peritoneal mesothelioma, 
and gastrointestinal cancer. In some studies, 
asbestos exposure has also been associated with 
increased risks for laryngeal cancer and cancer 
of the buccal cavity and pharynx. Table 11-11 con­
tains a brief summary of important mortality 
studies and significant findings. In this section, 
mortality studies are reviewed with emphasis on
asbestosis and lung cancer risk differences by 
fiber type, industry, and smoking patterns.
Mixed Fiber Exposures
In most plants processing asbestos, several 
different types of asbestos may be used or have 
been used in the past. Typically, chrysotile and 
one or more amphiboles are used.
Asbestos insulation workers have been ex­
tensively studied in the United States and other 
countries. Selikoff et al. studied the mortality ex­
perience of 632 insulation workers followed be­
tween 1943 and 1962 and observed 45 lung can­
cer deaths whereas only 6.6 were expected (123). 
Of the 255 deaths in this cohort, 28 (11%) were 
due to asbestosis and 3 (1.2%) to mesothelioma. 
An SMR of 309 was observed for cancer of the 
stomach, colon, and rectum (although it was 
based on a small number of observed cases).
A much larger cohort of 17,800 insulation 
workers was followed by Selikoff et al. between 
1967 and 1976 (126X127). Among this cohort, 
2,271 deaths were observed including 429 lung 
cancers (SMR-406), 78 asbestosis deaths, and 
49 deaths due to mesotheliomas. Significant in­
creased mortality was also observed for cancers 
of the esophagus, stomach, colon-rectum, lar­
ynx, buccal cavity and pharynx, and kidney. 
Only 2 of the 78 asbestosis deaths occurred prior 
to 20 years from onset of employment, based on 
death certificate information. Review of all 
available autopsy, surgical, and clinical material 
indicated an additional 90 deaths were due to 
asbestosis, 57 to lung cancer, and 126 to meso­
thelioma.
Elmes and Simpson studied the mortality 
of 162 insulation workers in Belfast between 
1940 and 1975 (27)(28). Among this cohort, 122 
deaths were observed including 16 (13.1%) due 
to asbestosis and 13 (10.7%) to mesothelioma. 
A large excess due to respiratory cancer was 
observed.
There are several important studies of mor­
tality among textile workers exposed to mixed 
asbestos types. In an early study in the United 
States published in 1963, Man cuso and Coulter 
observed more than a threefold excess risk of 
lung cancer among workers producing textile and 
friction products (73). Fourteen percent of 195 
deaths were due to asbestosis and 2 (1%) were 
due to mesotheliomas.
Mortality among employees in the plant in­
itially studied by Doll in 1955 has been in-
Table 11-11
SUMMARY OF MORTALITY STUDIES OF ASBESTOS EXPOSED POPULATIONS
Author(s) Date Study Population Fiber Type Study Design Summary of Important Findings
Doll 1955 113 textile 
workers employed 
20 or more years
Mixed Retrospective cohort 
1922-1953
11 lung cancers observed versus 
0.8 expected, 14 death certificates 
mentioned asbestosis.
Mancuso and Coulter 1963 1,495 workers 
producing textile, 
friction products
Mostly chrysotile Retrospective cohort, 
1940-1960
28 asbestosis deaths, 19 lung 
cancers observed versus 5.6 
expected, 5 peritoneal neoplasms 
(2 were mesotheliomas).
Selikoff, Churg and 
Hammond
1964 632 insulation 
workers with 
20 or more years 
employment
Mixed Retrospective cohort, 
1943-1962
12 asbestosis deaths, 45 lung 
cancers observed versus 6.6 
expected. Increased gastro­
intestinal cancer, 3 pleural 
mesotheliomas.




Mixed Retrospective cohort, 
1922-1966
27 lung cancers observed versus 
10.75 expected, 42 with asbestosis 
on death certificate. Authors 
suggested reduced risks after con­





Mixed Retrospective cohort, 
1933-1968
Significant excesses for lung 
cancer among workers in highest 
exposure category; 24 meso­
theliomas among males.




Mixed Retrospective cohort, 
1942-1968
14 lung cancers observed versus 
0.5 expected in those working 2 
years in highest exposure jobs. 
Approximately threefold excess of 
respiratory disease mortality in 





SUMMARY OF MORTALITY STUDIES OF ASBESTOS EXPOSED POPULATIONS (Continued)
Author(s) Date Study Population Fiber Type Study Design Summary of Important Findings
Selikoff, Hammond 
and Churg




Mixed Retrospective cohort, 
1963-1967
Observed strong interactive effect 
between asbestos exposure and 
smoking for lung cancer; 10 
mesothelioma deaths observed 
and 15 asbestosis deaths.




Mixed Retrospective cohort, 
1940-1975
16 asbestosis deaths, 13 meso­
theliomas. Large excess risk for 
respiratory cancer throughout 
follow-up period.







Chrysotile Retrospective cohort, 
1926-1975
Among those achieving >20 years 
latency, overall lung cancer 
SMR = 125, with 42 pneumo­
coniosis deaths and 11 mesotheli­
oma deaths. Linear dose-response 













Lung cancer SMR = 270; 19 
asbestos deaths. Linear dose- 
response observed for lung cancer 
with SMR = 198 at 62 mppcf-yrs. 
and SMR = 778 at 976 mppcf- 
yrs.; 2 mesothelioma deaths.




Mixed Retrospective cohort, 
1967-1976
429 lung cancers observed versus 
105.6 expected; 78 asbestosis 
deaths and 49 mesotheliomas.
Meurman et al. 1974 1,092 asbestos 
mine and mill 
workers
Anthophyllite Retrospective cohort, 
1936-1974
21 lung cancers observed versus 
13 expected; 13 asbestosis deaths 
but no mesotheliomas. A strong 
interactive effect on lung cancer 
with smoking and asbestos ex­
posure was observed.
Table IM1
SUMMARY OF MORTALITY STUDIES OF ASBESTOS EXPOSED POPULATIONS (Continued)
Authors) Date Study Population Fiber Type Study Design Summary of Important Findings





Mixed Retrospective cohort 36 respiratory cancers observed 
versus 19.3 expected among those 
only employed in controlled 
areas. Significant excess of non- 
malignant respiratory diseases.
Weiss 1977 264 paper and 
millboard workers
Chrysotile Retrospective cohort, 
1945-1974
2 asbestosis deaths among a total 
of 66 deaths. No excess of lung 
cancer but numbers were small; 
no mesotheliomas reported.
Jones et al. 1976,
1979
1,088 gas mask 
workers during 
WW II
Crocidolite Retrospective cohort, 
1939-1976
12 lung cancers observed versus 
6.3 expected in women; 17 meso­
thelioma deaths. Linear dose- 
response for mesothelioma with 
employment duration; 3 
mesotheliomas observed among 






Mixed Prospective follow-up 
1968-1974
19 broncogenic cancers observed 
versus 4.0 expected; 23 meso­
theliomas observed. Shipyard 
workers with plaques had 2.5 
times lung cancer risk when com­
pared to matched controls with­
out plaques.







23 lung cancers observed versus 
9.3 expected among those with 
cumulative fiber exposures>100 
mppef/yr.; 2 pleural meso­
theliomas observed versus 4.4 ex­
pected among those not exposed 
to crocidolite.
Table 11-11
SUMMARY OF MORTALITY STUDIES OF ASBESTOS EXPOSED POPULATIONS (Continued)
Authors) Date Study Population Fiber Type Study Design Summary of Important Findings




Mixed Prospective follow-up 
1967-1976
6 mesothelioma deaths among 
those with plaques and 2 with 
only pleural fibrosis. Author sug­
gested pleural plaques are of 
greater biological significance 




1979 820 men producing 
insulation between 
1941-1945
Amosite Retrospective cohort, 
1961-1975
83 lung cancers observed versus 
23.9 expected. Among 61 men 
employed<l month, 3 lung 
cancers observed versus 1.3 ex­
pected. 4 mesotheliomas by death 
certificate diagnosis but an addi­
tional 10 identified using necropsy 
data. 15 deaths observed due to 
asbestosis.




Mixed Retrospective cohort, 
1967-1976
Asbestos workers who did not 
smoke had a fivefold risk of lung 
cancer compared to nonsmoking 
controls. Smoking asbestos work­
ers had 53 times the lung cancer 
risk of nonasbestos exposed per­
sons who also did not smoke.
Robinson, Lemen 
and Wagner
1979 3,276 workers 
producing textile, 
friction products
Mostly chrysotile Retrospective cohort, 
1940-1975
Overall lung cancer SMR -  136 
for males and 824 among females. 
Some increasing trends in lung 
cancer with employment duration. 
Large excesses due to asbestosis.
17 mesothelioma deaths observed.
Table 11-11
SUMMARY OF MORTALITY STUDIES OF ASBESTOS EXPOSED POPULATIONS (Continued)
Authors) Date Study Population Fiber Type Study Design Summary of Important Findings
Nicholson et al. 1979 544 chrysotile 
miners and millers, 
>20 years 
employment
Chrysotile Retrospective cohort» 
1961-1977
28 lung cancers observed versus 
11.1 expected; 26 cases of asbes­
tosis observed; 1 pleural meso­
thelioma observed.
Dement et al. 1980 768 textile 
workers
Chrysotile Retrospective cohort, 
1940-1975
26 lung cancers observed versus 
7.47 expected; 15 asbestosis 
deaths and 1 mesothelioma death. 
Linear dose-response for lung 
cancer with SMR = 223 at cumula 
tive exposures <30 fiber/cc x yrs.
Brown» Dement, 
and Wagoner






9 lung cancers observed versus 3.3 
expected. Significant excess due to 
nonmalignant respiratory diseases; 
1 mesothelioma death.
VO
vestigated by Knox et al. (59)(60), and more 
recently by Peto et al. (108)(109). Peto studied 
1,106 men and women who had worked 20 or 
more years in asbestos exposed areas. Among 
those who were first employed after 1933 (when 
control regulations were enacted), 31 lung can­
cer deaths were observed whereas 19.3 were ex« 
pected. Additionally, 35 deaths were observed 
due to nonmalignant respiratory disease versus 
25 expected, and there were 5 deaths due to 
pleural mesothelioma. Dust exposures in this 
plant were reported to be generally above 5 
fiber/cc until about 1970.
Newhouse (96X97) and New house et al. (98) 
have studied patterns of mortality among 4,600 
male and 922 female workers in a plant which 
chiefly produced asbestos textiles but later as­
bestos insulation products. Exposures were clas­
sified as low to moderate (5-10 fibers/cc) and 
severe (>10 fibers/cc). Among males, there were 
46 mesothelial tumors and an SMR for lung 
cancer of 538 was observed for those employed 
more than ten years in the severe exposure group. 
In those with lowest exposure, a lung cancer SMR 
of 154 was observed. Deaths from chronic 
respiratory diseases were 1.8 times expected in the 
highest exposure group. A remarkable cancer 
SMR was observed among females in the highest 
exposure group (21 observed versus 0.8 expected). 
Both males and females were found to have 
smoked more than the comparison population; 
however, this could only account for 10°7o to 20% 
of the observed excess lung cancer mortality.
The asbestos cement product industry is one 
of the largest consumers of asbestos in the 
United States. In addition to their asbestos ex­
posure, workers in this industry may also be ex­
posed to low levels of crystalline silica and other 
materials associated with cement dust. Weill et 
al. reported mortality patterns among 5,645 
asbestos cement product workers with a mini­
mum of 20 years since initial employment (156). 
Exposures for the cohort were estimated and ex­
pressed as mppcf x yrs. Among those exposed 
to greater than 100 mppcf x yrs., 23 lung can­
cers were observed versus 9.3 expected. No ex­
cess lung cancer risk was reported among those 
with cumulative exposures less than 100 mppcf 
x yrs. Two pleural mesothelioma deaths were 
observed. Weill et al. reported that exposure to 
crocidolite in addition to the (predominant)
chrysotile used in cement products increased the 
lung cancer risk in comparison to chrysotile ex­
posure alone. The unusually low SMRs for all 
causes regardless of exposure category suggest 
that cohort follow-up and death certificate ascer­
tainment was less complete than desired.
Crocidolite
Wagner et al., in 1960, reported 33 pleural 
mesotheliomas among men working in crocido­
lite mines and mills and the population living in 
the vicinity of these mills in the Northwest Cape 
Province of South Africa (152). The high in­
cidence of mesotheliomas in this area has been 
confirmed by other investigations (13)(39)(155).
Crocidolite was commonly used in the pro­
duction of gas mask canisters during World War 
II and mortality among these workers has been 
investigated. Jones et al. studied the mortality 
of 1,088 workers exposed between 1940 and 1945 
and followed through 1976 (46)(47). Twenty-two 
pleural and 7 peritoneal mesotheliomas were ob­
served and a linear relationship was observed bet­
ween employment duration and the risk of 
mesothelioma. There was also a modest excess 
of bronchial carcinoma. Similar results have been 
reported by McDonald and McDonald who 
studied a smaller cohort of gas mask workers in 
Canada and found that 7% of all deaths were 
due to mesotheliomas (75).
Amosite
Mortality patterns among a cohort of 
workers producing amosite asbestos insulation 
between 1941 and 1945 have been reported by 
Selikoff et al. (125) and more recently by Seid- 
man et al. (118X119). This group of 820 men were 
observed over a 35 year period during which 528 
deaths occurred: by death certificate information 
15 (2.8%) were due to asbestosis and 1 was due 
to mesothelioma. Review of available surgical, 
pathological, and clinical data for this group 
identified 13 additional mesotheliomas and 15 
additional cases of asbestosis not listed on death 
certificates. Overall there were 83 lung cancers 
observed whereas 23.1 were expected and among 
those employed less than one month, 3 lung 
cancers were observed versus 1.3 expected. 
Anderson et al. have observed four confirmed 
cases of mesothelioma among household con­
tacts of workers at this plant (1).
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AnthophyHite and Tremolite
The only location in the world where an- 
thophyllite has been commercially mined and 
processed is Finland. These ores are also known 
to contain smaller quantities of tremolite. Mor­
tality among workers in two Finnish mines and 
mills has been studied by Meurman et al. (86) 
(87). In their first report, 1,092 workers were 
followed from 1936 until 1974. A relative risk 
for lung cancer of 1.6 was observed and there 
were 13 (5.2%) asbestosis deaths but no deaths 
due to mesothelioma. Their subsequent study 
concerned 793 workers with known smoking his­
tories with 10 additional years of follow-up. A 
relative risk for lung cancer of 19 was observed 
for smoking asbestos workers and 1.6 for asbes­
tos workers who did not smoke. Asbestosis mor­
tality was found to be equally frequent among 
smokers and nonsmokers. All lung cancer cases 
with more than 10 years of exposure were also 
found to have asbestosis.
ChrysotHe
Chrysotile is the major asbestos fiber type 
used in the United States, but most of this fiber 
is imported from Canada. The mortality of 
Quebec chrysotile miners and millers has been 
extensively studied by McDonald et al. (76) (79- 
81). The most recent report for this cohort in­
cluded 10,939 men who had been employed one 
or more months and followed between 1926 and 
1975. An overall SMR for lung cancer of 125 was 
observed; 42 deaths were due to asbestosis and 
11 to mesothelioma. A nearly linear dose- 
response relationship was reported for lung 
cancer. Increased mortality was also observed for 
cancer of the stomach and esophagus but no 
other gastrointestinal sites. Similar patterns of 
lung cancer and asbestosis mortality have been 
reported by Rubino et al. in Italian chrysotile 
miners and millers where an SMR for lung can­
cer of 206 was observed among those with suf­
ficient latency (117).
The McDonald et al. studies demonstrated 
a low lung cancer risk even in the highest ex­
posure group. Nicholson et al. have reported 
larger excesses from lung cancer and asbestosis 
in their study of chrysotile miners and millers 
in Quebec (99). This latter study cohort consisted 
of 544 miners and millers with at least 20 years 
seniority and followed between 1961 and 1977. 
A total of 28 lung cancers were observed versus
11.1 expected (SMR = 252). There were 30
deaths due to noninfectious respiratory diseases 
whereas only 6.7 were expected. Of these 30 
deaths, 26 were due to asbestosis. Only one 
mesothelioma (pleural) was observed.
Mortality among chrysotile asbestos miners 
and millers in the Urals has been investigated by 
Kogan et al (61). The overall cancer mortality risk 
was found to be 1.6 times that for the general 
male population and was higher in mining than 
in milling. Among males, the relative risk for 
lung cancer was 2.0 and ranged from 1.4 to 2.1 
for females. The lung cancer risk was con­
siderably greater in older age groups having the 
longest latency. No mesotheliomas were reported; 
however, Kogan et al. attributed this to insuffi­
cient experience of pathologists in that 
geographic area (61). Nonetheless, the low 
mesothelioma risk is consistent with other studies 
of chrysotile-exposed populations.
There have been several studies of factory 
populations exposed only to chrysotile. Weiss 
studied a small cohort of 264 workers in a plant 
producing asbestos millboard and reported no 
excess cancer mortality (160). However, there 
were only 66 deaths (2 of which were due to 
asbestosis) and cancer latency was not taken in­
to account in the analysis.
A facility manufacturing asbestos textile, 
friction, and packing products has been studied 
by Robinson et al. (113). Chrysotile constituted 
over 99% of the total quantity of asbestos pro­
cessed per year in this plant except during World 
War II; the remaining 1 % was crocidolite and 
amosite. The cohort consisted of 2,722 males and 
544 females followed between 1940 and 1975. 
Among males, an overall lung cancer SMR of 
135 was observed but among females the excess 
lung cancer risk was much higher with an overall 
SMR of 824. There were 76 deaths in males due 
to noninfectious respiratory disease but only 16.4 
expected. Again, the chronic respiratory disease 
risk was higher among females with an SMR of 
1,555. There were 4 mesotheliomas among fe­
males and 13 in males.
Dement et al. have reported mortality 
among a cohort of asbestos textile workers ex­
posed only to chrysotile (18). This cohort con­
sisted of 768 white males employed at least 6 
months and followed between 1940 and 1975. 
There were 26 lung cancers observed versus 7.47 
expected. Of the 191 deaths in this cohort, 15 
(7.9%) were due to asbestosis or pulmonary 
fibrosis and 1 (0.5%) was due to a peritoneal
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mesothelioma. Linear relationships were demon­
strated between cumulative fiber dose and the 
risk of mortality for lung cancer and noninfec­
tious respiratory diseases. An SMR for lung can­
cer of 223 was observed for the lowest cumulative 
exposure category of less than 30 fibers/cc 
x years.
Fibers and Asbestos-like Contamination of 
Other Minerals
Both serpentines and amphiboles may be 
found as contaminants in other mined and pro­
cessed ores and may result in significant fiber 
exposures to workers in these operations.
Fibers and cleavage fragments of fibrous 
grunerite occur where ore from some iron for­
mations are crushed and comminuted and have 
been found in high concentrations in Lake 
Superior as a result of mining and milling opera­
tions (64). Gillam et al. studied mortality among 
gold miners exposed to cummingtonite-grunerite 
and found a threefold excess risk of lung cancer 
and a twofold excess of nonmalignant respira­
tory disease, excluding influenza and pneumonia 
(32). However, workers in this mine were also ex­
posed to silica. McDonald et al., in a subsequent 
study of the same mine, examined the mortality 
experience of persons with at least 21 years of 
employment with the company (78). This study 
demonstrated excess mortality due to 
pneumoconiosis (mainly silicosis), tuberculosis, 
and heart disease but no overall excess of malig­
nant diseases was found. However, when the 
population was stratified by exposure, respira­
tory cancer was elevated (but was not statistically 
significant) in the highest exposure group.
Commercial talc deposits are sometimes 
found to contain serpentines (chrysotile, antigor- 
ite, rnd lizardite) and fibrous and nonfibrous am­
phiboles. Kleinfeld et al. demonstrated sig­
nificantly increased proportionate mortality due 
to lung cancer and nonmalignant respiratory 
disease among talc miners and millers in New 
York State exposed to fibrous anthophyllite and 
fibrous tremolite (53)(58). Brown et al. have 
reported a further mortality of talc miners and 
millers in one company mining this same ore 
body (9). This cohort consisted of 398 workers 
followed between 1947 and 1975. Among this 
cohort, 10 respiratory cancers were observed 
whereas only 3.5 were expected. Approximately 
a threefold excess risk of nonmalignant respira­
tory disease was reported; however, only one
death due to mesothelioma was observed. 
Effects of Smoking
Smoking and asbestos exposure are more 
than additive in their combined ability to increase 
the risk of lung cancer. Hammond et al. reported 
results of their 10-year follow-up of 8,220 as­
bestos insulation workers with known smoking 
status (38). The mortality experience of these 
workers was compared with that expected among 
smokers and nonsmokers of the American Can­
cer Society’s prospective cancer prevention study. 
Asbestos workers who did not smoke showed ap­
proximately a fivefold risk of lung cancer com­
pared to the nonsmoking control population. On 
the other hand, a more than sixtyfold risk of lung 
cancer was observed for smoking asbestos work­
ers compared to nonsmoking controls. A similar 
multiplicative effect was observed by Selikoff et 
al. among a factory cohort producing amosite 
insulation (129).
Although less striking, cigarette smoking 
may also contribute to the risk of death due to 
asbestosis. Hammond et al. reported that asbes­
tosis death rates of smoking asbestos workers 
were 2.8 times as high as that of nonsmoking 
asbestos workers. Meurman found less associa­
tion between asbestosis mortality and smoking; 
he reported 7 of 42 asbestosis deaths among non- 
smokers (86).
Mortality and Pleural Radiographic 
Changes
The relationship between pleural thicken­
ing and calcification and subsequent mortality 
is important insofar as surveillance of asbestos 
workers is concerned. Edge studied the mortality 
of 429 shipyard workers with plaques and com­
pared this to matched controls without plaques 
(25). Among those with plaques, 23 mesotheli­
omas were observed and workers with plaques 
had 2.5 times the lung cancer risk of those with­
out plaques. Sheers observed 6 mesothelioma 
deaths among 410 dockyard workers with 
plaques, but he found just 2 mesotheliomas in 
those with only pleural fibrosis (130). Neither 
of these studies established causality between 
pleural changes and subsequent development of 
mesothelioma or lung cancer because neither 
asbestos exposure or latency were controlled for 
in the analysis. Meurman has shown that antho­
phyllite asbestos workers have a high prevalence
of pleural changes but a minimal mesothelioma 
risk (86X87). However, plaques and pleural thick­
ening do indicate an asbestos exposure and this 
fact alone places the workers at an increased risk 
for lung cancer and asbestosis.
Respiratory Morbidity
All types of asbestos have been shown in 
epidemiologic studies to be associated with as­
bestosis, pleural thickening, and pleural calcifica­
tion. Available evidence from cross-sectional and 
prospective respiratory disease studies provide lit­
tle evidence that any one type of asbestos is more 
biologically active than another insofar as x-ray 
or clinical changes are concerned (149) (164). 
These findings are fully supported by animal 
bioassay data.
Important epidemiologic studies of respira­
tory morbidity among asbestos workers are sum­
marized in Table 11-12. In these studies, various 
objective measures of effect or disease outcome 
have been used including chest roentgenographs, 
spirometry, measures of diffusion capacity, and 
chest auscultation. Subjective data such as re­
spiratory symptoms obtained by questionnaire 
have also been used. In the diagnosis of “definite 
asbestosis,’* most studies have relied upon com­
binations of objective and subjective data.
Mixed Fiber Exposures
Early cross-sectional studies of chest roent­
genographs of asbestos workers by Merewether 
and Price, Donnelly, Schull, and Dreessen et al. 
demonstrated a striking prevalence of pulmonary 
fibrosis of as much as 80% for workers employed 
more than 20 years (22)(23)(84)(131).
Several studies have been conducted among 
insulation workers. Selikoff et al. studied chest 
films of 1,117 insulation workers exposed to 
chrysotile and amosite (122)(124). A 50% over­
all prevalence of pulmonary fibrosis was ob­
served increasing to 90% among those employed 
more than 30 years. Pleural calcification showed 
an increasing prevalence with latency reaching 
57.9% at 40 years since initial employment. Pleu­
ral fibrosis (thickening) occurred earlier than 
calcification. Murphy et al. also studied shipyard 
insulation workers and found a prevalence of 
asbestosis 11 times that of age matched, non­
exposed controls (92)(93). Exposures among this 
group were thought to be low.
Cross-sectional data from an asbestos textile 
plant processing a mixture of asbestos types were
used by the British Occupational Hygiene Society 
(BOHS) in establishing occupational exposure 
standards (8). Among 290 workers employed 
after dust controls were installed in 1933, only 
8 workers (2.7%) demonstrated x-ray changes 
considered consistent with asbestosis. Basal rales 
was taken as an early disease marker with a 1% 
risk estimated for a working lifetime of 50 years 
at an average exposure of 2 fibers cc. Workers 
at this same plant were subsequently studied 
cross-sect ionally by Lewinsohn (67). This latter 
and much larger study demonstrated a signifi­
cantly greater prevalence of pulmonary fibrosis; 
reaching 40.5% among workers employed from 
30-39 years. Pleural fibrosis (thickening) was 
observed in 1.6% of those employed 1-9 years and 
in 50% of workers employed more than 40 years.
Berry et al. reported the results of a prospec­
tive study of workers employed in the same plant 
studied by Lewinsohn (67). This study consisted 
of 379 persons completing 10 or more years em­
ployment by 1971. Possible asbestosis was diag­
nosed based on one or more combinations of 
basal rales or crepitations, radiological changes, 
a falling transfer factor and restrictive lung func­
tion changes. Among these 379 men, 60 cases of 
possible asbestosis were diagnosed by the factory 
medical officer, whereas 85 cases were diagnosed 
by an independent clinician. Using plant expo­
sure data, it was estimated that the cumulative 
dose necessary for a 1% incidence for crepita­
tions, possible asbestosis, and certified asbesto­
sis was 43 fiber/cc-yr, 55 fiber/cc-yr, and 72 
fiber/cc-yr, respectively. Two cases of certified 
asbestosis were observed among nonsmokers and 
nine among ex-smokers, suggesting a contribu­
tory smoking role. Weiss reported similar find­
ings in his study of 100 asbestos textile workers 
where a 24% prevalence of pulmonary fibrosis 
was observed in nonsmokers versus 40% for 
smokers (159)(161). Gregor et al. demonstrated 
a progression of radiological changes in asbes­
tos workers referred to the British Pneumoconi­
osis Medical Panel without further asbestos 
exposures (36).
Lung function and chest film effects of ex­
posure to asbestos cement dust have been studied 
by Weill et al. (157X158). This study included 859 
workers in two asbestos cement plants who were 
administered respiratory symptom question­
naires, spirometry, and chest films. Cumulative 
dust exposures were estimated and expressed as 
mppcf-yr. Both small rounded and linear opac-
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SUMMARY OF RESPIRATORY MORBIDITY STUDIES OF ASBESTOS EXPOSED POPULATONS
AuthoKs) Date Study Population Fiber Type Study Design Summary of Important Findings
Selikoff, Churg, 
and Hammond






50% prevalence of pulmonary 
fibrosis. Increasing prevalence of 
all chest film changes with 
employment duration increasing 
to 90% prevalence at >30 years
Kilviluoto et al. 1960,
1965,
1979




Case series Pleural calcification observed in 
persons only secondarily exposed 
to asbestos. Pleural changes un­
related to lung cancer mortality.






Pleural calcification showed in­
creasing prevalence reaching 
57.9% among those with 40 years 
since first exposure. Pleural fibro­
sis occurred earlier than calcifica­
tion, 50% of cases were bilateral.
McDonald et al. 1972 1,015 chrysotile 
miners and millers
Chrysotile Cross-sectional, no 
externals
Shortness of breath increased 
with estimated cumulative dust 
exposure but bronchitis showed 
little correlation.
Becklake et al. 1972 1,105 chrysotile 
miners and millers
Chrysotile Cross-sectional, no 
externals
FVC found to decrease with 
estimated cumulative dust ex­
posure in smokers and non- 
smokers. Same trends seen in 
FEV,. Obstructive impairment 
seen in high exposure group. Few 
trends in diffusing capacity.
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SUMMARY OF RESPIRATORY MORBIDITY STUDIES OF ASBESTOS EXPOSED POPULATONS (Continued)
Authors) Date Study Population Fiber Type Study Design Summary of Important Findings
McDonald et al. 1974 5,082 miners and 
millers with chest 
films
Chrysotile Mortality follow-up Increased mortality observed for 
those with parenchymal changes 
but not in those with only pleural 
changes, 32 deaths observed due 
to all respiratory diseases versus 8 
expected,
Liddell et al. 1977 267 miners and 
millers with chest 
films
Chrysotile Prospective follow-up During 20-year period, the follow­
ing cumulative incidence was 
reported: small opacities 16%, 
pleural thickening 5.3%, pleural 
calcification 5.3%, obliteration of 
c/p angle 7.3%
Weiss 1971 100 asbestos 
textile workers
Unknown Cross-sectional, no 
external controls
Overall prevalence of fibrosis 
36% with 24% prevalence in non- 
smokers and 40% in smokers. 
None of 11 nonsmokers with ex­
posures less than 20 years showed 
fibrosis.
BOHS 1968 290 asbestos 
textile workers
Mixed Cross-sectional, no 
external controls
Basal rales used as early disease 
marker, 1% risk estimated for a 
working lifetime of 50 years at 2 
fibers/cc.
Lewinsohn 1972 1,287 asbestos 
textile workers
Mixed Cross-sectional, no 
external controls
Prevalence of pulmonary fibrosis 
0% with 0-9 years exposure up to 
40.5% with 30-39 years exposure. 
Pleural fibrosis prevalence 1.6% 
in 0-9 years and 50% in 40-49 
years exposure group.
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Author(s) Date Study Population Fiber Type Study Design Summary of Important Findings
Berry et al. 1979 379 asbestos 
textile workers
Mixed Prospective follow-up 6.6V0 of workers had “possible” 
asbestosis after 16 years follow-up 
and an average exposure of 5 
fibers/cc. Cumulative exposure 
for lVo incidence of “ possible 
asbestosis" for 40 years employ­
ment estimated to be 55 fibers/cc 
X years.
Weill et al. 1973 908 asbestos 
cement workers
Mixed Cross-sectional, no 
external controls
Overall prevalence of small 
rounded opacities I/O or greater 
was 3.1%, for small irregular 
opacities prevalence was 2.5Vo. 
Reduced FEV„ FEF2575 and 
FEV,/FVC ratio found in those 
with x-ray abnormalities.
Weill et al. 1975 859 asbestos 
cement workers
Mixed Cross-sectional, no 
external controls
Prevalence of small rounded and 
irregular opacities, 4Vo in lowest 
exposure group and 30% in high­
est. Pleural changes 11 Vo in low­
est exposure group and 30Vo in 
highest. FVC and FEV, reduced 
in those with x-ray changes.
Weiss and Theodas 1978 98 workers age 40 






Prevalence of profusion (1/1)
17.5Vo in chrysotile workers and 
16.5Vo in mixed fiber workers. 
Pleural thickening prevalence,
17.5Vo in chrysotile workers and 
35.4V« in mixed fiber workers. 
Smoking found to be significant 
factor in those exposed to amosite.
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SUMMARY OF RESPIRATORY MORBIDITY STUDIES OF ASBESTOS EXPOSED POPULATONS (Continued)
Author(s) Date Study Population Fiber Type Study Design Summary of Important Findings
Selikoff et al. 1977 485 miners and 
millers
Chrysotile Cross-sectional, no 
external controls
10% prevalence of all radiographic 
abnormalities. Pleural changes 
seen in 3% of all workers. Prev­
alence of abnormalities among 
those employed less than 5 years 
was 5% with 3% being paren­
chyma changes (profusion > 1/ 0).
Jones et al. 1979 204 asbestos 
cement workers
Mixed Prospective follow-up 
1970-1976
Progression of small opacities 
dependent upon both average and 
cumulative exposure. Lung func­
tion declines were associated with 
smoking and cumulative exposure. 
Pleural abnormalities progressed 
more as a function of time with 
little association with additional 
exposure.
Anderson 1979 Household contacts 
of factory workers
Amosite Cross-scctional, age, 
sex matched controls
35.9% prevalence of x-ray abnor­
malities compared to a 4.6% 
prevalence in the control group. 
Pleural abnormalities more 











Talc workers with greater than 15 
years employment had increased 
prevalence of pleural abnor­
malities compared to comparison 
populations, FEV, and FVC re­
duced in association with dust 
and fiber exposures.
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SUMMARY OF RESPIRATORY MORBIDITY STUDIES OF ASBESTOS EXPOSED POPULATONS (Continued)
Authors) Date Study Population Fiber Type Study Design Summary of Important Findings
Irwig et al. 1979 1,801 miners and 






Prevalence of pleural changes 
increased from 2.5Vo for workers 
with less than 1 year employment 
to 33.6Vo for workers with 15 or 
more years. Parenchymal changes 
(>1/0 ILO) found in 2.3Vo of 
workers employed less than 1 year 
and 26.7Vo in workers employed 
more than 15 years.




Mixed Prospective follow-up One-third of workers showed 
progression after 6 years follow- 
up and no further asbestos expo­
sure. Progression frequency 
higher among those with 
profusion>l/l or 1/2 (ILO).




Chrysotile Prospective follow-up 39Vo of persons with abnormal 
films (profusion >1/0 ILO) 
showed progression after an aver­
age follow-up of 8 years. 7.9Vo of 
workers with normal initial films 
developed radiographic changes.
Murphy et al. 1971»
1978
101 shipyard pipe 
coverers and 95 
controls
Mixed Cross-sectional with 
further follow-up 
matched controls
Prevalence ratio of asbestosis 
11 times greater than controls. 
Asbestosis evidenl after cumula­
tive exposures of 60 mppcf-years.
ities were observed, indicating the possible role 
of small quantities of silica present in cement 
dust. Among those with a cumulative exposure 
less than 50 mppcf-yr, and approximately 4Vo 
prevalence of small opacities (rounded or irreg­
ular, profusion > 1/0 was observed; the preva­
lence of these changes increased to 30Vo with an 
exposure of more than 400 mppcf-yr. Pleural 
changes were seen in 11 Vo of those in the lowest 
exposure category. Both F VC and FEV, were 
reduced in those with x-ray changes. There was 
no apparent interaction effect of cigarette smok­
ing on the development of diffuse fibrosis.
Jones et al. studied the progression of radio- 
graphic abnormalities and lung function changes 
among 204 asbestos cement workers between 
1970 and 1976 (48). Filmswere read side by side 
in known order and ranked according to progres­
sion. These authors concluded that: (1) progres­
sion of small opacities depended upon both ave­
rage and cumulative exposure; (2) declines in lung 
function were related to both smoking and cum­
ulative exposure; and (3) pleural abnormalities 
progressed as a function of time. Disease inci­
dence was not estimated in relation to exposure.
Anthophyllite and Tremolite
Respiratory morbidity among Finnish an­
thophyllite miners and millers has been studied 
by Meurman et al. (87). Among 787 active em­
ployees, a threefold excess of dyspnea and a two­
fold excess of cough was observed among asbes­
tos workers compared to controls. The prevalence 
of dyspnea was not found to be associated with 
smoking habits.
A high prevalence of pleural plaques has 
been reported among persons residing near an­
thophyllite mines and mills in Finland (51)(85). 
In two mining communities where mass roent­
genological surveys were conducted, prevalences 
of pleural plaques of 9Vo and 6.5Vo were ob­
served compared to less than 0.1 Vd for the Fin­
nish population.
Talc deposits found in upper New York 
State contain both anthophyllite and tremolite. 
Workers in talc mines and mills in this area have 
been shown to experience pulmonary fibrosis, 
pleural changes, and restrictive lung function 
changes (52)(54-57)(107)(132)(133). A recent 
cross-sectional study of lung function and chest
x-rays among talc workers in this area was 
reported by Gamble et al. (31). Compared with 
coal and potash miners, talc miners and millers 
were found to have an increased prevalence of 
cough and dyspnea along with reduced FEVlt 
FVC, and flow rates. Talc workers with more 
than 15 years employment were found to have 
a 33Vo prevalence of pleural calcification and 
pleural thickening. Recent exposures in these 
operations were reported by Dement and Zum- 
walde (19). Time-weighted-average fiber ex­
posures were found to range from 0.8 to 16.0 
fibers/cc with 12-19Vo identified as tremolite and 
38-45Vo anthophyllite.
Chrysotile—Radiological changes, lung 
function, and respiratory symptoms among 
Canadian chrysotile miners and millers have 
been extensively studied by McDonald et al. (76) 
(77) and Becklake et al. (4). A total of 1,015 cur­
rent employees were given chest x-rays, under­
went pulmonary function studies, and were ad­
ministered a standard British Medical Research 
Council Questionnaire on respiratory symptoms. 
Both persistent cough and phlegm (bronchitis) 
and breathlessness on exercise were found to in­
crease with exposure. The prevalence of bron­
chitis rose to 50Vo among smokers in the highest 
dust exposure categories. The prevalence of 
breathlessness was not affected by smoking but 
rose to greater than 40Vo in those with cumu­
lative dust exposures over 800 mppcf-years. The 
prevalence of irregular small opacities (>1/0 
ILO/UC) in the lowest exposure category was 
found to be 1.8Vo for the Thetford mine and 
6.4Vo for the Asbestos mine. Prevalences in­
creased to 26.4Vo for Thetford and 10.9Vo for 
Asbestos in the group with exposures more than 
800 mppcf-yr. The prevalence of pleural thick­
ening was found to be less strongly related to 
exposure. Among various lung function pa­
rameters measured, both FVC and FEV, de­
clined more with exposure. Those with small 
opacities of category 2/1 or greater were found 
to have significantly reduced functional residual 
capacity, residual volume, and single breath dif­
fusing capacity at rest. Only FVC and FEVL were 
reduced in those with earliest roentgenographic 
changes.
Cross-sectional respiratory disease studies 
have been conducted among chrysotile miners 
and millers in Newfoundland and Corsica (7) 
(121). Selikoff studied 485 current employees
of a chrysotile mine in New foundland and found 
a 5% prevalence of parenchymal abnormalities 
(ILO U/C >1/0) (121). This prevalence increased 
to 11.5% among those employed more than 10 
years. The prevalence of pleural changes was less 
than that observed for parenchymal changes.
Boutin et al. studied chest films of 16 ex- 
workers of chrysotile mines and mills in Corsica 
which had been closed in 1965 (7). Compared 
with controls, chrysotile miners and millers had 
2.4 times the risk of parenchymal abnormalities 
and 2 times the risk of pleural abnormalities. Ex­
posure levels among those workers were extreme­
ly high, ranging from 85 to 267 mppcf.
The above studies of chrysotile asbestos 
workers have been cross-sectional by design and 
have likely underestimated risks since: (1) those 
who develop severe disease are likely to have al­
ready left employment, and (2) chest film changes 
may develop after termination of employment, 
or changes may be progressive without additional 
exposure. Liddell et al. studied chest film changes 
in a 20-year longitudinal study of chrysotile 
miners and millers (62). These authors observed 
a 20-year cumulative incidence for small irregular 
opacities of 16Vo, a pleural calcification incidence 
of 5.3 Vo, and a pleural thickening incidence of 
5.3 Vo. Only the incidence of small opacities was 
strongly associated with smoking. Rubino et al. 
studied the progression of chest film changes 
among retired chrysotile asbestos miners and 
millers and found that 39 Vo of those who had 
initial films with a profusion of 1/0 or greater, 
demonstrated progression without further ex­
posure (116). Becklake et al. also studied radio­
logical changes after withdrawal from asbestos 
exposure (5). Parenchymal progression was ob­
served in 7Vo of the films, pleural progression 
in 19.8 Vo, and both parenchymal and pleural pro­
gression in 2.3 Vo. These changes were found to 
be independent of age and smoking, but paren­
chymal “attacks” occurred more among those 
with higher asbestos exposure prior to employ­
ment termination.
Relationships between radiological findings 
and subsequent mortality among chrysotile 
miners and millers have been studied by Liddell 
and McDonald (69). This study consisted of 
4,559 whose latest film had been read according 
to the UICC/Cincinnati classification system 
with mortality follow-up from time of film as­
sessment through 1975. Overall, this cohort ex­
perience significantly increased mortality for all 
causes (SMR = 144), lung cancer (SMR = 177), 
pneumoconiosis (31 cases), other respiratory 
diseases (SMR = 127), diseases of the heart 
(SMR = 136), cancer of the esophagus or stom­
ach (SMR = 170), and cerebrovascular diseases. 
There were 5 pneumoconiosis deaths among 
those classified as having normal radiographs; 
however, the risk of death due to pneumoconiosis 
was 11.75 times greater among those with “less- 
than-normal” films. The lung cancer relative risk 
for those with chest film changes was 3.24 and 
most who died of lung cancer were found to be 
smokers. Small parenchymal opacities were pre­
sent in most but not all persons whose deaths 
were attributed to lung cancer. The authors 
concluded that the chest radiograph was useful 
for surveillance of asbestos workers but was 
limited due to radiological progression after 
withdrawal from exposure and by the carcino­




Hyaline plaques of the parietal pleura oc­
cur in association with exposure to all commer­
cial types of asbestos. They are more common 
than the pulmonary parenchymal lesions of as­
bestosis, thus their presence does not necessarily 
imply coexistent asbestosis. The majority occur 
in men, 20 years or more after first exposure. The 
plaques almost invariably involve the parietal 
pleura; less commonly they are found on the 
visceral pleura or parietal pericardium. They are 
usually bilaterally symmetrical and appear as well 
circumscribed, pearly white or creamy, fibrotic 
elevations of the pleura (Figure 11-11). Their sur­
face is smooth and glistening with either a fiat, 
plateau-like or nodular contour. They’ range in 
size from a few’ millimeters to several centimeters 
in diameter. Most commonly they are found 
following the lines of the lower ribs posteriorly 
or on the diaphragm. On cut section, they have 
the consistency of cartilage. Histologically, the 
plaques are composed of avascular and acellular 
bundles of hyalinized collagen arranged in a 
reticulated mesh or “basket weave” pattern 
(Figure 11-12). Some of the more nodular plaques 
show a whorled pattern of collagen fibers. Focal
calcification is fairly common and elastic fibers 
are sometimes demonstrable within the plaque 
(112). Although the plaques are almost acellular, 
lymphocytes and plasma cells may be present 
around blood vessels beneath the plaque. The 
origin of the plaque is not known; histological 
studies suggest an extrapleural rather than a 
pleural origin (145). Asbestos bodies are rarely 
seen in pleural plaques, though they can usually 
be detected in the underlying pulmonary paren­
chyma (40)(112). Short, uncoated fibers may be 
present in a proportion of plaques (40) (65). 
Pleural plaques rarely, if ever, undergo malignant 
change.
Asbestosis
In early or mild cases of asbestosis, the lungs 
may be of normal size and shape; in advanced
cases, they show a marked reduction in volume. 
The visceral pleura is usually pale, opaque, and 
thickened, particularly over the lower lobes. 
Adhesions between the visceral and parietal 
pleura may be present. In the absence of other 
exposures, pleural pigmentation is usually slight.
The lungs may appear grossly normal in 
cases showing histological evidence of mild dis­
ease. However, on careful palpation, it is usual­
ly possible to detect an increased firmness of the 
parenchyma. With advancing disease, the lungs 
are dark tan in color and show a pale reticular 
fibrosis. Characteristically, the fibrosis is most 
prominent in the lower lobes and dependent parts 
of the upper and middle lobes. In the late stages 
of the disease, the lungs have firm, spongy tex­
ture and show dense fibrosis with areas of cyst 
formation (honeycombing). The honeycomb
Figure 11-11. Diaphragmatic pleura of 68»year-old ex-construction worker. 
Numerous dome shaped and flattened, ivory colored plaques are seen over 
both hemidiaphragms.
51
Figure 11-12. Histological section of pleural plaque. The plaque is composed 
of acellular bundles of collagen fibers arranged In a “basket weave” pattern. 
Hematoxylin and eosin x 64.
cysts vary in size from a few millimeters to a 
centimeter or more in diameter and are most 
prominent in the lower lobes and subpleural areas 
of the lungs (Figure 11-13, A & B). Emphysema 
is unusual and, when present, is not related to 
asbestos exposure. Massive fibrosis is a less com­
mon feature of asbestosis and probably results 
from mixed dust exposure. Necrotic nodules 
similar to Caplan’s lesions in coal workers have 
been described in patients with asbestosis and 
circulating rheumatoid factor (91).
Microscopically, the earliest lesion attribut­
able to asbestos inhalation involves the respira­
tory bronchiole. Fibers deposited on the walls of 
respiratory bronchioles and adjacent alveoli 
stimulate a macrophage response. Depending 
on fiber size, giant cells may form. The macro- 
phagic response is followed by the deposition of
reticulin and collagen in the walls of the respira­
tory bronchioles (Figure 11-14). Asbestos bodies 
and fibers are found in association with the le­
sions of the respiratory bronchioles and within 
alveoli. A similar lesion has been described in 
cigarette smokers (100). The early lesion of as­
bestosis differs from the respiratory bronchiol­
itis of cigarette smokers only with respect to 
the presence of asbestos bodies. The diagnosis, 
therefore, of asbestosis depends upon the recog­
nition of asbestos bodies within the lesion.
As the disease evolves, the fibrosis extends 
out to involve the walls of adjacent alveoli. Even­
tually, adjacent acini are affected resulting in a 
diffuse interstitial fibrosis (Figure 11-15). With 
further progression of the disease, the pulmonary 
architecture becomes distorted. Intra-alveolar 
fibrosis leads to obliteration of alveolar spaces
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Figure 11-13 (A). Freeze dried whole lung section from 
51-year-old male plumber exposed to asbestos lag* 
ging for 16 years. There is marked honeycombing of 
the mid and lower zones.
and eventually to areas of conglomerate fibrosis 
(Figure II-16). Despite the obliteration of alveolar 
spaces, the outline of the walls of the alveoli 
usually remain intact and can be demonstrated 
with elastic stains (138). Eventually, fibrous- 
walled (honeycomb) cysts form (Figure H-17). 
The cysts are lined by flattened or metaplastic 
epithelial cells of ciliated cuboidai, goblet, or 
squamous type. These changes are nonspecific 
and may occur in the late stages of pulmonary 
fibrosis, whatever the etiology. This pathogenetic
sequence of events forms the basis for a grading 
system developed by a committee of U.S. pulmo­
nary pathologists assembled under the auspices 
of the National Institute for Occupational Safety 
and Health and the College of American Path­
ologists (16).
The above features appear to be common 
to all the commercially available types of asbes­
tos. Several other types of tissue response have 
been described in association with asbestosis. 
These include chronic inflammatory cell infil­
trates, desquamative interstitial pneumonia (15), 
and the formation of intra-epithelial eosinophilic 
hyaline bodies (62). These features are not spe­
cific for asbestos.
Asbestos Bodies and Fibers
Two types of fibers are encountered in the 
lungs; uncoated fibers that resemble the inhaled 
particle and coated fibers or asbestos bodies. The 
ratio of uncoated fibers to coated bodies is high, 
ranging from 5:1 to 10,000:1 (10).
Asbestos bodies are an index of asbestos ex­
posure and are considered an essential feature 
for the histological diagnosis of asbestosis (16). 
They may be formed in the lungs as early as two 
months after first exposure (135). Asbestos 
bodies tend to form on the larger fibers, ije., those 
greater than 5fim in length and result from the 
deposition of iron-protein complexes on the core 
fiber by alveolar macrophages (143). In hematox­
ylin and eosin stained sections they appear as 
golden brown segmented structures with a clear 
central core fiber. In Perl’s iron stained sections 
they appear blue. The morphology of the coating 
is variable, with club-shaped or beaded bodies 
predominating (Figure II-18). Similar structures 
may form around other minerals such as carbon, 
ceramic aluminum silicate fibers, and fiberglass, 
and they have been termed ferruginous bodies 
(37X42). They usually lack the clear central core 
of a typical asbestos body. These types of bodies 
are relatively uncommon, however, and for prac­
tical purposes, it can be assumed that a typical 
asbestos body contains an asbestos fiber. Al­
though all major commercial types of asbestos 
can produce asbestos bodies, the majority of the 
core fibers, when analyzed by selected area elec­
tron diffraction, are found to be amphibole 
asbestos (11). Several procedures exist for the 
quantification and identification of fibers in 
tissues (11)(16X137)(150). The majority of these 
fibers are too small (<5 Mm in length) to be
Figure 11-13 (B). Roentgenogram showing marked interstitial disease with 
honeycombing which is most severe In the mid zones.
resolved by the light microscope: Electron micro­
scopical studies on selected cases have shown that 
occupationally exposed workers have pulmonary 
asbestos fiber counts orders of magnitude greater 
than the genera! population (16)(163). The value 
of these techniques is to establish exposure and 
to identify the mineral type and should not be 
considered a substitute for more conventional 
diagnostic methods. Currently, the role of the 
short fibers in the pathogenesis of asbestosis and 
asbestos-associated lung cancer has not been 
resolved.
Lung Cancer
The association between asbestos exposure,
smoking, and lung cancer is now firmly estab­
lished. The majority of asbestos-associated bron­
chial carcinomas arise in lungs that also show 
asbestosis. Autopsy and mortality studies in­
dicate that thf prevalence of lung cancer in per­
sons with asbestosis ranges from 12-55 Vo (42) 
(136).
The lung cancers associated with asbestos 
exposure occur at a slightly earlier age than in 
nonexposed individuals (74). They arise in rela­
tion to the fibrotic lesions and are thus more 
common in the periphery of the lower lobes 
(49)(162). All histological types of cancer occur 
with most (41)(42)(162), but not all (49), studies
Figure 11-14. Section of lung from 68-year-old asbestos insulation worker showing the histological 
features of mild asbestosis. The lesion is characterized by peribronchiolar fibrosis in which there 
are numerous asbestos bodies. Inset shows an asbestos body. Hematoxylin and eosin x 100.
Figure 11-14 (Inset).
Figure H-16. Section of lung from same case as figure 15 showing interstitial and intraalveolar fibrosis. 
Hematoxylin and eosin x 40.
3 0  «
Figure 11-17. Section of lung showing honeycombing. The pulmonary architecture has been replaced 
by thick bands of fibrous tissue outlining cystic spaces. There is a moderate chronic inflammatory 
cell infiltrate of the parenchyma. Hematoxylin and eosin x  40.
showing a preponderance of adenocarcinomas.
Metaplastic and pre-malignant changes have 
been observed in the bronchi and within areas 
of fibrosis in asbestosis (42)(101). It has yet to 
be determined whether sputum cytology is of 
value in early detection of carcinoma in asbestos 
workers (35).
Mesothelioma
Mesothelioma is a rare tumor arising from 
the mésothélial cells that Une the pleural, peri­
cardial, and peritoneal cavities. The first case 
associated with asbestos exposure was reported 
by Wyers in 1946 (165). In I960 this association 
was firmly established by Wagner and co-workers 
in a study of individuals exposed to crocidolite 
asbestos in the Northwest Province of South 
Africa (152). Since then, cases have been reported 
from all major industrial countries. Exposure to 
crocidolite and amosite (45) (125) appear to carry 
the greatest risk for developing mesothelioma, 
whereas workers exposed predominantly to chry- 
sotile asbestos appear to have the least risk (18)
(45). The tumor is almost invariably associated 
with asbestos exposure—a positive history being 
obtained in 80-90% of cases (13)(151); however, 
there is no evidence for a dose-response relation­
ship. Although exceedingly rare in the general 
population, mortality from mesothelioma may 
approach lOVo among some groups of asbestos 
workers (127).
The tumor occurs in both sexes and has a 
latency period in excess of 20 years—usually 30 
to 40 years. There is no association with cigarette 
smoking. The tumors are ivory colored and, in 
typical cases of pleural mesothelioma, encase the 
lungs in a rubbery mass of tissue. Pleural plaques 
and asbestosis may also be present, though in the 
majority of cases mesotheliomas occur in the 
absence of these lesions. The tumor tends to 
spread along the interlobar fissures and to in­
vade the subpleural portions of the lungs. Direct 
invasion of adjacent organs, such as heart, dia­
phragm, and liver and extension into surgical in­
cisions and aspiration needle tracts are charac­
teristic Metastases to local lymph nodes and the
Figure 11*18. Asbestos body within an area of fibrosis. The body is composed of a translucent core 
fiber with a beaded iron-protein coat. An uncoated fiber is also seen (arrow). Hematoxylin and eosin 
X 600.
lung are also fairly common. Extrathoracic me* 
tastases are relatively rare, and their presence 
should raise a suspicion as to the authenticity of 
the tumor.
Microscopically, the tumor can be classified 
into tubo-papillary, sarcomatous, and mixed 
types. The tubo-papillary is the most common 
type and is easily confused with metastic car* 
cinoma from the lung or elsewhere. Special stains 
may aid in differentiation in some cases. Meso­
theliomas usually contain the mucopolysaccha­
ride, hyaluronic acid, which stains with Hale’s 
colloidal iron and with alcian blue. The specificity 
of the reaction can be determined by pretreat­
ment of the tissue section with hyaluronidase 
(16). Hyaluronic acid may also be demonstrated 
by electrophoresis of tumor tissue (154). Adeno­
carcinomas usually contain intracytoplasmic 
mucin droplets rather than hyaluronic acid (16). 
More recently it has been suggested that the 
absence of carcinoembryonic antigen (CEA) may 
be a useful adjunct for diagnosis (153). In the 
United States and Canada, special panels of
pathologists (mesothelioma panels) exist to pro­
vide a diagnostic referral service (50).
CLINICAL EVALUATION
Clinical evaluation of the asbestos*exposed 
worker should include a full occupational and 
environmental history, full medical history, chest 
radiographs, and spirometry. Evaluation of the 
occupational and environmental history is 
especially important. The patient may have had 
only a few weeks of employment in construction 
or a shipyard as a summer job years before; yet, 
it is well documented that such brief exposures 
may manifest in asbestos related diseases 20 to 
30 years later. It is important to assess other oc­
cupational exposures, such as coal or hard rock 
mining, which may produce rounded opacities 
on radiographic evaluation. Family history is also 
important. Asbestos insulation workers, as in 
many trades, tend to work in that trade from gen­
eration to generation. Therefore, the possibility 
of asbestos exposure in the home as a child 
should not be overlooked. Although a single PA 
radiograph is recommended for screening for
asbestos related disease in the clinical evaluation, 
a lateral chest radiograph should also be obtained 
to evaluate the lung zones behind the heart and 
provide a baseline for future evaluation. Although 
impairment is better correlated with radiographic 
abnormality in asbestosis than in other forms of 
pneumoconiosis, it is still highly variable. 
Therefore pulmonary function evaluation is re­
quired to assess the nature and extent of lung 
function abnormality.
Symptoms and Signs: Unlike silicosis and 
coal workers’ pneumoconiosis, the asbestos 
worker may present with dyspnea in the absence 
of radiographic abnormality. Exertional dyspnea 
is the most prominent symptom with progres­
sion and is the major complaint in asbestosis. 
A chronic cough which is usually dry, but which 
may be productive especially among smokers 
and those working a dusty job, is another com­
mon finding. This is consistent with epidemio­
logical studies showing increased bronchitis and 
airways obstruction especially among smoking 
asbestos workers. With progression of asbes­
tosis, dyspnea becomes marked and is accom­
panied by tachypnea.
Pleural plaques or thickening are typically 
not accompanied by symptoms and may there­
fore be present years before detection. Some of 
these patients will report chest tightness or diffi­
culty taking a deep breath. With marked pleural 
thickening, dyspnea is usually the principal com­
plaint. Asbestos induced pleural effusions are not 
unusual and may cause pleuritic pain, but pleural 
pain is often not present even when a friction rub 
is heard.
Physical examination is usually not remark­
able, especially in early cases of asbestosis. In 
most cases, the first sign, and often the only sign, 
is crisp basal crepitations usually best detected 
anteriorly and laterally at the end of a full ins­
piration. Clear mid-inspiratory crepitations may 
be heard over the mid and lower lung zones in 
more advanced cases of asbestosis. Digital club­
bing is found in advanced asbestosis. Cyanosis, 
like clubbing, is a late sign in those with far 
advanced disease.
Physical findings in patients with pleural 
plaques or thickening are few unless the thicken­
ing is marked or an effusion is present. In such 
instances decreased thoracic expansion, dullness 
to percussion, and diminished breath sounds are 
found. Pleural friction rubs may also sometimes 
be detected in patients with pleural involvement.
Radiographic Findings: The radiographic 
findings of asbestosis and asbestos related pleu­
ral plaques and thickening are best described 
through systematic application of the 1980 ILO 
Classification for interpretation of the pneumo­
conioses (44). Guidelines for obtaining a tech­
nically satisfactory radiograph and for its inter­
pretation are included in the 1980 ILO Classi­
fication. Because of the well known variation in 
interpretation of radiographs from reader to 
reader, it is recommended that the ILO standard 
films be used as a guide and that more than one 
independent reading be obtained (89). This is 
especially important in evaluation of clinical 
series and in population studies.
The small irregular opacities of asbestosis 
are most commonly distributed in the mid and 
lower lung zones. Their profusion (number of 
opacities per unit area) is dependent on the de­
gree and length of asbestos exposure and may be 
quantified into categories (0,1,2,3, by the 1980 ILO 
Classification). The size and shape of the opac­
ities may be described by using the symbols “s” 
(irregular opacities less than 1.5 mm in diameter), 
“t” (irregular opacities 1.5 to 3.0 mm in diam­
eter), or “u” (irregular opacities greater than 3 
mm, but less than 10 mm in diameter). Rounded 
opacities (p,q,r) may also be seen, but if profuse 
should alert the reader to the possibility of other 
siliceous dust exposure—this pattern is not un­
common among asbestos miners and asbestos ce­
ment manufacturers. With progression, all lung 
zones may be affected and radiological evidence 
of honeycombing in the lower zones is not un­
usual (Figure 11-19). Rarely coalescence of opac­
ities may produce large opacities which are ill 
defined and may be several centimeters in diam­
eter (Figure 11-20). Other late manifestations in­
clude irregular diaphragmatic, pleural and cardiac 
borders (“shaggy heart”), often associated with 
pleural thickening or plaques (Figure 11-21).
It is, however, the early cases of asbestosis 
rather than the advanced cases which are diffi­
cult to interpret. It is known that smoking and 
repeated infections (bronchitis and pneumonia) 
may produce irregular opacities, especially in 
older individuals. Morgan et al. have shown that 
as a consequence, the frequency distributions 
of small opacities in persons with and without 
pneumoconiosis may be expected to overlap each 
other at a low profusion level (90). This obser­
•Figure 11*19. Advanced asbestosis—profusion 3/3 with all lung zones involved 
with six opacities.
'Source: American College of Radiology leaching Module on Asbestos Related Disease. 
American College of Radiology, Chevy Chase, Maryland, 1981 NIOSH contract.
vation, together with reader variability, means 
that caution must be used in ascribing low levels 
of profusion (0/1,1/0) to asbestos exposure, with­
out consideration of other factors or etiologies— 
scleroderma, lipoid pneumonia, desquamative 
interstitial pneumonitis, and sarcoid may all pre­
sent with basal irregular opacities similar to 
asbestosis.
Pleural plaques are fibrotic processes which 
begin below the surfaces of the parietal pleura, 
are usually smooth or nodular, are often bilat­
eral, and are rarely over 1 cm in thickness. They 
are most commonly found on the posterolateral 
or anterior chest walls between the sixth and 
tenth ribs and in the aponeurotic portion of the 
diaphragm. Pleural plaques tend to spare the 
apices and costophrenic angles and, with time, 
tend to calcify. Plaques vary from small circular 
or linear opacities to large irregular opacities—
some may encircle the lung. Even without calci­
fication, they are sufficiently characteristic that 
an asbestos etiology should be presumed when­
ever they are seen. They greatly assist in the 
assessment of early parenchymal disease.
The 1980ILO Classification provides an ex­
panded and complete scheme for codifying pleu­
ral changes arising from asbestos exposure (44). 
The reader is asked to note whether the dia­
phragm and costophrenic angles are affected. 
Classification is provided for both diffuse and cir­
cumscribed plaques by width (Q, A, B, Q  and ex­
tent (0,1, 2, 3) evaluated en face on projections. 
Finally, pleural calcification on the diaphragm, 
chest wall, or other sites may be specified.
Pleural plaques are often mimicked by the 
images of small divisions of the external abdom­
inal oblique and the serratus anterior muscles 
which originate from the external surfaces of the
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* Figure 11*20. Advanced asbestosis—profusion 2/3 with all lung zones involved 
with s/t opacities. Large opacities in left mid-zone. Poorly differentiated 
squamous cell carcinoma of the right hilum.
* Source: American College of Radiology Teaching Module on Asbestos Related Disease 
American College of Radiology, Chevy Chase, Maryland, 1981 NIOSH contract.
ribs posteriorly and laterally. Unlike most plaques, 
however, these images are bilaterally symmetri­
cal, occur in rhythmic sequence along the lateral 
chest walls, are generally smooth, regular, and 
less opaque than plaques. Oblique radiographs 
are often useful in differentiating these shadows 
from plaques or to better define plaques.
Lung Function; Lung function testing has 
been applied to the study of asbestosis since its 
introduction to clinical medicine in the 1940’s. 
The specific type of lung function test is dictated 
by the type of investigation. Spirometry has 
served well as a tool for industrial medical sur­
veillance and for prospective epidemiological 
studies. Assessment of lung volumes and gas ex­
change (Dlcq and arterial blood gases) have 
been useful additional laboratory tests used to 
evaluate those exposed to asbestos.
Classically, advanced asbestosis has been 
considered as a disease which restricts lung 
volumes (especially VC, and to a lesser extent, 
RV) and produces gas exchange measurements 
consistent with an “alveolar capillary” block (i.e., 
decreased Dlc0 and in more advanced cases, 
depressed resting Pao2)(3). C 02 exchange is 
usually not affected. In far advanced cases 
arterial oxygen desaturation is observed; this 
usually corresponds to central cyanosis and 
marked dyspnea.
Recent papers on lung function among those 
with asbestosis have suggested that a mixed re­
strictive and obstructive pattern and obstructive 
defect are also commonly found among those 
with asbestosis. In 1972, Muldoon and Turner- 
Warwick reported 13 of 60 asbestos workers 
evaluated at the Brompton Hospital had a pure
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* Figure 11*21. Chronic calcified fibrous pieuritis involving the right chest wall 
and costophrenlc angle.
‘Source: American College of Radiology Teaching Module on Asbestos’Related Disease. 
American College of Radiology, Chevy Chase, Maryland, 1981 NIOSH contract.
obstructive ventilatory defect; 3, a mixed pattern; 
32, restriction; and 12 were normal (72). In 1975, 
Foumier-Massey and Becklake reported that 
among 1,000 Canadian asbestos miners and 
millers, 12.8 Vo had a restrictive pattern and
12.2 Vo an obstructive pattern (30). Murphy et al. 
in a study of shipyard workers, found no more 
obstruction among asbestos workers than matched 
controls (94). However, Rodriquez-Roisen et al. 
recently reported an obstructive pattern, defined 
by reductions in forced expiratory flow at 75Vo 
of the vital capacity, in 34 of 40 asbestos workers 
referred to the Pneumoconiosis Medical Panel 
and the Brompton Hospital, London (114). 
Although only 7 of 34 were considered non- 
smokers, the authors suggest that airways ob­
struction, particularly affecting small airways, is 
a common functional abnormality attributable
to asbestos exposure. This view is consistent with 
pathological observations which show peribron­
chiolar fibrosis to be an early lesion in asbestosis 
(see Pathology). The extent and severity of ob­
structive defects among asbestos workers, how­
ever, still needs full epidemiological evaluation 
with attention to other risk factors, especially 
smoking.
Other Medical Tests: Serological tests of 
those with asbestosis have shown increased levels 
of antinuclear factor (ANF) and rheumatoid fac­
tor (RF)(142)(147). Others have reported normal 
levels in mild cases, suggesting that these findings 
may be the result of nonspecific lung damage 
(24)(144). However, Gregor et al. have recently 
reported a series of 119 subjects followed pro- 
spectively at the Brompton Hospital and assess­
ed for progression in asbestosis relative to auto­
antibody status (36). Although the numbers were 
small, there was some suggestion that those who 
showed a progression over three to seven years 
had higher antinuclear antibody titers and with 
greater frequency. These authors suggest that this 
finding, if confirmed, might indicate a greater 
degree of inflammation associated with greater 
alveolar macrophage turnover; this may be an 
important event in rapid progression among 
some with asbestosis.
HLA phenotype is another serological test 
which has been studied in relationship to asbesto­
sis, extent of radiographic profusion, and pro­
gression of asbestosis. In a preliminary study, 
Merchant et al. reported a slight increase in 
H LA-2 7 phenotype among men with asbestosis 
and this was associated with a greater degree 
of fibrosis (radiographic profusion) (82). How­
ever, upon prospective evaluation of the HLA 
system in asbestosis, Turner-Warwick concluded 
that HLA phenotype was not of significant im­
portance in the etiology of asbestosis (146).
PREVENTION
Available epidemiologic data support a 
linear, no threshold dose-response relationship 
between asbestos exposure and the risk of lung 
cancer. Additionally, no threshold has been con­
vincingly demonstrated for nonmalignant respi­
ratory diseases associated with asbestos exposure. 
Thus, any asbestos exposure carries with it some 
increased risk of asbestos related diseases. Ac­
cordingly, asbestos exposure should be eliminated 
or reduced to the lowest level possible.
The most effective method for eliminating 
asbestos related diseases is substitution of less 
toxic materials or modification of a process or 
product to eliminate asbestosis. Materials com­
monly used for substitution include fibrous glass, 
rock wool, slag wool, and various ceramic and 
man-made fibers. Asbestos pipe insulation has 
been satisfactorily replaced with calcium-silicate 
insulation block. These substitute materials are 
not totally without risk; thus appropriate work 
practices and engineering controls are still 
required.
Appropriately designed and maintained 
engineering techniques are the control method 
of choice where asbestos substitutes cannot be 
used. Processing of asbestos in a wet state has 
been shown to be an effective control method 
in many asbestos processing industries, includ­
ing the asbestos textile industry. The most com­
monly used control measure in asbestos process­
ing plants is local exhaust ventilation whereby 
liberated dust is collected at the dust source and 
removed from the breathing zone of workers. 
Methods of local exhaust ventilation also have 
been developed for handtools such as saws and 
drills used in the construction industry.
Appropriate work practices are an impor­
tant component of any dust control program. 
These include use of wet methods or high effi­
ciency vacuum cleaners for cleaning of asbestos 
contaminated areas and proper disposal of asbes­
tos contaminated waste. Showering and chang­
ing of work clothes at the end of the work shift 
are important in eliminating “take-home” expo­
sures. Respiratory protection is appropriate for 
short-term jobs or operations where controls may 
be unfeasible; however, use of respirators is not 
an acceptable substitute for engineering controls.
The combined effects of asbestos exposure 
and cigarette smoking in increasing the risks of 
lung cancer and asbestosis are well established. 
In addition to reducing or eliminating asbestos 
exposures, asbestos workers should be educated 
on the multiplicative risks of smoking and as­
bestos exposures and encouraged not to smoke. 
Anti-smoking programs are important for as­
bestos workers.
Various regulations have been promulgated 
in the United States specifying exposure limits, 
exposure monitoring requirements and medical 
surveillance requirements. In 1972, the Occupa­
tional Safety and Health Administration pro­
mulgated its first exposure standard for asbestos 
fibers, specifying a limit of five fibers/cc of fibers 
longer than 5/im (fibers/cc) on an eight hour 
time-weighted-average basis. This was reduced to 
two fibers/cc on July 1,1976. Subsequent reviews 
of new literature on health hazards of asbestos 
prompted the National Institute for Occupa­
tional Safety and Health to recommend an eight 
hour exposure limit of 0.1 fiber/cc and elimina­
tion of all but essential uses of asbestos.
Research Priorities: Although asbestosis is 
well characterized clinically and has been the 
subject of a good deal of epidemiological re­
search, a number of research priorities remain:
1. Epidemiological studies are needed to 
further characterize: potential asbestos 
risk from exposure in the railroad in-
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dustry; tremolite exposure from contami­
nated vermiculite and talc in the users of 
these products; the risk (if any) among 
those working in the crushed stone in­
dustry; and to assess the risk of pleural 
abnormalities in the absence of paren­
chymal changes.
2. Research is needed to further assess dif­
ferences in lung cancer and pneumo­
coniosis risks for various manufacturing 
and mining populations.
3. Pathological standards developed to char­
acterize asbestosis need to be tested for 
reliability and validity in a controlled 
trial.
4. More sensitive and specific tests are need­
ed to assess asbestos lung deposition and 
injury.
5. Immunological, serological, and bron­
chial lavage studies of the progression of 
asbestosis are needed to better charac­
terize the natural history of asbestosis.
6. Experimental animal and clinical trials 
with promising chemotherapeutic modal­
ities, for both asbestosis and asbestos as­
sociated cancer, should be a high priority.
7. Research must continue on other fibrous 
materials, such as wollastonite and fine 
fibrous glass and mineral wool, to docu­
ment other health effects which may be 
associated with these fibrous materials.
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OCCUPATIONALLY INDUCED LUNG CANCER 
EPIDEMIOLOGY
Richard A . Lem en
INTRODUCTION
It has been estimated that lung cancer will 
kill approximately 77,000 men and 28,000 women 
in the United States during 1981 (16). This ac­
counts for 3 4 Vo of all types of cancer deaths in 
males and for 15 Vo in females. It is expected that
122.000 new cases of lung cancer will occur in 
the United States in 1981. This will account for 
a total of 22Vo of deaths in males and 8Vo of 
deaths in females. The age-adjusted lung cancer 
death rates have increased steadily in men from 
5 per 100,000 deaths in 1930 to about 70 per
100.000 deaths in 1980. In females, the rate did 
not climb as steadily: from 2 to 3 per 100,000 
deaths in 1930 to about 7 to 8 per 100,000 deaths 
in the mid-sixties. However, from the mid-sixties 
to 1980, the rate has increased rapidly to approx­
imately 18 per 100,000 deaths. It has been sug­
gested that the rapid rise in lung cancer among 
females is because of the increasing number of 
women in the work force and because many 
more women have taken up smoking (128).
ASBESTOS 
Occupational Exposure—Historical Studies
In 1935, 55 years after the usage of asbestos 
was introduced on a large-scale basis in industry, 
suspicion of an association between asbestosis 
and lung cancer was reported by Lynch and 
Smith (75) in the United States and by Gloyne 
(38) in the United Kingdom. About 10 years 
later, case reports of pleural and peritoneal 
tumors associated with asbestos began to appear 
(144)(145)(149). Epidemiologic evidence from 
Doll showed a tenfold risk of lung cancers in the 
U.K. asbestos textile workers who had been em­
ployed from 1930, that was prior to regulations 
that were written to help workers improve dust 
conditions in factories (27). Similar findings were
reported in the United States in 1961. Meso­
theliomas were also detected, but this fact was 
not published until later (81)(119). Possible 
variations in risk with other types of asbestos 
fibers were rarely considered in the earlier re­
ports. Since 1964, following the recommenda­
tions of the UICC Working Group on Asbestos 
Cancers (UICC 1965)(136) for new studies, there 
has been an expansion of epidemiological studies 
in many parts of the world.
Epidemiologic Studies—Lung Cancer
Mixed Fiber Types
In most industrial processes different fiber 
types are mixed, so that pure exposures to a 
single asbestos type are rare. Mortality studies 
of defined populations of asbestos manufactur­
ing, insulating, and shipyard workers have pro­
vided the most concrete evidence concerning the 
association between bronchial cancer and ex­
posure to asbestos. Reports received from several 
countries: England (30)(92), Germany (12), the 
United States (118), the Netherlands (129), and 
Italy (112) have confirmed this evidence.
Elmes and Simpson (31) have extended their 
earlier report (30) to include deaths occurring 
since 1965 through 1975. The mortality trend has 
shifted from a preponderance of asbestosis and 
gastrointestinal deaths to malignancies from lung 
cancer and mesothelioma, (diseases associated 
with longer latent periods). These authors report 
that their findings would suggest any standard 
based “on the prevention of asbestosis, may not 
provide adequate protection against neoplasia.”
A sevenfold excess of lung cancer was found 
in a group of insulation workers who had been 
exposed to chrysotile and amosite asbestos, but 
not crocidolite (121). Enterline and Henderson 
reported a 4.4 times increased risk of (respiratory 
cancer) mortality among retired men who had
73
worked as production or maintenance employees 
in the asbestos industry and who had been ex­
posed to mixed fibers (32). Among men with 
mixed fiber exposure (crocidolite and chrysotile) 
in the asbestos cement industry, the rate was 6.1 
times the expected rate. In a British naval dock­
yard population, Harries showed that there had 
been an increased rise in mesotheliomas since 
1964 (43). However, the full biologic effects of 
asbestos in shipyard workers would not have 
been expected to be detected until the 1970’s and 
thereafter (117).
Edge reported that shipyard workers with 
mixed asbestos exposure and pleural plaques 
(without evidence of pulmonary fibrosis) had a
2.5 times increased risk of developing carcinoma 
of the bronchus, when compared with matched 
controls without plaques (29). In a study of sheet- 
metal workers with measurable and mixed as­
bestos exposure, an excess of deaths from malig­
nant neoplasms (24.7 Vo of the deaths for two co­
horts, selected for 5 or more years, who worked 
in the trade; with 19.1 Vo of deaths for a group 
where 14.5Vo was expected) was largely at­
tributed to an excess of malignant tumors of the 
respiratory tract (21). Of the 307 deaths in the 
first cohort, 32 lung cancer deaths were signifi­
cantly in excess (1.7 times the expected level).
Weill et al. reported on the mortality experi­
ence of a cohort of 5,645 men employed in the 
production of asbestos cement products and who 
had at least 20 years since first exposure (146). 
These workers were exposed largely to chrysotile 
with some crocidolite and amosite. Among this 
group, 601 persons were identified as deceased 
by the Social Security Administration. The vital 
status of 25 Vo was unknown, and were assumed 
to be alive, which probably resulted in under­
estimation of the true risk. Death certificates 
were obtained for 91 Vo of the known dead. Dust 
exposures were estimated, using each worker’s 
employment history in conjunction with histor­
ical industrial hygiene data.
Weill et al. observed increased respiratory 
cancer mortality only among those with exposure 
in excess of 100 mppcf-year, where 23 cases were 
observed vs. 9.3 expected (146). The unusually 
low SMR for all causes in the low-exposure 
groups suggests the possibility of a selection bias 
and any interpretation of risks at low exposures 
should be done with caution. Separating the 
cohort by fiber type exposure, the authors con­
cluded that the addition of crocidolite to chryso­
tile enhanced the risk for respiratory malignancy; 
however, an excess risk was observed among 
those not exposed to crocidolite with cumulative 
exposures in excess of 200 mppcf-months. Both 
average concentration of exposure and duration 
of exposure were found to be related to cancer 
risk.
McDonald and McDonald studied the mor­
tality of 199 workers exposed to crocidolite dur­
ing gas mask manufacture in Canada from 1939 
to 1942 (84). This cohort was followed through 
1975, when by this time 56 deaths occurred. Out 
of these 56 deaths, 4 (7Vo) were from meso­
thelioma and 8 (14Vo) from lung cancer.
Chrysotile
McDonald et al. reported an increased risk 
of lung cancer among men employed in Quebec 
chrysotile mines and mills (85)(86). The risk of 
lung cancer among those workers most heavily 
exposed was five times greater than those least 
exposed.
Kogan et al. investigated the cancer mortal­
ity among workers in asbestos mining and mill­
ing industries between 1948 and 1967 (54). The 
total cancer mortality rate among workers was
1.6 times higher than that found in the general 
male population; for female workers the rate? 
were 0.8 times higher for those in mines and 1. 
for those in mills. The lung cancer risk for maji 
miners and millers was twice that of the general 
male population. For females in mines and mills, 
the risks were 2.1 and 1.4 times that of the gen­
eral female population, respectively. For workers 
over 50 years of age, the risk of lung cancer was 
greater: for men in mining, 4.0; those in milling, 
5.9; for women in mining, 9.5; and those in mill­
ing, 39.8 times that found in the general 
population.
Wagoner et al. reported on the cancer risk 
among a cohort of workers in a major manu­
facturing complex utilizing predominantly chry­
sotile asbestos in textile, friction, and packag­
ing products (143). An excess of respiratory can­
cer occurred among asbestos workers in each 
duration-of-employment category down to and 
including one through nine years. They observed 
statistically significant standard mortality ratios 
of 122 for all malignant neoplasms of the res­
piratory system. The asbestos workers in this 
study were located in the area of predominant­
ly Amish dutch population with known low fre­
quencies of smoking. The authors, nevertheless,
74
used the general white male U.S. population as 
a control group, which most likely resulted in 
an underestimation of the degree of risk.
Robinson et al. (106) reported an additional 
8 years of observation and 385 deaths to the 
Wagoner et al. (143) study of mortality patterns 
of workers among one facility manufacturing 
asbestos textile, friction, and packing exposed 
predominately to chrysotile. Except for 3 years 
(during World War II), chrysotile constituted over 
99Vo (per year) of the total quantity of asbestos 
processed. During those 3 years, amosite was 
selectively used to a limited extent because of 
Naval specifications and accounted for approx­
imately 5Vo of the total asbestos used per year. 
Crocidolite and amosite (for the other years) ac­
counted for less than lVo of the total usage in 
very selected areas. Exposures to these two types 
may have played a role in the etiology of disease; 
however, due to the overwhelming exposure of 
the cohort to chrysotile, it is likely that the other 
exposures played a minor role in the overall mor­
tality patterns. Robinson et al. confirmed the 
observations of Wagoner et al. that statistically 
significant excess deaths were due to bron­
chogenic cancer.
Weiss reported no unusual mortality ex­
perience over a 30-year period for a cohort of 
workers employed in a paper and millboard plant, 
reported to be using only chrysotile (147). The 
author concluded the study results were suggestive 
of a minimal hazard from chrysotile. This con­
clusion must be viewed in light of the limitations 
inherent in the study. First, the population studied 
was small (n=264) and only 66 workers had died 
at the time of the analyses. Moreover, the 
unusually low SMR for many of the contrasts in 
the Weiss et al. paper suggests the possibility of 
a selective bias greater than usually seen when 
contrasting industrial populations are contrasted 
with the general population.
Enterline and Henderson found that retired 
men who had worked as production or main­
tenance employees in the asbestos industry, and 
had been exposed only to chrysotile, and who had 
reached 65 years of age, had a respiratory cancer 
risk 2 to 4 times greater than that expected (32). 
Among men within the asbestos cement industry 
exposed only to chrysotile, a one- to four-fold 
excess of respiratory cancer was found.
Anthophyffite
In Finland, anthophyllite mining has been 
associated with an excess bronchial cancer risk
of 1 to 4 times the overall expected and about 
double this figure for those with more than 10 
years’ exposure time (53)(87)(88).
Synergism
There is marked enhancement of the risk 
of lung carcinoma in those workers exposed to 
asbestos who smoke cigarettes (11X25). Hammond 
and Selikoff interpret the excess lung carcinoma 
risk from asbestos in nonsmokers to be small 
(41). No link between cigarette smoking and 
mesotheliomas has been observed in a prospec­
tive study by Hammond and Selikoff (41). A pre­
liminary study on female workers employed be­
tween January 1940 and December 1967, in a 
predominantly chrysotile asbestos textile plant, 
revealed 7 lung cancer deaths among 580 women 
when only 0.63 deaths were expected (p<0.01) 
(64). One lung cancer death was observed in a 
smoker, two in women of undetermined smok­
ing history, and four in women who “ never” 
smoked cigarettes (as determined from hospital 
admission charts).
It is important to note that the historic docu­
mentation of cigarette consumption patterns is 
lacking for most retrospective cohort studies 
done on asbestos workers. It is also important 
to note that a sizable portion of the general 
population, the group usually selected for com­
parison in these studies, are cigarette smokers. 
Therefore, the risk of lung cancer demonstrated 
for these industrial groups exposed to asbestos 
is of such magnitude that it precludes the iden­
tification of an independent etiologic role for 
cigarette smoking.
Hammond et al. have attempted to correct 
this methodological problem by comparing 12,051 
asbestos insulation workers having complete smok­
ing histories to a control population, with no 
smoking histories (42). Their control population 
consisted of 73,763 men from the American Cancer 
Society’s prospective cancer prevention study who 
were similar to the asbestos workers in that they 
were white males; nonfarmers; had no more than 
a high school education; a history of occupa­
tional exposure to dust fumes, vapors, gases, 
chemicals, or radiation; and were alive as of 
January 1, 1967. Non-smoking asbestos workers 
showed a five times greater risk of dying from 
lung cancer than their smoking controls. Both 
smokers and nonsmokers exhibited a fivefold 
relative risk; however, the attributable risk was 
greater among the smokers. This higher at­
tributable risk can be accounted for by the large
number of smokers in the asbestos-exposed 
population and the comparison population.
Liddell et aL has also studied the smoking 
patterns among asbestos workers through ad­
ministering questionnaires to living workers or 
relatives of deceased workers, who died after 1951 
(68). The authors report SMR’s of 48 and 46 for 
nonsmokers and ex-smokers, increasing to 206 
for heavy smokers. This study is unreliable 
however, because specific smoking death rates 
were not used for the calculation of expected lung 
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The primary malignant neoplasm of the pleura 
—diffuse pleural mesothelioma—has been recog­
nized and accepted as a nosologic entity only 
during the last 20 years (77), although as early 
as 1767 Joseph Lieutand (cited by Robertson) 
reported twô cases of probable mesothelioma 
among 3,000 autopsies, and E. Wagner describ­
ed the pathology in 1870 (53)(72).
It is not known with certainty when the term 
“mesothelioma” was first used; one of the early 
reports indicating a primary and malignant tumor 
of the pleura and using the term mesothelioma 
was that by Du Bray and Rosson (14).
In 1931, Klemperer and Rabin published a 
comprehensive description of the distinctive fea­
tures of diffuse pleural neoplasms and recom­
mended these tumors “should be designated 
mesothelioma^ since they arise from the surface 
lining cells of the pleura, the mésothélium (27). 
The malignant, diffuse pleural mesothelioma 
arises from the multipotential coelomic 
mésothélial cell of the pleura. Similarly, malig­
nant tumors originating in the mésothélial cells 
of the peritoneum are peritoneal mesothelioma.
The definition of pleural mesothelioma thus 
includes:
• the origin of the tumor in the mésothélial 
cells of pleura
• the diffuse character of the tumoral growth, 
often involving a large surface or even the 
entire pleura of one lung, at the time of 
diagnosis
• the characteristic rapid growth and exten­
sion over the surface of the pleural serosa 
(closely related to the diffuse character)
• the high degree of malignancy, expressed 
in rapid growth, local invasiveness (soft 
tissue and bone structures of chest wall,
underlying lung, adjacent pericardium, 
regional lymph nodes), and frequent me- 
tastases to a variety of organs, including 
brain, liver, kidney, adrenals, etc. These 
characteristics of pleural mesothelioma 
have an integrative expression in the mean 
survival time after diagnosis, which does 
not exceed 12 months in most reported se­
ries, with or without therapeutic attempts.
The association between malignant “endo­
thelioma of the pleura” (mesothelioma) and 
asbestos exposure was first reported by Wyers 
(80). Wagner et al., published a report on 33 cases 
of diffuse pleural mesothelioma from the North 
West Cape Province of South Africa; most of 
these cases had occurred over a four year period, 
and in all but one, exposure to asbestos 
(crocidolite) could be established (77). Mesothe­
lioma was not necessarily preceded by asbestosis 
(interstitial pulmonary fibrosis); the exposure was 
occupational in some cases, but in others, only 
environmental (residential) exposure had occur­
red. The long latency period—a mean of 40 
years—between initial asbestos exposure and the 
development of malignant pleural mesothelioma 
was another striking characteristic of these cases. 
The carcinogenic hazard of relatively low levels 
of asbestos exposure; the possibility that pleural 
mesothelioma associated with asbestos exposure 
may develop in the absence of preceding 
pulmonary interstitial fibrosis; and the long 
latency period between onset of exposure and 
development of the malignant mesothelioma, 
were thus outlined.
LIST OF CAUSATIVE AGENTS
Asbestos fiber is widely accepted as the caus­
ative agent in the vast majority of mesothelioma 
cases. So far, asbestos is the only fibrous mineral
where epidemiologic data have shown an asso­
ciation between exposure and pleural and peri­
toneal mesothelioma in man.
Asbestiform minerals are grouped in two 
major categories: chrysotile, which is a serpen­
tine, and the amphiboles, which include croci- 
dolite, amosite, anthophyllite, and tremolite.
The first large group of malignant pleural 
mesothelioma cases due to asbestos exposure was 
related to crocidolite in South Africa (77). This 
fact, and subsequent reports on mesothelioma 
cases from Great Britain where crocidolite had 
been extensively used, contributed to the em­
pirical and one-sided view that crocidolite was 
the main or even the only type of asbestos with 
a specific carcinogenic potential resulting in the 
eventual development of mesothelioma.
The major increase in mesothelioma inci­
dence in the United States—where chrysotile has 
been and still is the main type of asbestos used— 
supports a causal association between chrysotile ex­
posure and development of mesothelioma 
(4)(31X59X63)(64). Epidemiologic evidence for 
worker cohorts has shown chrysotile to be equally 
as potent as other fiber types insofar as lung 
cancer is concerned (13X49X80). While the number 
of mesothelioma cases from populations exposed 
only to chrysotile has been small, an association 
with chrysotile exposure has been definitively 
established. Amosite has also been shown to have 
a similar carcinogenic effect; a significant 
number of mesothelioma cases have occurred in 
a cohort of 933 amosite factory workers(62). 
Experimental studies on rats using inhalation of 
five types of asbestos fiber resulted in the devel­
opment of mesothelioma with chrysotile (Cana­
dian), crocidolite, amosite, and anthophyllite 
(74). Previous experiments using intrapleural ad­
ministration of amosite, chrysotile, and croci­
dolite had given similar results, with chrysotile 
giving the largest number of mesotheliomas, fol­
lowed by crocidolite and amosite (73). Shabad et 
aI  also reported on the experimental production 
of pleural mesothelioma in rats, with intrapleural 
administration of chrysotile (65). Thus, both 
epidemiologic evidence and experimental confir­
mation indicate that chrysotile, amosite, and 
crocidolite asbestos are causative agents for 
mesothelioma.
Recently another type of fibrous mineral— 
naturally occurring zeolites (aluminum silicates) of 
the fibrous variety (erionite, mordenite)—has come 
under close scrutiny as a potential causative agent
for malignant mesothelioma. The evidence for this 
association is based on the findings in a rural area 
of endemic mesothelioma in Turkey, where 
mineralogic investigations have not found any 
asbestos minerals, but have identified fibrous 
zeolites. Although this is still being actively resear­
ched and conclusive evidence is not yet resolved, 
fibrous zeolites are considered highly suspicious 
at the present time.
Reports on endemic mesothelioma in other 
parts of the world—such as in a rural area in 
India—have not yet identified the etiologic agent; 
the possibility that zeolites may be the causative 
agent cannot be excluded, since zeolites are 
known to be present in that area.
Experimental studies using intrapleural appli­
cation suggest that other fibrous materials, such 
as fibrous glass, may also induce malignant meso­
thelioma (68). Epidemiologic evidence for fibrous 
glass as a causative agent for mesothelioma has 
not been reported, but fibrous glass has to be in­
cluded as a suspected causative agent.
LIST OF OCCORATIONS AND 
INDUSTRIES INVOLVED
Occupations and industries at risk to meso­
thelioma include all of those listed for asbestosis.
All available information indicates that 
mesothelioma may be the result of low levels 
and/or relatively short (of the order of several 
weeks to several months) asbestos exposure. The 
dose-response relationship for mesothelioma is 
therefore different than that for asbestosis (which 
develops with higher exposure levels over longer 
time periods) or bronchial carcinoma associated 
with asbestos exposure (which increases in inci­
dence even after short periods of high asbestos 
exposure levels, but shows a marked increase in 
incidence with duration of exposureX58). Since 
low asbestos exposure levels carry a significant risk 
of mesothelioma, occupations and industries 
characterized by relatively low asbestos levels (auto 
mechanics and brake repair, tapers in dry wall 
construction, handling of finished asbestos pro­
ducts including asbestos cement), while at relative­
ly low risk for the development of parenchymal 
interstitial fibrosis (asbestosis), are nevertheless at 
high risk for mesothelioma.
Equally important is the fact that numerous 
workers in the various trades which do not simply 
direct asbestos exposure, such as electricians, 
painters, welders, carpenters, etc., in shipbuilding 
or ship repair, in construction, in maintenance
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work at chemical plants, and even automobile 
salesmen supervising repair work, are frequently 
exposed to asbestos due to their mere presence 
in work areas where asbestos is being handled. 
This “bystander” exposure has been repeatedly 
documented to be responsible for numerous cases 
of mesothelioma (20)(51). It is therefore impor­
tant to establish the principle that such indirect 
exposure carries a significant risk of mesothe­
lioma.*
Whitwell et al. found that 83Vo of meso­
thelioma cases reviewed contained over 100,000 
asbestos fibers per gram of dried lung tissue; in 
cases of asbestosis the number of asbestos fibers 
was much higher, exceeding 3,000,000 per gram 
of dried lung tissue (79).
In shipyard workers, more and more meso­
thelioma cases have been reported; most of these 
have occurred in trades other than insulation work­
ers, indicating that the risk is widespread (20X61). 
The distribution of trades in private shipyards 
in the United States in 1943 is presented in Table 
VIII-24. A list of occupational titles in an Eastern 
U.S. shipyard in 1975 is given in Table VIII-25.
It is difficult to construct a complete list of 
all occupations in which asbestos exposure may 
occur at one time or another. Since short-term as­
bestos exposure (several weeks to several months) 
is often responsible for mesothelioma occurring 
25, 30, 40, or 50 years later, the occupation/in­
dustry involved at the time of the diagnosis of a 
malignant tumor may differ from the occupation/ 
industry where the exposure actually occurred. 
Therefore, at any point in time; much higher num­
bers of individuals are al risk for the development 
of mesothelioma than those working in industries 
and occupations known to be associated with 
asbestos exposure. Recollection of remote past ex­
posures and of specific jobs in which they occur­
red is a formidable task, but crucial when assess­
ing whether one particular case of mesothelioma 
is related to past asbestos exposure.
EPIDEMIOLOGY
The relationships between asbestos exposure 
and pleura! mesothelioma regarding latency peri­
od, dose-response characteristics, populations at 
risk, and incidence of disease have been pre­
sented in the section—List of Occupations and 
Industries Involved, page 672.
Pleural mesothelioma is a rapidly progres­
sing malignant tumor, the resulting disability is
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Source: Bureau of Labor Statistics, Bulletin 824, “War­
time Employment, Production, and Conditions of 
Work in Shipyards,” 1945.
total, and the condition is usually fatal in one 
to two years. There are no confounding condi­
tions or risk factors which limit the ability to 
establish cause-effect relationships.
ESTIMATE OF POPULATION AT RISK 
AND PREVALENCE OF DISEASE
The population at risk for developing meso­
thelioma includes:
• all occupations with direct contact and 
handling of asbestos.
• employees with other occupations (elec­
tricians, welders, painters, carpenters, etc.) 
who work or have worked—even for short 
periods—in areas where asbestos has been 
handled by others.
• family members (household contacts) of 
asbestos workers who have been exposed 
to asbestos fibers brought into the house­
hold by the worker. Household contami­
nation has been found to result in asbestos 
exposure of family members of asbestos 
workers, sufficient in magnitude to induce 
mesothelioma (1X2X5X32X41X46X55X56).
• individuals who have resided in the vi-
87
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cinity (one mile) of an asbestos plant, 
shipyard, or other source of asbestos con­
tamination.
The population at risk at any point in time 
has to include all persons who have been exposed 
in the past. Given the long latency period be­
tween asbestos exposure and development of 
mesothelioma (on the average 35-40 years), in­
dividuals who have been exposed (even for short 
periods of time) during the last 50 years have to 
be considered potentially at risk.
Contributing to the population size at risk 
is (1) the fact that short duration of asbestos ex­
posure (several weeks to several months) is suf­
ficient to induce mesothelioma; (2) the high job 
mobility, especially during World War II; (3) the 
marked increase in the total amount of asbestos 
used per year; and (4) the diversification of its 
uses. The estimate of the population at risk is, 
for the same reasons, a complex and difficult 
task.
Attempts to assess the incidence of meso­
thelioma in populations at risk are also fraught 
with difficulties; these have multiple sources.
1. The complexity of the diagnostic criteria, 
which require pathologic confirmation; 
the most rigorous criteria make the diag­
nosis dependent on a complete autopsy 
(for the exclusion of another primary site 
of the tumor, which might have metasta-
sized to the pleural cavity). Only a pro­
portion of all deaths are followed by a 
postmortem examination. This propor­
tion varies with geographic area, with the 
time period considered, and with other 
factors.
2. Even when tissue specimens are examined 
by experienced pathologists, the diagnosis 
is not always simple; differences of opin­
ion may persist and result in conclusions 
on the pathologic characteristics such as 
“ possible mesothelioma” or probable 
mesothelioma.*’
3. Evaluation of the incidence of meso­
thelioma from death certificates has been 
reported, by all those who have investi­
gated this problem, as incomplete, leading 
to a marked but quantitatively variable 
underestimate of the number of cases. 
This problem is compounded by the fact 
that the coding of causes of death does 
not provide a separate code for mesothe­
lioma, but includes it with cancer of the 
lung or pleura.
4. The most reliable data are those based on 
the cohort approach: asbestos-exposed 
employees followed for many years, with 
a comprehensive assessment of causes of 
death. The long latency period between
onset of asbestos exposure and mesothe­
lioma has resulted in a limited number 
of studies with a long enough follow-up 
period to realistically reflect its incidence. 
In all these cohort studies, most with 
several reports published over time, it is 
a rule without exception that the longer 
the observation period, the higher the in- 
. cidence of mesothelioma.
Although the most relevant data on meso­
thelioma risk in asbestos-exposed populations are 
derived from long-term cohort studies, other 
studies following different approaches have also 
revealed the paramount importance of long-term 
follow-up and completeness of diagnostic means. 
The most significant information follows.
By 1965, 160 cases of mesothelioma had 
been recorded in the United Kingdom, 123 from 
England and Wales, 36 from Northern Ireland, 
and only one from Scotland (39). When a 
systematic review of all necropsy and surgical 
biopsy reports in all hospitals was undertaken, 
80 cases of mesothelioma were found to have 
occurred in Scotland for the years 1950-1967. 
Many cases were in employees who had had no 
direct exposure to asbestos but had been em­
ployed in the shipbuilding industry, in a wide 
variety of trades.
The Mesothelioma Register in Great Britain 
(Employment Medical Inspector’s Advisory Ser­
vice)—with data sources in death certificates, 
Cancer Bureau registrations, Pneumoconiosis 
Medical Panels (claims for benefits under the 
National Insurance Acts), chest physicians, 
surgeons, pathologists and coroners—had 413 
cases reported for 1967-1968; 75Vo of the con­
firmed cases with definite asbestos exposure 
came from shipbuilding, asbestos factories, and 
insulation work; the other 25 Vo from a variety 
of occupations (welders, electricians, gas work­
ers, mechanics, chemical workers, etc.). The 
highest rate/million per year of mesothelioma 
(confirmed cases) figures were 8.93 and 8.24, 
both in shipbuilding areas. The incidence of 
definite mesothelioma in the United Kingdom 
for the period 1967-1968 was 120 per year. It was 
concluded that this figure may considerably 
understate the true incidence.
McDonald and McDonald reviewed evi­
dence published between 1959 and 1976, includ­
ing cohort studies of asbestos workers; “ popula­
tion studies** (mesothelioma surveys in Canada 
and the United States describing “ case-series
referable to some kind of denominator” ); case 
reports unrelated to any denominator; and mor­
tality statistics, mainly in Canada, the United 
States, and the United Kingdom (37). Data from 
the Third U.S. National Cancer Survey (42) was 
also reviewed. A total of 4,539 cases had been 
published after 1958. (This figure did not include 
cases from official mortality statistics and Third 
U.S. National Cancer Survey.) The incidence of 
mesothelioma for the period preceding 1958 had 
been very low: in 1957 Hachberg mentioned 43 
cases in 60,042 autopsies over the 40-year period, 
1910-1949, i.e., less than 1 case per year and only
0.07 Vo of the autopsies performed (Philadelphia, 
Baltimore, Minneapolis, New York, and Toronto 
in North America and Munich, Prague, and 
Copenhagen in Europe).
The marked increase in the incidence of 
mesothelioma over the last 20 years is evident 
when comparing the total number of reported 
cases (436) for the period 1955-1959, with that 
of 1,697 cases of mesothelioma for the period 
1965-1969 (an almost fourfold increase). In­
terestingly, 9Vo of cases were due to neighbor­
hood or household-family exposure.
In the Third National Cancer Survey (1975), 
a thorough ascertainment was done using hos­
pital records and pathology material, besides death 
certificates, in selected areas comprising approx­
imately lOVo of the population of the United States 
(deaths in 1971). The annual rate per million for 
males 45 and over was 11.20 and for females in 
the same age range, 3.53.
Reports from other countries, such as Ger­
many, Sweden, the Netherlands and Great Brit­
ain, indicate much higher rates than those published 
for Canada by McDonald (10 per million for 
males and 4 per million for females, over 
45-years-old) for some cities and regions, most 
with large shipyards: Walcheren had a death rate
23.3 times higher than that expected according 
to the Canadian rates; Wilhelmshaven (21.5 times 
higher); Plymouth (14.3 times higher); and Rot­
terdam, Harlem, Hamburg, Malmo, Nantes, and 
Trieste (with rates 7-8 times higher) (38)(51)(69). 
These data indicate that annual incidence rates 
for mesothelioma in geographical areas with 
shipyards and/or other important asbestos in­
dustries or uses are of the order of 200/1 million 
or higher, for men aged 45 or over.
The most relevant data on the incidence of 
mesothelioma in exposed populations are derived 
from cohort studies of occupational groups. But
only studies with long follow-up (3040 years) can 
provide comprehensive information, although even 
these might not include all the cases. It has been 
estimated, from the relatively limited number of 
such studies, that between 5 Vo and II Vo of all 
deaths in asbestos-exposed workers are due to 
mesothelioma (16X26X43X45X61X62X63). In a 
cohort of 632 asbestos insulation workers observed 
prospectively from January 1, 1943 to December 
31, 1976, 38 out of a total of 478 deaths were due 
to mesothelioma (see Tkble VIII-26) (60). The mor­
tality experience of a large cohort of 17,800 
asbestos workers in the United States and Canada 
(Table VIII-27) observed from 1967 to 1977 in­
dicates that 175 out of 2^70 deaths were due to 
mesothelioma. In a cohort of amosite asbestos fac­
tory workers employed from 1941-1945, and ob­
served until 1977, 16 out of 594 deaths were due 
to mesothelioma flkble VIII-28) (62). In another 
cohort of 689 asbestos factory workers employed 
before January 1939, and observed from 1959 
through 1975, 26 out of 274 deaths were due to 
mesothelioma (48X60). Newhouse reported the 
mortality experience of workers in an East London 
asbestos factory, 1931-1970; out of a total of 461 
deaths, 35 were due to mesothelioma (43).
The importance of long-term observation is 
shown in Tables VIII-29, VIII-30, and VIII-31.
Two further problems arc: 1) the correct assess­
ment of all those at risk for developing meso­
thelioma in various occupations, or who have 
had such exposure even for short periods of time 
sometime during the last 40-50 years; and 
2) quantification of the risk for “bystander” ex­
posure, neighborhood or other types of en­
vironmental exposure (buildings, schools, etc.), 
and household-family exposure.
Although no firm data are as yet available 
for these types of asbestos exposure, according 
to the information available on cases occurring 
after short (several weeks) and relatively low levels 
of exposure, it has to be assumed that the risk 




The pathology of mesothelioma is largely 
determined by the potential of the mesothelial 
cells to produce tumors of epithelial, mesen­
chymal, or most commonly a mixed type. This 
potential is related to the embryologic origin of 
the mesothelium, which is derived from coelomic 
epithelium developed from the mesoderm and
underlined by mesenchymal tissue (27).
The macroscopic features of pleural meso­
thelioma are those of a gray-white or yellow-gray 
mass, varying in extent from a part of the lung’s 
surface to a complete; or almost complete, encase­
ment of the lung. The tumor has a rapid growth 
rate, extending along the serosa, with a tendency 
to grow along the interlobar fissures. Both the 
parietal and visceral pleura are involved; often the 
tumor seems to have originated in the visceral 
pleura (for example, in the minor fissure).
Two types of mesothelioma can be observed: 
1) the scirrhous type, presenting as a hard sheet, 
with variable thickness often exceeding one inch, 
rapid encasement and compression of the lung, par­
tial or total obliteration of the pleural cavity, and 
contraction of the hemithorax; and 2) the enceph- 
aloid type, presenting as large tumor masses, 
often multiple, sometimes with extremely rapid 
growth (seen on chest x-rays as “scalloping”).
Continuous spread—with local invasion of 
the pericardium, mediastinum, chest wall, dia­
phragm, and, through it, the liver and 
peritoneum, or into the contralateral pleura—is 
frequent. The underlying lung can be invaded 
directly, into the pulmonary parenchyma im­
mediately underlying the pleura, or by spread in­
to septal and perivascular lymphatics, with lymph 
node involvement in about 50Vo of cases. Dis­
tant metastases, thought in the past to be rare, 
are, on the contrary, quite frequent, affecting the 
brain, liver, kidney, adrenals, thyroid, lung, or 
other organs in more than 50Vo of cases. Tumor 
growth along the needle biopsy track or surgical 
scar after thoracotomy is common.
Microscopic features are characterized by 
diversity of appearance, not only from case to 
case, but also in the same tumor, where both 
epithelial (or tubulo-papillary) and mesenchymal 
(or fibrosarcomatous) areas can be observed. 
According to the microscopic pattern, meso­
thelioma can be classified into four types: 1) 
epithelial or tubulo-papillary, with the epithelial 
cells usually cuboidal or flattened, tending to 
form tubular and papillary structures, separated 
by a more or less abundant matrix; 2) mesen­
chymal or fibrosarcomatous, appearing as a 
spindle cell sarcoma, but sometimes with exten­
sive areas of acellular collagen; 3) mixed, the 
most frequent form, containing both epithelial 
and fibrosarcomatous areas; 4) the undifferen­
tiated type, with polygonal, less often spheroidal 
cells, with large nuclei and scanty mitotic figures. 
These cells resemble those of the tubulo-papillary
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Table VIII-26
EXPECTED AND OBSERVED DEATHS AMONG 632 NY-NJ ASBESTOS INSULATION 
WORKERS OBSERVED PROSPECTIVELY JANUARY 1, 1943 - DECEMBER 31, 1976




Deaths 1.1.43-12J  1.76
Cause o f death Expected* Observed
Total deaths, all causes 328.9 478
Total cancer, all sites 51.0 210
Lung cancer 133 93
Pleura] mesothelioma ** 11
Peritoneal mesothelioma ** 27
Cancer of esophagus 1.4 1
Cancer of stomach 5.4 19
Cancer of colon - rectum 8.3 23
All other cancer 28.06 36
Asbestosis ** 41
All other causes 262.6 227
•Expected deaths are based upon age and sex-specific US death rates of the National Center for Health Statistics, 
1949-1975 actual rates, 1943-1948 extrapolated from 1949-1955 rates, and 1976 extrapolated from 1967-1975 data.
♦•These are rare causes of death in the general population.
Copyright by the New York Academy of Sciences, NY, NY 10021. Reprinted with permission by the Oepeitment Health and Human Services. 
Further reproduction prohibited without permission of copyright holder.
Tkble Vm-27
DEATHS AMONG J7,800 ASBESTOS INSULATION WORKERS IN THE 
UNITED STATES AND CANADA JANUARY 1, 1967 — JANUARY 1, 1977





Total deaths, all causes 1,660.96 2270 1.37
Total cancer, all sites 319.90 994 3.11
Lung cancer 105.97 485 4.58
Pleural mesothelioma •* 66 —
Peritoneal mesothelioma ** 109 —
Cancer of esophagus 7.01 18 2.57
Cancer of stomach 14.23 22 1.55
Cancer of colon - rectum 37.86 59 1.56
All other cancer 154.83 235 1.52
Asbestosis *• 162 —
All other causes 1351.06 1,114 0.82
•Expected deaths are based upon white male age-specific mortality data of the US. National Center for Health Statistics 
for 1967-1975 and extrapolation to 1976.
••These are rare causes of death in the general population.
Table Vm-28
EXPECTED AND OBSERVED DEATHS 
AMONG 933 AMOSITE FACTORY WORKERS EMPLOYED
1941-1945, OBSERVED TO DECEMBER 31, 1977
Deaths 1941-1977
Expected* Observed Ratio
Total deaths 368.62 594 1.61
Cancer, all sites 73.35 195 2.66
Lung cancer 19.16 100 5.22
Pleural mesothelioma <b) 8 —
Peritoneal mesothelioma <b> 8 —
G.l. cancer 21.55 32 1.48
All other cancer 32.64 47 1.44
Asbestosis <b> 30 —
Other noninfectious
respiratory disease 8.47 19 224
All other causes 286.80 350 1.22
u> Expected deaths based upon age-specific death rate data for New Jersey white males in corresponding years. In 4 
cases, ages were not known; omitted from calculations. 39 men partially traced and 890 traced to death on December 
31, 1977.
<bt Death rates not available, but these have been rare causes of death in the general population.
type.
A property of mésothélial cells is the pro­
duction of acid mucopolysaccharides, especially 
hyaluronic acid, which stains strongly with col­
loidal iron, but not with periodic add Schiff 
(PAS). This last characteristic is useful in differ­
entiating mesothelioma from adenocarcinoma; 
the latter usually gives a positive stain with PAS. 
The hyaluronidase test (digestion of hyaluronic 
acid by the enzyme) is useful in a limited number 
of cases, since the tubulopapillary type of the 
tumor is the only form which consistently pro­
duces hyaluronic acid. Therefore a negative hyal­
uronidase test does not exclude the diagnosis of 
mesothelioma.
The pathogenesis of mesothelioma is not yet 
completely understood. Nevertheless, the follow­
ing facts of major theoretical and practical con­
sequence have been established:
• mesothelioma may result from exposure 
to crocidolite, chrysotile and/or amosite; 
the evidence is derived from epidemiologic 
and experimental animal studies.
• relatively low levels and short duration of 
exposure can produce meso:? elioma.
• while a dose-response relationship may 
exist, it has not been quantitatively clari­
fied, and therefore available information 
can only be interpreted to indicated that 
any asbestos exposure, given a long enough 
period of follow-up, may induce meso­
thelioma.
• the hypothesis according to which poly- 
cyclic aromatic hydrocarbons adsorbed 
on asbestos fibers are important in the in­
duction of mesothelioma has not been con­
firmed, nor has that attributing a similar 
effect to adsorbed trace metals (19).
• cigarette smoking has no etiologic relation­
ship with mesothelioma.
• in experimental studies, intrapleural ad­
ministration of asbestos, but also of simi­
larly sized fibers of fibrous glass and fib­
rous aluminum oxide, resulted in pleural 
mesothelioma (66)(67)(68). This seems to 
indicate that fibrous characteristics, rather 
than the chemical composition, are crucial 
for this specific carcinogenic effect.
• a special selectivity in the distribution of 
asbestos fibers, relevant to the problem
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Table VIII-29
EXPECTED AND OBSERVED DEATHS AMONG 689 ASBESTOS FACTORY WORKERS, 
EMPLOYED BEFORE JANUARY I, 1939 DURING THE SEVENTEEN YEARS 









A ll causes 59 52.41 123 69.85 92 65.93 274 188.19 1.46
Cancer, all sites 21 10.47 45 14.70 33 14.73 99 39.92 2.47
Lung cancer 6 2.96 18 4.65 11 4.92 35 12.53 3.91'
Pleural mesothelioma 1 n.a. 5 n.a. 7 n.a. 14 n.a. —
Peritoneal mesothelioma 1 n.a. 6 n.a. 4 n.a. 12 n.a. —
Cancer of esophagus, stomach, 
colon and rectum 4 2.23 5 2.92 3 2.83 15 7.99 1.88
Cancer, all other sites 9 5.28 11 7.13 8 6.98 23 19.40 1.19
AH respiratory disease 14 3.01 10 4.56 18 4.60 42 12.16 3.45
Asbestosis 12 n.a. 8 n.a. 15 n.a. 35 n.a. —
Other respiratory 2 (b) 2 (b) 3 (b) 7 (b) —
All other causes 24 38.93 68 50.59 41 46.60 133 136.11 0.98
Person-years of observation 3,962 3,411 2,273 9,646
(a) Pleural mesothelioma included with cancer of bronchus in calculating ratio since expected rates are based upon “cancer of lung, pleura, bronchus», uuchea.”




MORTALITY EXPERIENCE AMONG 17,800 ASBESTOS INSULATION WORKERS 
IN THE UNITED STATES AND CANADA 1967-1977: 
OBSERVATIONS IN 2,270 CONSECUTIVE DEATHS
Number of men 17,800
Man-years 166,855
Duration from  onset o f work exposure (years)
Cause o f death Total <70 10-14 15-19 20-24 25-29 30-34 35-39 4044 45 +
A ll causes 2,270 51 85 188 320 388 340 253 203 442
Cancer, all sites 994 7 17 59 125 193 186 128 95 184
Lung 485 0 7 29 59 104 112 66 39 69
Pleural mesothelioma 66 0 0 2 6 15 10 16 4 3
Peritoneal mesothelioma 109 0 0 3 3 18 22 18 16 29
Table VHI-31
EXPECTED AND OBSERVED DEATHS 
AMONG 933 AMOSITE ASBESTOS FACTORY WORKERS EMPLOYED 1941-45
OBSERVED TO DECEMBER 31, 1977
Deaths o f  lung cancer and mecnthehnma
Time from  
onset Man- Lung cancer Mesothelioma
(years) years Exp. Obs. Ratio Pleural Peritoneal
<5 4,331 0.95 0 — 0 0
5-9 4,095 1.78 3 — 0 0
10-14 3,784 2.57 13 5.06 0 0
15-19 3,362 3.19 20 6.27 0 0
20-24 2,837 3.49 18 5.16 1 0
25-29 2,250 3.59 25 6.96 2 4
30-34 1,553 3.16 17 5.38 5 3
35 + 192 0.41 4 — 0 1
22,404 19.14 100 5.22 8 8
of mesothelioma induction, has been dem­
onstrated by Roe et al. (54). After sub­
cutaneous injection in mice (experiments 
with three types of asbestos), wide dissem­
ination from the site of injection and a 
highly selective distribution were observed; 
the main sites of asbestos accumulation 
were the visceral and parietal pleura and 
the serosal surface in the abdominal cavity.
• the fiber size (cross-sectional diameter and 
length) seems to be important, since smaller 
fibers penetrate deeply into the periphery
of the lung and subpleural areas (21X22) 
(67X68X70X75).
The evidence for marked effects, including 
the carcinogenic mesothelioma inducing effect 
of small fibers Gength less than 5 um) has emerged 
relatively recently (122X24)(75). This is impor­
tant in view of the fact that handling or treating 
asbestos as well as use of asbestos products gen 
erates fragmentation (both longitudinally and trans­
versely) of fibers resulting in a larger number of 
shorter and thinner fibers or even fibrils. Chrys- 





Chest pain (unilateral) and shortness of breath 
are the most common presenting symptoms. The 
chest pain may be diffuse and dull or it may be 
of the pleuritic type; it often progresses to be sev­
ere. Shortness of breath may rapidly progress, espe­
cially with the development of a pleural effusion.
Other relatively frequent symptoms are loss 
of appetite; weight loss, fatigue, and in some cases 
fever; cough is infrequent.
Physical Signs
Pleural effusion occurs in the majority of 
cases, with dullness on percussion and decreased 
breath sounds. Rapid recurrence after aspiration 
of pleural fluid is the rule. The pleural fluid may 
be serous and clear but sometimes is hemor­
rhagic.
Retraction of the affected hemithorax, and 
shifting of the mediastinum to the side of the 
lesion may occur.
Natural History
Rapid tumor growth—often after pleural 
biopsy, i-e., needle biopsy or thoracotomy—with 
subcutaneous tumor nodules may involve the chest 
wall, the ribs and vertebrae, the mediastinum 
(sometimes with superior vena cava syndrome), 
and/or the pericardium with pericardial effusion. 
Distant metastases to the liver or other intra- 
abdominal organs, sometimes with ascites, can 
be clinically detected.
The metastatic spread of mesothelioma is 
much more frequent than previously thought and 
has been shown to occur in the majority of cases 
in which an autopsy was performed; both lymph 
node metastases and distant hematogenous me­
tastases can be found. Spread of the mesotheli­
oma to the opposite pleural cavity, and also to 
the peritoneum, is frequent; most often this is 
the result of a local invasive process, through the 
mediastinum or through the diaphragm.
The natural history of the disease is that of 
a rapid downhill course; death occurs in the 
majority of cases after an interval of months to 
one or two years. The mean survival from first 
diagnosis does not exceed 12 months. Although 
all therapeutic methods have been used, often in 
combination (surgery, radiotherapy; chemother­
apy), no significant difference in survival of pa­
tients with pleural mesothelioma has been con­
sistently achieved.
Laboratory Investigations
Radiographic changes are characteristically 
unilateral and progressive. The two main modal­
ities of radiologic changes in pleural mesothelioma 
are: 1) unilateral pleural effusion; 2) large, 
nodular, protuberant opacities projecting from 
the pleura into the pulmonary parenchyma. Most 
often a combination of these changes is found.
Aspiration of the pleural fluid may be help­
ful in revealing underlying solid tumoral 
opacities. Extension of the tumoral growth over 
the apical pleura and into the mediastinal pleura 
is frequent. PA chest radiographs should be com­
plemented by oblique views of the chest whenever 
a suspicion of pleural mesothelioma arises. Other 
radiographic evidence of asbestos-related paren­
chymal and/or pleural changes may or may not 
be present. Pleural plaques or calcifications are 
a useful marker of past asbestos exposure.
Pulmonary function studies are irrelevant 
for the diagnosis of mesothelioma.
Pleural fluid aspiration, while often neces­
sary to alleviate respiratory distress, is of limited 
diagnostic use. Cytology of the pleural effusion is 
often fraught with the difficulty of distinguishing 
between mésothélial malignant cells and “atypical” 
mésothélial cells. The detection of hyaluronic add 
in the pleural fluid is useful, although it can be 
found with other malignant tumors of the pleura; 
a negative result does not discard the diagnosis 
(6X25X76).
Needle biopsy specimens are insuffident for 
tissue diagnosis, since tissue specimens so obtained 
might not include malignant changes (although 
such changes may well be present in adjacent areas 
of the pleura) and since there is marked variability 
of pathologic changes.
Thoracotomy with surgical pleural biopsy, 
although providing adequate tissue specimens for 
diagnostic purposes, is often followed by local ex­
tension of tumor growth into the chest wall.
Treatment
There is no effective therapeutic approach, 
although surgery to reduce the tumor mass (9), 
radiotherapy (17)(57)(71), chemotherapy, single 
drugs (7X18X29X30X40), or combinations of two, 
three, or four drugs, and all possible combina­
tions of these methods have been attempted (35).
Wanebo et al. reported on 66 cases with
malignant mesothelioma (78). For the epithelial 
type, pleurectomy combined with irradiation and 
chemotherapy seemed to be more effective; in the 
fibrosacromatous type, surgery resulted in longer 
survival.
Prognosis
The disease is fatal, and progression is usu­
ally rapid, with marked deterioration over short 
periods of time. In exceptional cases, longer sur­
vival (several years) can occur even in the absence 
of any therapeutic procedure.
DIAGNOSTIC CRITERIA
The diagnostic criteria for pleural mesothe­
lioma are:
• a history of asbestos exposure in the past. 
Occupational exposure (even for short 
periods) or household or neighborhood 
exposure has to be actively searched for 
and can be established in the vast majority 
of cases if histories are taken by a physi­
cian with experience in occupational medi­
cine (11).
• ’ong latency period, usually more than 20 
years from onset of exposure, most often 
between 30 and 40 years.
• clinical symptoms: unilateral chest pain 
and/or significant increase in dyspnea over 
a short period of time (weeks or months).
• physical findings: consistent with pleural 
effusion.
• radiographic abnormalities presenting as 
pleural effusion or pleural thickening often 
with large nodular opacities projecting from 
the pleura. Rapid increase in pleural 
thickening or the the appearance of irregu­
larities of the pleura are highly suspicious. 
Rapid progression of radiologic changes.
• tissue diagnosis on an adequate specimen 
(thoracotomy with pleural biopsy). Micro­
scopic findings consistent with the epi­
thelial (tubulopapillaryX mesenchymal (fibro- 
sarcomatous), or mixed or undifferen­
tiated type.
The complexities and difficulties of the 
pathologic diagnosis have been discussed. The 
finding of hyaluronic add in the pleural fluid 
of tissue specimen is useful, but the diagnosis 
cannot be discarded when the test is negative.
In the differential diagnosis of pleural 
mesothelioma, the following problems are of 
practical importance: (a) Benign pleural effusions 
may occur in a patient with present or past 
asbestos exposure. The clinical course is usually 
indicative, since benign pleural effusions tend to 
resolve spontaneously over several weeks. Never­
theless, such a “benign pleural effusion” has been 
observed, in some cases, to be a precursor of 
pleural mesothelioma, (b) Pleural fibrosis is a 
common finding in persons with present or past 
asbestos exposure; the prevalence increases with 
time since onset of exposure. In cases with ex­
tensive pleural fibrosis, especially when the width 
on chest x-ray exceeds 10 mm, the differential 
diagnosis between pleural fibrosis and pleural 
mesothelioma may be difficult. The presence of 
similar pleural changes on previous x-ray films 
makes the diagnosis of mesothelioma less like­
ly; repeat chest x-ray films after several weeks are 
necessary when no previous chest x-ray are 
available, (c) The differential diagnosis between 
pleural mesothelioma (primary malignant tumor 
originating in the pleura) and secondary involve­
ment of the pleura by a malignant tumor, either 
lung cancer or another primary malignant tumor 
with metastatic spread to the pleura, has been 
given much attention. In the case of lung cancer, 
sputum cytology and fiber optic bronchoscopy 
with bronchial biopsy, in addition to the 
radiologic appearance, contribute to the differen­
tial diagnosis. The proportion of cases which re­
main undedded is small. The possibility of a 
malignant primary tumor originating in another 
site, with metastatic spread to the pleura is in­
vestigated by the routine clinical work-up. Pa­
tients with no other detectable primary tumor 
but with clinical and radiologic features of 
mesothelioma have, with a high degree of pro­
bability, pleural mesothelioma. The absolute cer­
tainty of this differential diagnosis is reached on­
ly after postmortem examination.
In reviewing the experience accumulated 
over the last 20 years, it becomes obvious that 
pleural mesothelioma has been largely under­
diagnosed in the past. This has been established 
in prospective cohort studies of asbestos-exposed 
workers (28)(33)(34)(38)(44)(47)(60); in many 
studies investigating diagnostic accuracy in series 
of reported mesothelioma cases (15); and in sys­
tematic reviews of all pathology material—as in 
Scotland where 80 undiagnosed cases were dis­
covered (39).
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In the 1967-1977 cohort study of 17,800 as­
bestos insulation workers in the United States 
and Canada, out of a total of 2,270 consecutive 
deaths, 60 were recorded on the death certificate 
as mesothelioma (31 pleural, 29 peritoneal). Re­
view of medical records, including pathology 
reports, chest x-ray films, postmortem exami­
nations (when available) and independent review 
of tissue specimens by experienced pathologists 
resulted in a diagnosis of mesothelioma in 175 
cases (66 pleural, 109 peritoneal). The death 
certificate accuracy was 47 Vo for pleural meso­
thelioma and 27 Vo for peritoneal mesothelioma 
(Table VI11-32). In another cohort of 689 asbes­
tos workers, 11 cases of mesothelioma (4 pleural, 
7 peritoneal) were recorded on death certificates 
for the period 1959-1975. Review of medical rec­
ords and pathology material resulted in a diag­
nosis of mesothelioma in 26 cases (14 pleural, 
12 peritoneal), with the death certificate accuracy 
only 28Vo for pleural mesothelioma, and 58Vo 
for peritoneal mesothelioma (Table VIII-33).
In the majority of pleural mesothelioma 
cases it is possible to establish the diagnosis in- 
travitam. The greater awareness of population 
groups with present or past exposure, of the 
Department of Health, Education and Welfare, 
of other governmental agencies, and of the medi­
cal community are expected to result in earlier 
diagnosis. This is a prerequisite for future mean­
ingful attempts of therapy.
The requirement of postmortem examina­
tion for the definitive diagnosis is necessary for 
the complete assessment of mesothelioma in­
cidence from an epidemiologic point of view, 
although it is expected that a higher index of 
suspicion will substantially reduce the difference 
between the number of cases diagnosed while 
alive and those in which the diagnosis is reached 
only after postmortem examination.
METHODS OF PREVENTION
The prevention of pleural mesothelioma is 
dependent on the reduction of exposure to asbes­
tos fiber to the minimum possible level, since this 
adverse health effect has been specifically associ­
ated with low level and short-term exposure. In 
December 1976, NIOSH, based on a “Reexami­
nation and Update of Information on the Health 
Effects of Occupational Exposure to Asbestos,” 
recommended to the DHEW and OSHA that the 
standard be reduced to 0.1 fibers /cm1. This was
based on the lowest concentration at which as­
bestos fibers can be reliably identified by phase 
contract microscopy.
RESEARCH NEEDS
Critical problems where research is needed:
1. Determine mechanisms of carcinogenicity 
(mineral fibers; potential effect of other 
mineral fibers, such as zeolites, titanite 
fibers, etc.).
2. Define, to the extent that it is at all possi­
ble, the lowest level of asbestos exposure 
which may result in mesothelioma. This 
is of paramount importance for the accept­
able standard.
3. Establish the role(s) of immune mecha­
nisms in individual susceptibility for mes­
othelioma.
4. Determine mechanisms of carcinogenicity 
in peritoneal mesothelioma, including the 
significance of ingestion of fibers. This 
is important since water may be polluted 
with mineral fibers from various sources, 
and the risk of mesothelioma from such 
a situation has not yet been assessed.
5. Establish mesothelioma therapy.
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I am pleased to testify on the science and the health effects caused by exposures to 
asbestos. I am currently Assistant Director of the National Institute for Occupational Safety 
and Health (NIOSH). I have been involved with the study of occupational exposures to 
asbestos since 1970. I am also the primary author of the NIOSH recommended standard for 
occupational exposure to asbestos, the asbestos monograph published by the International 
Agency for Research on Cancer, and numerous articles on asbestos in the scientific 
literature, I have attached a copy of my complete curriculum vitae.
Asbestos is a generic term referring to a group of naturally occurring fibrous minerals 
that are commercially prized for their thermal and insulative properties, in addition to their 
flexibility, durability and tensile strength. Because of these characteristics, asbestos is highly 
persistent in the human body once inhaled or ingested
Based on studies of workers who were heavily and regularly exposed to asbestos before 
general government regulation of the workplace, we know that asbestos causes specific 
diseases such as asbestosis, an irreversible and progressively disabling lung disease which 
impairs breathing, and mesothelioma, an invariably fatal cancer of the lining of the chest, 
pericardium, or abdominal cavity. Asbestos is one of the leading causes of lung cancer in 
non-smokers. Asbestos exposure for smokers increases the risk of lung cancer approximately 
55 times that of those who are not exposed to asbestos and who do not smoke. Asbestos is 
also associated with an increased risk of gastrointestinal and other cancers.
The conclusion drawn by many experts, in this and other countries, and best 
summarized in the 1987 Supplement of the World Health Organization’s International
Agency for Research on Cancer, is that * occupational exposure to chrysotüe, amosite
and anthophyllite asbestos and to mixtures containing crocidolite results in an increased risk 
of lung cancer, as does exposure to minerals containing tremolite and actinolite and to 
tremolitic material mixed with anthophyllite and small amounts of chrysotüe. Mesotheliomas 
have been observed after occupational exposure to crocidolite, amosite, tremolitic material 
and chrysotüe asbestos. Gastrointestinal cancers occurred at an increased incidence in 
groups occupationally exposed to crocidolite, amosite, chrysotüe or mixed fibres containing 
crocidolite, although not all studies are consistent in this respect An excess of laryngeal 
cancer has also been observed in some groups of exposed workers. No dear excess of 
cancer has been associated with the presence of asbestos fibres in drinking water. 
Mesotheliomas have occurred in individuals living in the neighbourhood of asbestos factories 
and mines, and in people living with asbestos workers.”
Recent reports have appeared in the scientific literature to suggest that different forms 
of asbestos are not equally pathogenic (Mossman and Gee, 1989 and Mossman et aL, 1990). 
However, there is a great deal of uncertainty associated with these findings and equally 
important contradictory evidence. Results from research involving animal bioassays present 
a strong case that there is no safe form of asbestos. Wagner et aL (1979), then with the 
United Kingdom’s Medical Research Council, have shown that a commercial grade, 
predominantly short-fiber Canadian chrysotüe (a purportedly less hazardous form of 
asbestos), and an ingredient used primarily in paint and in plastic tüe fillers, induces 
mesotheliomas when injected intrapleurally into rats, and induces primary lung neoplasms in 
rats exposed by inhalation. Not only has chrysotüe been found to be as potent as crocidolite 
and other amphiboles in inducing mesotheliomas when injected intrapleurally (Wagner et aL, 
1973), it has been found equally potent in inducing pulmonary neoplasms through inhalation
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exposures (Wagner et aL, 1974). Chrysotile also appears to be more potently fibrogenic and 
cardnogenic than amphiboles, in relation to the quantity of dust deposited and retained in 
the lungs of rats (Wagner et aL, 1974).
There is the hypothesis that chrysotile is less hazardous because of its chemical and 
biological reactivity. In fact chrysotile fibers are much more chemically and biologically 
reactive than amphibole fibers (Davis et aL, 1978; Davis et aL, 1986a; and Davis et al., 
1986b). In contact with body tissues, chryostile fibers lose their structural elements and 
divide into smaller fibrils, making their recognition difficult by the usual analytical methods. 
In fact, many of the fibers are removed from the lungs to other organs in the body and up 
through the bronchi. These findings also support the hypothesis that chrysotile fibers cause 
cellular injury, fibrosis and lung cancer. These fibers are less readily detected in the tissue 
after the damage is done. The concentration of dust in the lungs of rats exposed to 
Canadian chrysotile (Wagner et aL, 1974) was only 1.8% to 22% of the dust concentration 
in the lungs of anim als exposed to amphiboles, after 24 months of inhalation exposure. Yet 
the lung tumor inddences and degree of pulmonary fibrosis were similar among groups of 
rats exposed to different forms of asbestos.
At this time, there is no compelling evidence to justify different public health policy for 
different asbestos fiber types. The reason for higher incidence of lung cancer and 
mesothelioma in workers exposed to amphiboles is probably related to higher concentrations 
of respirable fibers during their exposures (NIOSH, 1979). Furthermore, most commercially 
exploited deposits of chrysotile are contaminated with some type of the amphibole form of 
asbestos (Bartlett, 1988 and Campbell, 1988).
Other international expert groups have readied similar conclusions regarding the 
uncertainty of the hypothesis that some forms of asbestos may be less hazardous. In a 
recently released document from an expert panel convened by the World Health 
Organization in 1989, the panel conduded: "it is difficult to substantiate this difference [in 
pathogenidty] firmly after standardization for exposure levels, type of industry, duration of 
employment, etc.” This condusion agrees with the findings of the 1984 report of the 
Canadian Royal Commission on Matters of Health and Safety Arising from the Use of 
Asbestos in Ontario. The Commission recommended that textile manufacturing using a 
form of asbestos purported to be less hazardous (chrysotile) be banned, and concluded that 
"all fiber types can cause all asbestos-related diseases."
The Centers for Disease Control (CDC) through NIOSH has recently submitted to 
Occupational Safety and Health Administration (OSHA) on April 8, 1990 a reiteration of its 
previous testimony of June 21, 1984, that " . . .  there is no safe concentration for exposure to 
asbestos." Not even the lowest exposure limit for asbestos could assure all workers absolute 
protection from exposure-related cancer. OSHA projects that at the current occupational 
standard for asbestos of 0.2 fibers/cc over a working lifetime, 67 cancers for every 1,000 
exposed workers can be expected to devdop (OSHA, 1986). In the April 8, 1990 submittal 
to OSHA, CDC through NIOSH also reaffirmed its position that there is no sdentific basis 
for differentiating between types of asbestos fibers for regulatory purposes. The sdentific 
evidence to date suggests that fiber morphology (size and shape) is the most critical factor in 
the pathogenidty of the material and as such the most prudent public health policy is to 
regulate asbestos based upon its morphology and not on its mineralogic source.
I would be happy to answer any questions the subcommittee may have.
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Objectives, Thisartide examines 
the credibility and policy implica­
tions of the “amphibole hypothesis,” 
which postulates that (1) the meso­
theliomas observed among workers 
exposed to chiysotile asbestos may 
be explained by confounding expo­
sures to amphiboles, and (2) chiyso- 
tile may .have lower carcinogenic 
potency than amphiboles. *
Methods. A critical review was 7 
conducted of the lung burden, epide­
miologic, toxicologic, and mechanis­
tic studies that provide the basis for 
the amphibole hypothesis.
Results. Mechanistic and lung - 
burden studies do not provide con­
vincing evidence for the amphibole 
hypothesis. Toodcologic and epide­
miologic studies provide strong evi­
dence that chrysotile is associated 
.with an increased risk of lung cancer 
and mesothelioma. Chrysotile may 
be less potent than some amphiboles 
for inducing mesotheliomas, but there 
is little evidence to. indicate lower . 
lung cancer risk; ' /
Conclusions. Given die evidence 
of a significant lung cancer risk, the 
lack of conclusive evidence for the 
amphibole hypothesis, and the fact 
that workers are generally exposed to 
a mixture of fibers, we conclude that 
it is prudent to treat chrysotile with 
virtually the same level of ooncem as , 
the amphibole forms of asbestos. 
(Am J Public Heath. -199^86:179- 
.186) '
Introduction
Chiysotile is the predominant type of 
asbestos produced and consumed in the 
world today, and it accounted for over 
98.5% of US asbestos consumption in 
1992.1 Although asbestos consumption 
has dedined in North America and 
Europe, sales in other countries (e.g., 
Southeast Asia, South America, and East­
ern Europe) have increased primarily due 
to the use of asbestos-based construction 
materials.2
Chiysotile is a serpentine (curly) 
form of asbestos that is distinguished from 
other amphibole forms of asbestos 
(i.e., croddolite, amosite, tremolite). It 
has been hypothesized that (1) the 
mesothelioma risk observed among work­
ers exposed to chrysotile asbestos may 
be explained by the relatively tow con­
centrations ( < 1%) of tremolite fibers 
in commercial chrysotile asbestos fibers 
and (2) that chiysotile asbestos may 
be less potent than amphiboles in the 
induction of asbestosis and lung cancer. 
This has been dubbed the amphi­
bole hypothesis.3 It has even been 
suggested that exposure to chrysotile 
asbestos in the absence of tremolite 
may present little or no carcinogenic 
hazard.4
The arguments advanced to support 
the amphibole hypothesis have been pri­
marily based on pathologic studies of 
burdens of asbestos fibers in human lungs 
and on toxicologic, mechanistic, and epide­
miologic studies. This article presents a 
critical review of these arguments and of 
the literature on the carcinogenic hazards 
associated with exposure to chiysotile 
asbestos and considers the implications of 
these findings for the development of 
occupational health polides.
Lung Burden Studies
The development of methods that 
involve electron diffraction and energy 
dispersive analysis of x-rays (EDAX)3 has 
made possible the measurement of the 
amounts of different fiber types in the 
lung. The results from lung burden 
studies have provided the primary basis 
for the advancement of the amphibole 
hypothesis.
Case studies of individuals who have 
worked in industries using or produdng 
chiysotile asbestos revealed an unexpect­
edly high proportion of amphibole (pri­
marily tremolite) fibers, considering the 
relatively lew percentage of amphibole 
fibers in commercial chiysotile asbestos.6 
In one of the earliest studies, Pooley 
observed a greater number of amphibole 
fibers than chrysotile fibers in 7 of 22 
patients with asbestosis who had worked 
in the Canadian chiysotile mining indus­
try.7 Rowlands et al. also reported a 
nearly equal concentration of tremolite 
fibers and chiysotile fibers in the lungs of 
47 workers employed as miners or millers 
in Quebec.8 Similarly, in population- 
based studies the percentage of chiysotile 
fibers found in the lungs has been surpris­
ingly low considering the fact that chiyso­
tile is the major source of exposure for the 
general population.9
Most case-control studies that evalu­
ated the potential relationship between
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TABLE 1— Summary of Epldemlologlca! Cohort Studies of Workers Exposed to 
Predominantly Chrysotile Asbestos
Lung Cancer Deaths Mesothelioma Cases 
Study hdustry Observed Expected Observed Deaths. %
Acheson et al.*7 Gasmasks 6 4.8* 1 0.6
Cheng and Kong28 TexSes, friction mate­
rials, and cement
21 6.7* 0 0
Dement et al.29 Textiles 126 64.0* 2 0.2
Rnkelstein30 Electrical conduit pipe 6 3.7 1 1.0
Finkelstein31 Automotive 11 7.9 1-2** 1.0-1.9
Hughes et al.32* Cement manufacturing 70 53.2 1 • . «
HuBan and Zhiming33 8 asbestos factories 65 15.6** 2 0.4
McDonald et ai.34 Friction products 73 49.1* 0 0
McDonald et aI.,MM Mining and milling 518 389.7* 28 0.4
Piotatio et af.37 Mining 22 19.9 2 0.5
Shiqu et al.38 Mining 6 « • • 3 4.5
Weiss® Paper and mfflboaid 4 4 Z 0 0
Total 922* 618.9 41.0 0.3
Note. SMR *= the standanfeed mortafity ratio, which is the ratio between the observed and 
expected.
'The expected nunber is far cancer of tie  lung and pleura combined.
*One or two cases of mesolhefeomawere reported. Only one was kiduded in the totals.
«Results are tor workers exposed only to chrysotie from one of two plants studied. The total number 
of deaths was not reported; thus. Vie percentage of mesottiefioma deaths could not be estimated.
«Observed and expected numbers exclude observations from tie  asbestos factory.
'The Shiqu et aL study was not included in the total rexnber of lung cancer cases because expected 
numbers were not reported.*7
•Significantly different kotn tfie observed number, P < .05(twotaied).
mesothelioma risk and lung concentra­
tions of the different fiber types of 
asbestos demonstrated a clear relation­
ship with amphibole lung burdens but 
failed to find a relationship with lung 
chrysotile concentrations.10-14 McDonald 
et al. reported an association between 
mesothelioma and lung concentrations of 
long ( ¿8  |un) chrysptile fibers in univari­
ate analyses but not in multivariate analy­
sis, which controlled for the other fiber 
types.15 Rogers et al. reported a significant 
association between mesothelioma risk 
and lung concentrations of short chryso­
lite fibers (<10 jim) in multivariate 
models and a significant trend for lung 
concentrations among mesothelioma case 
and control subjects who had only chryso­
lite detected in their lungs.16
The interpretation of the results 
from the studies of lung burden is compli­
cated by differences in the respiratory 
clearance rates of the different forms of 
asbestos. Experimental studies demon­
strated that chrysotile fibers are cleared 
far more rapidly from the lungs than are 
amphibole fibers.17-19 The retention half- 
life of chrysotile in human lungs ts 
unknown, but a half-life of 90 days has 
been reported in experimental studies of 
baboons.20 If the half-life for chrysotile is 
similar for humans and baboons, then 
dearly the vast majority of the dose
received in early years would not be 
reflected in the lung burdens measured at 
the time of autopsy. This is of particular 
concern for mesothelioma, which has 
been estimated to have a latency period of 
at least 20 years.21 For example, assuming 
a 90-day half-life and first-order kinetics, 
only approximately 1/(8 x VHP) of the 
dose received 20 years earlier would be 
predicted to be present in the lungs at the 
time of the autopsy. Hence, lung burdens 
of chrysotile may be a poor measure of the 
integrated exposures to chrysotile.
The high degree of correlation be­
tween the lung concentrations of the 
different fiber types, which has been 
noted by several investigators, further 
complicates the interpretation of the lung 
burden analyses.15-16-23 Churg reported 
that the correlation coefficient between 
the numbers of chrysotile and croddolite 
fibers in lungs of asbestos is patients was 
.88 (P < J05).23 Rowlands et al. reported 
a stronger correlation between cumula­
tive asbestos exposure and lung fiber 
counts for tremoUte than between cumula­
tive asbestos exposure and lung burdens 
of chrysotile in their study of Quebec 
miners and millers.1 The high degree of 
correlation might explain the negative 
findings in some of the case-control 
studies if amphibole exposures are simply 
acting as a surrogate for integrated life­
time chrysotile exposure in these studies. 
As Churg et al. suggested, "It may be true 
that the tremolite serves as- a better 
measure of past chrysotile than the chiyso- 
tfleitselt”19
Finally, studies of fiber counts in 
extrapulmonary sites raise serious ques­
tions about the validity of using lung 
burden studies for assessing mesothe­
lioma risk. Several investigators reported 
cases in which short chrysotile fibers were 
the predominant fiber found in the pleura, 
pleural plaques, or pleural fibrotic tissue 
when amphiboles were the predominant 
fiber found in the lung.22*24-26 These 
results suggest that chrysotile may be 
preferentially translocated to the pleura 
and that the fiber counts found in the lung 
may not accurately reflect the concentra­




There have been 12 retrospective 
cohort mortality studies of workers who 
were predominantly exposed to chrysotile 
asbestos fibers. Results for mortality from 
lung cancer (and mesothelioma) from the 
most recent updates of these cohorts are 
summarized in Table 1. Mortality from 
lung cancer was greater than expected in 
nearly all of the studies. Combining the 
results from these studies, there were 928 
observed and 618.9 expected lung cancer 
deaths, resulting in a pooled standardized 
mortality ratio for lung cancer of 1.50 
(95% confidence interval [Cl] = 1.40, 
1.60). The observed excesses of lung 
cancer mortality did not appear to be 
explained by differences in cigarette smok­
ing habits in the studies that had informa­
tion on tobaoco consumption-2*-33’35-36-40-41 
Collectively, these studies provide strong 
evidence that exposure to chrysotile asbes­
tos is associated with an excess risk of lung 
cancer.
There is little, if any, evidence to 
suggest that the excess in lung cancer 
mortality observed in these cohorts may 
be attributable to tremolite contamina­
tion. In fact, this hypothesis is strongly 
contradicted by the fact that the lung 
cancer response in the studies of popula­
tions with relatively pure chrysotile expo­
sures is similar to that in studies of cohorts 
with amphibole or mixed exposures. Esti­
mates of the increase in excess relative 
risk per unit of exposure (Le_, potency) for 
lung cancer based on cohort studies by 
industry and fiber type are presented in 
Table 2. Variations in risk according to
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TABLE 2— Estimates of Asbestos Potency for Lung Cancer from Studies with 
Individual Exposure Estimates, by Industry and Fiber Type




Dement et al.29 Textiles Chrysotile 0.031
McOonaidetai.12 Mainly textiles Chrysotile, amosite, 
croddolfte
0.017*
Peto et al.42 Textiles Chrysotile, crocidolite 0.01 &
McDonald et al.43 Mining Tremolite 0.013
de Klerk et al.44 Mining and nulling Crocidolite 0.010
McDonald et ai.36 Mining and milling Chrysotile 0.0006«
Henderson and 
Enterline45
Asbestos products Chrysotile, amosite, 
crocidolite
0.002*
Hughes et al.32 Cement products Chrysotile,* chrysotile,6 
and crocidolite
0.0071 *0.0076*»
Berry and Newhouse 
et al.46
Friction products Chrysotile 0.00058
McDonald et al.34 Friction products Chrysotile 0.00053*
•A conversion factor of three fibers per cubic centimeter being equivalent to 1 minion particles per 
cubic foot was assumed.
•’Data are based on resufts lor workers employed atler 1951.
*8)006 was estimated by Ming a inear rotative risk Poisson regression model to the standardized 
mortality ratio results reported by McDonald et aJ.3*
industry type appear to be far more 
remarkable than variations according to 
fiber type. The potencies for lung cancer 
risk are similar among the cohorts with 
pure chrysotile and mixed exposures in 
the textile industry and are generally 
higher than the potencies observed among 
workers in the mining or asbestos prod­
ucts industries. The studies of asbestos 
products industry workers all show very 
low potencies, with the lowest unit risks 
observed among friction product workers. 
One study of cement workers, which 
provided separate analyses for workers 
exposed to chrysotile asbestos and work­
ers exposed to a mix of chrysotile and 
crocidolite fibers, produced remarkably 
similar potency estimates for these two 
groups.32 Among the studies of miners, 
lung cancer potency was substantially 
lower among workers in the Quebec 
mining industry who were exposed to 
chrysotile ores than among crocidolite or 
tremolite miners.
It has been suggested that the high 
lung cancer mortality observed among 
South Carolina textile workers might be 
explained by exposure to mineral oils.47 
However, Dement et al. demonstrated in 
case-control analyses that the risk of lung 
cancer observed in this cohort is unrelated 
to mineral oil exposure.29-48 In addition, 
studies of workers exposed to mineral oils 
have generally not demonstrated an ex­
cess of lung cancer.49 There is evidence 
that asbestos fibers in the textile industry 
were considerably longer than the libers 
measured in chiysotile mining and milling 
and other industries.50 Thus, differences 
in fiber dimensions would appear to be a 
more likely explanation than mineral oil 
exposures for the higher lung cancer rates 
observed in textile workers.
Mesothelioma
A total of 45 cases of mesothelioma 
(primarily pleural) were reported in the 
epidemiologic studies of workers who 
were predominantly exposed to chiysotile 
asbestos (Table 1). Although it has gener­
ally not been possible to estimate ex­
pected numbers of mesothelioma deaths, 
the percentage of deaths due to mesothe­
lioma may be estimated and compared 
with background percentages. This per­
centage is 03% for all studies combined. 
In contrast, the percentage of deaths due 
to pleural malignancies (most of which 
are mesotheliomas) was only 0.02% in the 
United States in 1988.51
Although the evidence of excess 
mortality of mesothelioma among work­
ers exposed to commercial chrysotile is 
compelling, the critical issue is whether 
this excess may be attributable to trace 
contamination by tremolite. All of the 
asbestos workers studied (Table 1) arc 
likely to have potential exposures to 
tremolite, although in minute concentra­
tions compared with their chrysotile expo­
sures.
In a few studies the percentage of 
tremolite is known and varies. Contrasting 
the results from these studies provides 
some information on the plausibility of 
the amphibole hypothesis. Two cases of 
mesothelioma have been reported among 
chrysotile asbestos miners and millers in 
Zimbabwe, where the chiysotile ores are 
believed to be free of tremolite contamina­
tion.52 Begin et al. noted that although 
exposure to tremolite may be as much as 
7.5 times higher in Thetford than in 
Asbestos, the incidence of mesothelioma 
in these two Quebec mining towns was 
proportional to the size of their work 
forces.53 He suggested that this fact may 
indicate that tremolite contamination may 
not be a determinant of mesothelioma 
risk in Quebec. In the most recent update 
of the study of Quebec miners and millers, 
McDonald et al.36 presented separate 
exposure-response analyses for workers 
at the TTietford and Asbestos mines and 
mills. There is no indication in their 
findings that these two facilities exhibit a
different exposure-response relationship 
for mesothelioma. On the other hand, 
McDonald and McDonald54 recently re­
ported that the average concentration of 
tremolite fibers in the lungs of miners was 
higher in one area of the Thetford mine, 
which also demonstrated a stronger asso­
ciation with mesothelioma risk than an­
other area of the mine.
Informative comparisons may also be 
made between the proportion of deaths 
from mesothelioma observed in the South 
Carolina textile workers study and that 
observed in the Quebec miners and 
millers study. Based on lung burden 
studies, Sebastien et al. estimated that the 
proportion of tremolite in dust was prob­
ably 2~5 times higher in the Thetford 
mines of Quebec than in the Charleston 
textile facility.47 The percentage of deaths 
due to mesothelioma in the most recent 
reports was one half as high in the South 
Carolina textile workers (0.2%) as it was 
among Quebec miners and millers (0.4%) 
(Table 1). However, in making this com­
parison one needs to consider the fact 
that the incidence of mesothelioma is 
known to increase exponentially with 
follow-up time,55 and 72% of the Quebec 
miners and millers had died,36 compared 
with 42% of the workers in the South 
Carolina study,29 in the most reccnt 
updates of these cohorts. In the previous
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FIGURE 1—Lung tumors in rats exposed to 10 mg/m3 concentrations of 
asbestos for 3 ,6 ,12, or 24 months.
update of the Quebec mineis and millers 
study, the percentage that had died was 
41% and the percentage of deaths due to 
mesothelioma was 02%, which is nearly 
identical to the percentage of deaths from 
mesothelioma in the most recent update 
of the South Carolina textile workers.35 
The fact that these percentages are so 
similar is even more remarkable when it is 
recognized that the fiber exposure levels 
were approximately ten times higher in 
the Quebec miners and millers than in the 
South Carolina textile workers.47 Thus, 
comparison of the mesothelioma results 
from the study of Quebec mineis and 
millers with those from the study of South 
Carolina textile workers does not provide 
support for the hypothesis that tremolite 
exposure explains the mesothelioma ex­
cess observed in these studies.
In contrast to the evidence for lung 
cancer, there is epidemiologic evidence 
indicating that exposure to chrysotfle may 
be less potent than exposure to some 
amphiboles with regards to the induction 
of mesothelioma. Hughes and Weill esti­
mated that the ride of mesothelioma was 
approximately five times lower among 
workers exposed to chrysotfle fibers than 
among workers with mixed fiber expo­
sure.56 The percentage of deaths due to 
mesothelioma among South African asbes­
tos miners was recently reported to be 
4.7% among those exposed to croddolite, 
which is substantially greater than the 
percentage of deaths due to mesothe­
lioma observed in either the Quebec 
miners (0.4%) or the South Carolina 
textile workers (02%) exposed to pre­
dominantly chrysotfle fibers.57 The per­
centage of deaths due to mesothelioma 
was only slightly higher among South 
African miners exposed to amosite (0.6%) 
than among the chiysotile-exposed co­
horts.57 McDonald et al.43 reported that 
the percentage of deaths due to mesothe­
lioma was 2.4% among vermiculite miners 
who were predominantly exposed to 
tremolite fibers, which is approximately 
six times higher than the percentage 
(0.4%) reported in the study of Quebec 
miners and millers.36 It must be recog­
nized that the usefulness of these compari­
sons is limited by our inability to control 
for potential differences in exposure con­
centrations, fiber size distributions, and 
length of observation and are thus difficult 
to interpret Nonetheless, the differences 
in mesothelioma response observed among 
chrysotfle- and amphibole (primarily cro* 
ddolite)-exposed workers are so striking 




Toxicologic studies demonstrated that 
all forms of asbestos can induce lung 
cancere in experimental animals. For 
example, the lung tumor response to 3- to 
24-month exposures to Union Interna­
tional Contre le Cancer reference amos­
ite, anthophyllite, Canadian chrysotfle, 
Rhodesian chiysotile, and croddolite is 
shown in Figure I.17 The overlapping 95% 
confidence intervals suggest that there is 
no significant difference in potency among 
the five types of asbestos (Le., the am­
phiboles are not systematically more or 
less potent than the chrysotiles).
Davis and co-workers also compared 
the carcinogenic potencies of chiysotile 
and amphibole asbestos by exposing rats 
to 10 mg of amosite, croddolite, and 
Zimbabwe chrysotfle per m3 for I year. 
These investigators found that chiysotile 
actually produced more lung tumors than 
the other forms of asbestos.38 These 
results obviously differ from those of 
Wagner et al.17 and may point to the need 
to consider differences in fiber length 
when comparing the potencies of differ­
ent types of asbestos. Davis et al. noted 
that 5% of the chrysotilc in their study 
consisted of fibers greater than 20 pm in 
length vs 0.5% of the fibers for the 
amosite and croddolite exposures.® Other 
studies by Davis et al. showed that 
long-fiber samples of amosite99 and chryso- 
tile60 are considerably more active than 
short-fiber samples in indudng lung 
tumors.
Davis et al. also showed that tremo­
lite,61 croddolite,5* and long-fiber chryso­
lite60 produce similar numbers of lung 
tumors. Figure 2 represents lung tumors 
due to amosite, croddolite, chrysotfle, or 
tremolite from the 1-year inhalation stud­
ies of Davis et al. and Davis and Jones, 
plotted against the exposure concentra­
tion in units of fiber count.58“61 Inspection 
of Figure 2 suggests that the tumor 
inddence is strongly related to the concen­
tration of fibers 5 pm or greater in length, 
regardless of which type of asbestos is 
involved.
More recently, Coffin et al.62 re­
ported the results from studies of rats 
exposed via intratracheal instillation of 
chrysotilc or croddolite. Although these 
investigators focused primarily on meso­
theliomas, it is worth noting that (summed 
across all dose groups) intratracheal instil­
lation of chiysotile asbestos produced
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RGURE 2— Lung tumors in rats exposed to 10 mg/m3 concentrations of 
crocidolite, amosfte, chrysotile, or tremollte for 1 year.
lung carcinomas in 183% of the animals 
tested vs 4.6% for crocidolite.62
Overall, the toxicologic data suggest 
that chrysotile asbestos is at least as 
potent, if not more so, as the amphibole 
forms in the induction of lung tumors on a 
per-milligram basis. The data shown in 
Figure 2 further suggest that the carcino­
genic potencies of the various types arc 
similar when the dosage is measured in 
terms of the number of fibers greater than 
5 pm in length, as is customary in 
epidemiologic studies.
Mesothelioma
Rats exposed to asbestos by inhala­
tion also develop mesotheliomas, albeit at 
a low incidence. Wagner et al.17 exposed 
rats to 10 mg/m3 of Union International 
Contre le Cancer reference asbestos63 for 
periods of 1 day to 2 years; the mesothe- 
lioma yields were amosite, 0.7%; antho- 
phyllite, 1.4%; crocidolite, 2.8%; and 
Canadian chrysotile, 2.9%. No mesothelio­
mas were observed in control animals or 
animals exposed to chrysotile from Zim­
babwe.17 Similarly, Davis et al. and Davis 
and Jones reported small numbers of 
mesotheliomas in response to 1-year 
inhalation exposures to amosite, crocidol­
ite, Canadian chrysotile, and Zimbabwe 
chiysotile.5®-60 The highest mesothelioma 
incidence in these studies, 7.5%, was 
produced by exposure to long-fiber chryso­
tile.60 Although the low incidence rates 
and small numbers of animals make 
quantitative comparisons uncertain, it 
cannot be said that these studies provide 
convincing support for the amphibole 
hypothesis.
The mesothelioma-inducing poten­
tial of asbestos fibers that reach pleural 
surfaces has also been examined via 
implantation studies. Union International 
Contre le Cancer reference amosite, 
anthophyilite, crocidolite, Canadian 
chiysotile, and Zimbabwe chrysotile all 
produced mesotheliomas in rats after 
intrapleural inoculation.64 Extensive stud­
ies by Stanton and co-workers suggest that 
all long, thin, durable fibers have the 
potential to induce mesotheliomas after 
surgical implantation and that fiber dimen­
sions have much more influence on 
mesothelioma yield than any differences 
that may exist between types of asbestos.65 
However, it is certainly possible that 
different types of asbestos fibers may have 
differing probabilities of reaching pleural 
surfaces'when inhaled into the lungs. 
Overall, the implantation studies suggest 
that chrysotile asbestos does have the 
potential to induce mesothelioma, but
these studies do not resolve the question 
of whether or not chrysotile is less potent 
in this regard than the amphibole forms.
Coffin et al. recently reported that 
both chrysotile and crocidolite produce 
mesotheliomas when administered intra- 
tracheally.62 No consistent dose-response 
relationship was observed in these experi­
ments, but (summing across all dose 
groups) chrysotile asbestos produced me­
sotheliomas in 95% of the animals vs 
5.1% for crocidolite. This suggests that 
chiysotile may have greater mesothelioma- 
inducing potential than crocidolite on a 
per-milligram basis. However, the chryso­
tile preparation used in this experiment 
contained more fibers per milligram than 
the crocidolite preparation, as well as a 
larger proportion of long fibers. If the 
experimental exposures are expressed on 
the basis of the number of fibers greater 
than 5 pm in length, it appears that 
crocidolite produced nearly 12 times more 
mesotheliomas per fiber than chrysotile. 
It should be noted that the fiber prepara­
tions in the Coffin et al. experiments
consisted primarily of short fibers, with 
median fiber lengths on the order of 1 pm 
for both chrysotile and crocidolite. If short 
fibers do in fact have some mesothelioma- 
inducing potential, the attribution of all 
mesotheliomas to the small fraction of the 
fibers that were greater than 5 pm in 
length may lead to an exaggerated esti­
mate of the difference in potency of 
crocidolitc vs chrysotilc. In addition, reli­
ance on the quantitative responses in this 
study should probably be limited due to 
the lack of dose-response. Nevertheless, 
these data do provide some support for 
the hypothesis that chrysotile may have 
lower mesothelioma-indudng potential 
than the amphibole forms of asbestos.
Mechanistic Studies
It has been hypothesized that the 
cytotoxic, genotoxic, and proliferative ef­
fects of asbestos are in part mediated by 
the production of reactive oxygen spedes 
released by alveolar macrophages in re­
sponse to engulfment of long fibers and
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that this process may be catalyzed by iron 
on the fiber surface. Furthermore, it has 
been suggested that the needle-like con* 
figuration, durability, and increased iron 
content of crocidolite render -it more 
pathogenic than either amosite or chryso­
tile.66 Experimental support for this hy­
pothesis is primarily derived from in vitro 
studies, which suggest that iron could 
potentially act as a source of free radicals, 
an inhibitor of tumoriddal defense mecha­
nisms, and a nutrient for unrestricted 
tumor cell replication.67 However, com­
parison of the carcinogenic potencies of 
fibers in the rat in vivo does not support 
the hypothesis that carcinogenic potency 
is related to iron content. As discussed 
above, Wagner et a I.17 observed similar 
numbers of tumors in rats with crocidol­
ite, amosite, and chiysotile, even though 
these fibers have an elemental iron con­
tent of 40%, 28%, and less than 1%, 
respectively.67 The nonasbestos mineral 
erionite does not indude iron as a 
constituent68 but is nonetheless a potent 
mesothelioma inducer in rats.69 Silicon 
carbide "whiskers," with an iron content 
of essentially zero, induce pleural tumors 
in rats after intrapleural implantation.65 
Therefore, no obvious correlation be­
tween iron content and cardnogenidty is 
apparent in the rat
Summary
Our review of both the toxicologic 
and epidemiologic literature strongly sup­
ports the view that occupational exposure 
to chrysotile asbestos is associated with an 
increased risk of both lung cancer and 
mesothelioma. The hypothesis that these 
observations may be attributable to trace 
amounts ( < 1%) of tremolite contamina­
tion may seem to be primarily of academic 
interest, because chiysotile exposures in 
workers and the public are also contami­
nated with tremolite. However, the per­
centage of tremolite has been reported to 
range from 0.5% to 6.9% in one analysis 
of eight commercial chiysotile asbestos 
samples,6 and it has been suggested that 
chrysotile from Zimbabwe10 and other 
countries may be free of contamination by 
amphiboles. Hence, the amphibole hy­
pothesis may be of some public health 
relevance.
In our view, the currently available 
sdentific literature does not provide per­
suasive evidence for the hypothesis that 
tremolite contamination explains the me­
sothelioma «cesses observed in the stud­
ies of chrysotile-exposed workers. The 
primary evidence for this hypothesis comes
from pathologic studies in which lung 
burdens were measured. However, inter- 
pretatkm of these studies is hampered by 
the fact that chrysotile lung burdens are a 
poor reflection of integrated exposures 
and the fact that chrysotile exposure is 
highly correlated with lung burden of the 
amphiboles (e.g  ̂tremolite). In addition, 
the pattern of asbestos fiber deposition in 
the lung does not appear to be consistent 
with the pattern of deposition in the 
taiget tissue (Le  ̂pleura). The previously 
reviewed empirical data from toxicologic 
studies and comparisons of mesothelioma 
mortality and lung cancer mortality be­
tween epidemiologic studies with differ­
ing levels of tremolite contamination do 
not provide support for this hypothesis. 
Mechanistic arguments that have been 
made to support the amphibole hypoth­
esis, which are based on in vitro studies of 
iron content, appear to be contradicted by 
the lade of correlation between iron 
content and carcinogenic potency ob­
served in experimental studies.
Whether chiysotile asbestos is less 
potent than the amphibole forms of 
asbestos is a question that has not yet 
been frilly resolved. There is currently 
very tittle toxicologic evidence to support 
this hypothesis. There is evidence from 
epidemiologic studies that chiysotile may 
be less potent for mesothelioma induction 
than crocidolite. The proportion of deaths 
due to mesothelioma are strikingly lower 
in chrysotile-exposed miners and millers 
than in cnxidolite miners. There is 
absolutely no epidemiologic or toxicologic 
evidence to support the argument that 
chiysotile asbestos is any less potent than 
other forms of asbestos for indudng lung 
cancer.
It should be recognized that compari­
sons of the potency of the different forms 
of asbestos are severely limited by uncon­
trolled differences in the bivariate distribu­
tion of fiber length and diameter (i.e., 
fiber dimensions). Experimental studies 
dearly demonstrated that fiber dimen­
sions are a critical component of the 
carcinogenic potency of fibers.65 This 
concern applies to most of the toxicologic 
studies in which exposure is determined 
on an equal mass basis and is particularly 
pertinent to the epidemiologic investiga­
tions. Historic exposures in most of the 
epidemiologic investigations were based 
on impinger samples that assessed the 
number of fibers, and conversion factors 
were applied to estimate the number of 
fibers longer than 5 pm. Concerns have 
been raised about the accuracy of these 
conversion factors and the potential im­
pact of associated errors on the assess­
ment of risk.71 The current Occupational 
Safety and Health Administration 
(OSHA) method counts asbestos fibers 
that are longer than 5 pm and that have a 
length-to-diameter ratio of at least 3 to 1. 
This method implidtly assumes that fibers 
less than 5 pm in length are not carcino­
genic and that all fibers greater than 5 pm 
in length are of equal carcinogenic po­
tency. These assumptions are dearly 
inconsistent with the experimental data 
and most likely result in substantial 
misdassification of exposure in the epide­
miologic studies.
Policy Implications
The American Conference of Gov­
ernmental Industrial Hygienists and sev­
eral countries (e.g., the United Kingdom) 
have adopted less restrictive standards for 
chrysotile asbestos than for the other 
forms of asbestos.72 In our view, the 
currently available sdentific evidence does 
not provide suffident support for develop­
ing separate standards for the different 
forms of asbestos. As this article docu­
ments, the sdentific evidence for the 
amphibole hypothesis is still tenuous. 
Furthermore, the fact remains that in 
practice workers in this country and other 
countries are not exposed to pure chryso- 
tilc, but rather to a mixture of chiysotile, 
tremolite, and other forms of asbestos. 
Thus, it is highly impractical to consider 
setting separate standards for the differ­
ent forms of asbestos. Finally, even if one 
accepts the argument that chiysotile asbes­
tos does not induce mesothelioma (which 
we do not), the risk of lung cancer (and 
asbestosis) can not be dismissed, and 
chiysotile appears to be just as potent a 
lung carcinogen as the other forms of 
asbestos. It is noteworthy that the risk of 
lung cancer is of greater concern than the 
ride of mesothelioma because in most 
studies there are at least two excess lung 
cancers for every mesothelioma observed 
(see Table 1). There is also the additional 
concern of asbestosis risk, which was not 
considered in this article but dearly adds 
to the risk assodated with chrysotile 
exposure.
Therefore, given the dear evidence 
of a lung cancer ride, the lack of compel­
ling evidence for the amphibole hypoth­
esis, and the fact that workers are gener­
ally exposed to mixture of fiber types, we 
believe that it is prudent policy to treat 
chiysotile asbestos with virtually the same 
level of concern as the amphibole forms of 
asbestos. This view is consistent with the
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past National Institute for Occupational 
Safety and Health Administration recom­
mendation and the recently revised OSHA 
standard to limit occupational exposures 
for all forms of asbestos to 0.1 fiber/cc. □
References
1. Pigg BJ. The uses of chiysotile. Ann Occup 
Hygr 1994;38:453-458.
2. Lemen RA, Bingham E. A case study in 
avoiding a deadly legacy in developing 
countries. Toxicol Ind Health. 1994;10(l/2): 
59-87.
3. Mossman BT, Bignon J, Corn M, Seaton 
A, Gee JBL. Asbestos: scientific develop­
ments and implications for public policy. 
Science. 199024:294-301.
4. Dunnigan, J. Linking chiysotile asbestos 
with meso\hc\k>ma.Am J Ind Med 1988; 14: 
205-209.
5. Pooley FD, Clark NJ. Quantitative assess­
ment of inorganic fibrous particulates in 
dust samples with an analytical transmis­
sion electron microscope. Ann Occup Hyg. 
1979;22:253-271.
6. Addison J, Davies LST. Analysis of am­
phibole asbestos in chiysotile and other 
minerals. Ann Occup Hyg. 1990;34:159- 
175.
7. Pooley FD. An examination of the fibrous 
mineral content of asbestos lung tissue 
form the Canadian chrysotile mining indus­
try. Environ Res 1976;12:281-298.
8. Rowlands N, Gibbs GW, McDonald AD. 
Asbestos fibres in the lungs of chrysotile 
miners and millers— a preliminary report. 
Ann Occup Hyg. 1982;26:411-415.
9. Churg A  Wamock M L  Asbestos fibers in 
the general population. Am  Rev Respir Dis. 
1980;122:669-678.
10. Jones JSP, Roberts GS, Pooley FD, et a!. 
The pathology and mineral content of 
lungs in cases of mesothelioma in the 
United Kingdom in 1976. In: Wagner JC, 
ed. Biological Effects o f Mineral Fibers. 
Lyon, France: International Agency for 
Research on Cancer, 1980:188-199. Scien­
tific Publication No. 30.
11. Wagner JC Pooley FD, Beny G, et al. A 
pathological and mineralogical study of 
asbestos-related deaths in the United King­
dom in 1977. Ann Occup Hyg. 1982̂ 6:423- 
431.
12. McDonald AD, McDonald JC, Pooley FD. 
Mineral fibre content of lung in mesothe- 
lial tumours in North America, .¿/in Occup 
Hyg. 1982;26:417-422.
13. Gaudichet A, Janson X, Monchaux G, et 
al. Assessment by analytical microscopy of 
the total lung fibre burden in mesothe­
lioma patients matched with four other 
pathological series. Ann Occup Hyg. 1988; 
32(suppl 1):213-223.
14. Wagner JC, Berry G, Pooley FD. Mesothe­
liomas and asbestos type in asbestos textile 
workers: a study of lung contents. BrMcdJ. 
1982;285:603-606.
15. McDonald JC, Armstrong B, Case B, et al. 
Mesothelioma and asbestos fiber type: 
evidence from lung tissue analyses. Cancer. 
1989;63:1544-1547.
16. Rogers AJ, Leigh J, Berry G, Ferguson 
D A  Mulder HB, Ackad M. Relationship 
between lung asbestos fiber type and
concentration and relative risk of mesothe­
lioma. Cancer. 1991;67:1912-1920.
17. Wagner JC, Berry G, Skidmore JW, Tim­
bre II V. The effects of the inhalation of 
asbestos in rats. BrJ Cancer. 1974;29:252- 
269.
18. Middleton AP, Beckett ST, Davis JMG. A 
study of the short-term retention and 
clearance of inhaled asbestos by rats, using 
U.I.CC standard reference samples. In: 
Walton WH, ed. Inhaled Particles IV. 
Edinburgh, Scotland: Institute of Occupa­
tional Medicine; 1975:247-258.
19. Churg A  Wright JL,Vedel S. Fiber burden 
and patterns of asbestos-related disease in 
chrysotile miners and millers. Am Rev 
Respir Dis. 1993;48:25-31.
20. Rendall RE. Retendon and Clearance o f 
Glass Fibers and Different Varieties o f 
Asbestos by the Lung. Johannesburg, South 
Africa: University of Witwatersrand; 1988. 
Dissertation.
21. Selikoff IJ, Hammond EC, Seidman H. 
Mortality experience of insulation workers 
in the United States and Canada, 1943- 
\976. Ann N Y  Acad ScL 1979;330:91-116.
22. Sebastien P, Janson X, Gaudichet A, 
Hirsch A  Bigon J. Asbestos retention in 
human respiratory tissues: comparative 
measurements in lung parenchyma and in 
parietal pleura. In: Wagner JC, ed. Biologi­
cal Effects o f Mineral Fibers. Lyon, France: 
International Agency for Research on 
Cancer, 1980:237-246.
23. Churg A  Asbestos fiber content of the 
lungs in patients with and without asbestos 
airways disease. Am Rev Respir Dis. 1983; 
127:470-473.
24. Le Bouffant L, Martin JC, Duyif S, Daniel 
H. Structure and composition of pleural 
plaque. In: Bogovski P, Gilson JCTimbrell 
V, Wagner JC eds. Biological Effects o f 
Asbestos. Lyon, France: International 
Agency for Research on Cancer, 1973:249- 
257. Scientific Publication No. 8.
25. Dodson RF, Williams MG, Com CJ, 
Brollo A  Bianchi C. Asbestos content of 
lung tissue, lymph nodes, and pleural 
plaques from former shipyard workers. ,4 m 
Rev Respir Dis. 1990; 142:843-̂ 847.
26. Kohyama N, Suzuki Y. Analysis of asbestos 
fibers in lung parenchyma, pleural plaques, 
and mesothelioma tissues of North Ameri­
can insulation workers./!/» N YAcad ScL 
1991;643:27-52.
27. Acheson ED, Gardner MJ, Pippard EC, 
Grime LP. Mortality of two groups of 
women who manufactured gas masks from 
chiysotile and crocidolite asbestos: a 40- 
year follow-up. BrJ Ind Med. 198239344- 
348.
28. Cheng W, Kong J. A retrospective mortal­
ity cohort study of chiysotile asbestos 
products workers in Tianjin 1972-1987. 
EmimnRes. 1992̂ 9:271-278.
29. Dement JM, Brown DP, Okun A. Mortal­
ity among chrysotile asbestos textile work­
ers: Cohort mortality and case-control 
analyses. Ann Occup Hyg. 1994;38:525-532.
30. Finkelstein MM. Mortality among employ­
ees of an Ontario factory that manufac­
tured construction materials using chiyso- 
tilc asbestos and coal tar pitch. Am J Ind 
Med. 1989;16:281-287.
31. Finkelstein MM. Mortality rates among 
employees potentially exposed to chiyso­
tile asbestos at two automotive parts
factories. Can Med Assoc /. 1989;141:327- 
330.
32. Hughes JM, Weill H, Hammad YY. Mortal­
ity of workers employed in two asbestos 
cement manufacturing plants. Br J Ind 
Med. 1987;44:161-174.
33. Huilan Z, Zhiming W. Study of occupa­
tional lung cancer in asbestos factories in 
China. BrJ Ind Med. 1993;50:1039-1042.
34. McDonald AD, Fiy JS, Woolley AJ, 
McDonald JC. Dust exposure and mortal­
ity in an American chrysotile asbestos 
friction products plant. Br J Ind Med. 
1984;41:151-157.
35. McDonald JC Liddell FDK, Gibbs GW, 
Eyssen GE, McDonald AD. Dust exposure 
and mortality in chiysotile mining, 1910- 
1975. BrJ Ind Med. 1980-37:11-24.
36. McDonald JC Liddell FDK, Dufresne A, 
McDonald AD. The 1891-1920 birth co­
hort of Quebec chiysotile miners and 
millers: mortality 1976-88. Br J Ind Med. 
1993;50:1073-1081.
37. Piolatto G, Negri E, LaVecchia C Pira E, 
Decarli A  Peto J. An update of cancer 
mortality among chrysotile asbestos miners 
in Balangero, Northern Italy. BrJ Ind Med 
1990;47:810-814.
38. Shiqu Z, Yongxian W, Fusheng M, Hong- 
shuen M, Wenzhi S, Zhenhuan J. Retro­
spective mortality study of asbestos work­
ers in Laiyuan. In: Proceedingy o f the VII 
International Pneumoconioses Conference, 
Part II; August 23-26,1988; Pittsburgh, Pa. 
National Institute for Occupational Safety 
and Health; 1990:1242-1244. DHHS publi­
cation 90-109, part il.
39. Weiss W. Mortality of a cohort exposed to 
chrysotile asbestos. J Occup Med. I977;19: 
737-740.
40. Dement JM, Harris RL, Symons MJ, Shy 
CM. Exposures and mortality among 
chrysotile asbestos workers, part I: expo­
sure estimates. Am J Ind Med. 1983;4399- 
419.
41. Dement JM, Harris RL, Symons MJ, Shy 
CM. Exposures and mortality among 
chiysotile asbestos workers, part II: mortal­
ity. Am J Ind Med 1983;4:421-433.
42. Peto J, Doll R, Hermon C, Binns W, 
Clayton R, Goffe T. Relationship of mortal­
ity to measures of environmental asbestos 
pollution in an asbestos textile factory. Ann 
Occup Hyg. 1985;29:305-355.
43. McDonald JC McDonald AD, Armstrong 
B, Sebastien P. Cohort study of mortality of 
vermiculite miners exposed to tremolite. Br 
J Ind Med 1986;43:436-444.
44. de Klerk NH, Armstrong BK, Musk AW, 
Hobbs MST. Cancer mortality in relation 
to measures of occupational exposure to 
crocidolite at Wittenoom Gorge in West­
ern Australia. Br J Ind Med. 1989;46:529- 
536.
45. Henderson VL, Enterline PE. Asbestos 
exposure: Factors associated with excess 
cancer and respiratory disease mortality. 
Ann N YAcad Sei. 1979; 117-126.
46. Berry G, Ncwhousc ML. Mortality of 
workers manufacturing friction materials 
using asbestos. BrJ Ind Med. 1983;40:1-7.
47. Sebastien P, McDonald JC, McDonald 
AD, Case B, llarley R. Respiratoiy cancer 
in chrysotile textile and mining industries: 
exposure inferences from lung analysis. Br 
J Ind Med. 1989;46:180-187.
48. Dement JM. Carcinogenicity of chiysotile
February 1996, Vol. 86, No. 2 American Journal of Public Health 1 1 3
asbestos: a case control study of textile 
workers. CeB Biol TadcoL 1991;7:59-65.
49. Tolbert P, Eisen E, Fothier LJ, Monson 
RR, HaOock MF, Smith TJ. Mortality 
studies of machining-fluid exposure in tbe 
automobile industry, II: risks associated 
with specific fluid types. Scand J Work 
Environ Health. 1992;I8351-360.
50. Dement JM and Wallingford KM. Com­
parison of phase contrast and electron 
microscopic methods for evaluation of 
occupational asbestos exposures. Appl Oc­
cup Environ Hyg. 1990 :̂242-247.
51. Vital Statistics o f the United States, 1989, VoJ 
II—Mortality, Part B. Hyattsville, Md: 
National Center for Heahb Statistics; 1992. 
DHHS publication PHS 92-1102.
52. Cullen MR and Bakjyi RS. Quysotik 
asbestos and health in Zimbabwe, I: analy­
sis of miners and millers compensated for 
asbestos-related diseases since indepen­
dence (1980). Am J Ind Med 1991^9:161- 
169.
53. Begin R, Gauthier J, Desmeules M, Os- 
tiguy G. Work-related mesothelioma in 
Quebec, 1967-1990./</n///u/Af«i 199222: 
531-542.
54. McDonald JC  McDonald AD. Chiysotile, 
tremolite and mesothelioma. Science. Feb­
ruary 10,1995;267:775-776.
55. Peto J, Seidman H, Sclioff U. Mesothe­
lioma mortality in asbestos workers: impli­
cations for models of carcinogenesis and 
risk assessment BrJ Cancer. 1982;45:124- 
135.
56. Hughes JM, Weill H. Asbestos Exposure- 
Quantitative Assessment of Risk. Am Rev 
Respir Dts. 1986;133:5-13.
57. Sluis-Cremer GK, Liddell FDK, Logan 
WPD, Bezuideahout BN. The mortality of 
amphibole miners in South Africa, 1946- 
M. BrJ Ind Med. 1992;49566-575.
58. Davis JMG, Beckett ST, Bolton RE, 
Collins P, Middleton AP. Mass and num­
ber of fibres in tbe pathogenesis of asbestos- 
related hmg disease in rats. Br J Cancer: 
197837:673-688.
59. Davis JMG, Addison J, Bolton RE, Donald­
son K, Jones AD, Smith T. The pathogenic­
ity of long versus short fibre samples of 
amosite asbestos administered to rats by 
inhalation and intraperitoneal injection. Br 
J Exp Pathol 1986;67:415-430.
60. Davis JMG, Jones AD. Comparisons of the 
pathogenicity of long and short fibres of 
duysotOe asbestos in rats. BrJ Exp PathoL 
1988;69:717-737.
61. Davis JMG, Addison J,BoIton RE, Donald­
son K, Jooes AD, Miller BG. Inhalation 
studies on tbe effects of tremolite and 
brudte dust in rats. Carcinogenesis. 1985;6: 
667-674.
62. Coffin DL, Cook PM, Creason JP. Relative 
mesothelioma induction in rats by mineral 
fibers: comparison with residual pulmo­
nary mineral fiber number and epidemiol­
ogy. Inhal TadcoL 1992;4:273-300.
63. Timbrel! V, Gibson JC  Webster L UICC 
standard reference samples of asbestos. Int 
J Cancer. 19683:406-408.
64. Wagner JC, Berry G, Timbre 11 V. Mesothe­
lioma ta in rats after inoculation with 
asbestos and other materials. B rJ Cancer.
197338:173-185.
65. Stanton MF, Layard M, Tegeris A, et aL 
Relation of particle dimension to cardno-
genkaty in amphibole asbestoses and other 
fibrous minerakj Sad Cancer Inst. 1981p67: 
965-975.
66. Mossman BT. Mechanisms of asbestos 
carcinogenesis and toxicity: the amphibole 
hypothesis revisited. BrJ Ind Med. 1993^0: 
673-676. Letter.
67. Weinberg ED. Association of non with 
respiratory tract neoplasia. J Trace E3em 
Exp Med 1993;6:117-123.
68. IGrk-Othmer Encyclopedia o f Chemical Tech­
nology- 3rd ed. Vol 15. New York, NY: 
John Wiley & Sons; 1981:639.
69. Davis JMG. Mineral fine carcinogenesis: 
experimental data relating to tbe impor­
tance of fibre type, size, deposition, dissolu­
tion, and migration. In: Bignon J, Peto J, 
Saracd R, eds. Nonoccupatkwud Exposure 
to Mineral Fibers. Lyon, France: Interna­
tional Agency for Research on Cancer, 
198933-45.
70. Baloyi R. Exposure to Asbestos among 
Chrysotile Miners, Millers and Mine Resi­
dents and Asbestosis in Zimbabwe. Helsinki, 
Finland: University of Kuopio; 1989. Disser­
tation.
71. Peto J. Fibre carcinogenesis and environ* 
mental hazards. In: Bignon J, Peto J, 
Saracd R, eds. Nan-occupational Exposure 
to Mineral Fibres. Lyon, France: Interna­
tiona] Agency for Research on Canoer; 
1989:457-470.
72. Threshold Limit Values for Chemical Sub­
stances and Physical Agents and Biological 
Exposure Indices. Cincinnati, Ohio: Ameri­
can Conference of Governmental Indus­
trial Hygjenists; 1994-1995.
1 1 4  American Journal of Public Health February 1996, VoL 86, No. 2
WORK-RELATED LUNG DISEASE 
SURVEILLANCE REPORT 
1996
D ivision o f  R espiratory D isease Studies 
N ational Institute for O ccupational Safety and H ealth
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES 
Public Health Service 
Centers for Disease Control and Prevention
October 1996
DISCLAIMER
Mention o f the name of any company or product does not constitute the endorsement by the 
National Institute for Occupational Safety and Health.
This document is in the public domain and may be freely copied or reprinted.
Copies of this and other NIOSH documents are available from:
Publications Dissemination, EID 
National Institute for Occupational Safety and Health 
4676 Columbia Parkway 
Cincinnati, OH 45226-1998 
FAX (513) 533-8573
DHHS (NIOSH) Publication No. 96-134
For further information about occupational safety and health, call 1-8QO-35-NIOSH
For n k  by the Superintendent of Documents, U J . Government Printing Office. Washington, D.C. 20103
116
Preface
This 1996 Work-Related Lung Disease (WoRLD) 
Surveillance Report is the fourth in a series of 
occupational respiratory disease surveillance reports 
produced by the National Institute for Occupational Safety 
and Health (NIOSH). The purpose of this 1996 report is to 
provide national and state-specific summaries of 
occupational respiratoiy disease surveillance data focusing 
on pneumoconiosis mortality. Selected occupational 
respiratory hazard sampling data relevant to 
pneumoconiosis are also presented.
The 1996 WoRLD Surveillance Report has three sections: 
1) a highlights and limitations section that provides data 
highlights and data usage limitations; 2) a United States 
section that serves to update and expand overall national 
data provided in the 1994 WoRLD Surveillance Report] 
and 3) a state section that provides detailed profiles of 
pneumoconiosis data for each state in the U.S..
The United States section updates pneumoconiosis 
mortality surveillance data published previously in the 
1994 WoRLD Surveillance Report, by including data 
available for 1991 and 1992. For each condition, this 
section presents national data such as counts, crude and 
age-adjusted mortality rates, and years of potential life lost 
to age 65 to and life expectancy. Proportionate mortality 
ratios by industry and occupation, are based on data from 
a subset of states (see state list, Appendix C) for which 
usual industry and occupation have been coded for 
decedents. Also presented are U.S. county level maps 
showing the geographic distribution of mortality for each 
pneumoconiosis condition. In addition, this section 
presents selected occupational exposure sampling data for 
asbestos, coal and coal mine dust, silica dust, cotton dust, 
etc. (see agent categories, Appendix D).
The State section provides more detailed pneumoconiosis 
mortality surveillance data for each state and for the 
District of Columbia. The State section is organized so 
that tables and graphs of data for each state are grouped 
together. Selected graphs, tables, and maps present 
pneumoconiosis mortality from 1968 to 1992 for each 
state, as well as for counties within each state. 
Surveillance data include counts, crude and age-adjusted 
mortality rates, and years of potential life lost to life 
expectancy.
Pneumoconiosis conditions highlighted in the report 
include asbestosis, coal workers' pneumoconiosis,
silicosis, byssinosis, and pneumoconioses classified as 
either "unspecified" or "other,” as well as all 
pneumoconioses aggregated. Although some experts do 
not consider byssinosis a typical pneumoconiosis, it is 
included because the International Classification of 
Disease GCD) system places byssinosis (code 504) within 
the series of codes for the pneumoconioses (500-505) and 
because byssinosis is included with other pneumoconioses 
in a new occupational safety and health objective for the 
nation (#10.17 in Healthy People 2000: Midcourse Review 
and 1995 Revisions).
Data contained in the report originate from publications, 
reports, and data provided by the National Center for 
Health Statistics (NCHS), the Occupational Safety and 
Health Administration (OSHA), the Mine Safety and 
Health Administration (MSHA), and the Bureau of Mines 
(BoM). Details on the major data sources and on the 
methods used to compute specific statistics can be found 
in Appendices A and B, respectively. Interpreted with 
appropriate care, information contained in this report can 
help to establish priorities for investigation and 
intervention, as well as to track progress toward the 
elimination of an important subset of preventable 
occupational respiratory diseases.
A description of previous editions of the WoRLD 
Surveillance Report, along with revisions and errata can be 
found in Appendix E. Comments and suggestions from 
users of earlier editions have influenced the content and 
format of this 1996 edition. To increase the utility of future 
editions, comments on the current report and descriptions 
of how the information is used are invited.
Send comments, suggestions, tear-out reader 
response card and other correspondence to:
E-M ail: WORLD@NIORDSl.EM.CDC.GOV
Work-Related Lung Disease Surveillance Report 
Surveillance Section 
Epidemiological Investigations Branch 
Division of Respiratory Disease Studies ^  m 
NIOSH
1095 Willowdale Road




Figure 1-1. Asbestosis: Number of deaths, crude and age-adjusted mortality rates, 
U.S. residents age 15 and over, 1968-1992
Number o f Deaths Deaths/Million
J 0
□Number of Deaths .U .S . Crude Rate «U.S. Age-adjusted Rate
NOTE: See Appendix A for source description and Appendix B for methods and ICD-8 and 1CD-9 codes.
SOURCE: National Center for Health Statistics multiple cause of death data. Population estimates from U.S. Bureau of the Census.
Figure 1-2. Asbestosis: Crude mortality rates by state, U.S. residents age 15 and 
over, 1991-1992
NOTE: See Appendix A for source description and Appendix B for methods and ICD-S and ICD-9 codes.
SOURCE: National Center for Health Statistics multiple cause of death data. Population estimates from U.S. Bureau of the Census.
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Figure 1-3. Asbestosis: Median age at death, U.S. residents age 15 and over, 1968-1992
•«•Asbestosis Deaths •O-U.S. Deaths
U.S. Male Deaths -O-U.S. Female Deaths
NOTE: Sec Appendix A for source description and Appendix B for methods and ICD-8 and I CD-9 codes.
SOURCE; National Center for Health Statistics multiple cause of death data.
Table 1-1. Asbestosis: Number of deaths by sex, race, and age, U.S. residents age 15 and 
over, 1991-1992 ____
. 1991 : 1992
Number Percent Number Percent
Total deaths 946 100.0 959 100.0
Sex Male 908 96.0 923 96.2
Female 38 4.0 36 3.8
Race White 877 92.7 898 93.6
Black 63 6.7 57 5.9
Other 6 0.6 4 0.4
Age 15-24 1 0.1 0 0.0
25-34 0 0.0 0 0.0
35-44 1 0.1 3 0.3
45-54 25 2.6 13 1.4
55-64 114 12.1 124 12.9
65-74 370 39.1 371 38.7
75-84 358 37.8 355 37.0
85 and over 77 8.1 93 9.7
Mean age 73.1 73.5
Range for age 19-96 38-100
NOTE; Percentages may not total to 100% due to rounding. See Appendix A for source description and Appendix B for methods and ICD-8 and ICD-9 codes. Data for 
1968*1990 can be found in the Work-Related Lung Disease Surveillance Report, 1994, see Appendix E.
SOURCE; National Center for Health Statistics multiple cause of death data.
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Table 1-2. Asbestosis: Nomber of deaths by state, U.S. residents age 15 and over, 1968-1992
State 1968-1978 1979-1990 1991 1992 TOTAL
Alabama 6 92 23 18 139
Alaska 3 4 1 1 9
Arizona 20 64 6 8 98
Arkansas I 35 6 5 47
California 157 954 94 95 1,300
Colorado 5 38 5 4 52
Connecticut 22 94 14 17 147
Delaware 4 37 14 8 63
District of Columbia 2 6 1 - 9
Florida 37 348 54 52 491
Georgia 16 78 10 18 122
Hawaii 1 31 4 4 40
Idaho 3 33 6 3 45
Illinois 40 147 20 21 228
Indiana 9 49 4 4 66
Iowa 5 25 3 7 40
Kansas 1 23 3 7 34
Kentucky 2 31 5 5 43
Louisiana 13 113 20 14 160
Maine 9 98 8 8 123
Maryland 19 172 27 33 251
Massachusetts 104 340 27 48 519
Michigan 19 85 15 16 135
Minnesota 11 68 6 17 102
Mississippi 2 97 25 25 149
Missouri 23 84 11 14 132
Montana 3 30 2 4 39
Nebraska 2 20 3 2 27
Nevada 3 19 3 1 26
New Hampshire 5 48 1 4 58
New Jersey 232 800 93 80 1,205
New Mexico 4 19 3 1 27
New York 91 272 37 30 430
North Carolina 24 140 21 25 210
North Dakota - 6 3 - 9
Ohio 32 167 24 32 255
Oklahoma 3 39 6 5 53
Oregon 25 144 22 22 213
Pennsylvania 165 640 83 100 988
Rhode Island 5 48 1 5 59
South Carolina 37 100 8 13 158
South Dakota 1 2 - - 3
Tennessee 12 73 8 4 97
Texas 34 354 95 54 537
Utah 1 16 - 4 21
Vermont 2 11 - 3 16
Virginia 39 271 36 43 389
Washington 81 342 50 40 513
West Virginia 6 88 20 28 142
Wisconsin 16 56 11 6 89
Wyoming 2 5 4 1 12
TOTAL - 1359 6,856 946 - ‘ : “ : 959 -• 10,120
- indicates mo listed.
NOTE; See Appendix A for source description and Appendix B for methods and ICD-8 aid ICD-9 codes.
SOURCE: National Center fi» Health Statistics multiple caase of death data.
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Table 1-3. Asbestosis: Mortality rates (per 1,000,000 population) by race and sex, 
U.S. residents age 15 and over, 1991-1992
White Black
Year Overall rate Males Females Males Females
Crude mortality rate
1991 4.80 10.42 0.42 5.86 0.16
1992 4.82 10.63 0.37 5.00 0.32
À?e-adj listed mortality rs te
1991 2.94 6.91 020 5.79 0.14
1992 2.90 6.93 0.17 4.99 0.28
NOTE:
SOURCE:
See Appendix A for source description and Appendix B for methods and I CD-8 and ICD-9 codes. Data for 1968-1990 can be found in the 
Work-Related Lung Disease Surveillance Report, 1994, see Appendix E.
See Appendix E for revised rates for 1968-1990.
National Center for Health Statistics multiple cause of death data. Population estimates from U.S. Bureau of the Census.
Table 1-4. Asbestosis: Years of potential life lost by race and sex, U.S. residents 
age 15 and over, 1991-1992
White Black
Year Overall Males Females Males Females
Years of potential life lost to age 65
1991 1,015 845 30 130 0
1992 890 780 15 50 30
Years of potential life lost to life expectancy
1991 11,883 9,294 466 664 28
1992 11,850 9,441 389 540 80
NOTE: See Appendix A for source description and Appendix B for methods and 1CD-8 and ICD-9 codes. Data for 1968-1990 can be found in the
Work-Related Lung Disease Surveillance Report, 1994, see Appendix E.




Table 1-5. Asbestosis: Total anmber of deaths, crude and age-adjusted mortality rates (per 1,000,000 population), and total 
years of potential life lost (YPLL) to life expectancy, by state, U.S. residents age 15 and over, 1988-1992
Total
deaths Rank
Crude mortality ARe^djusted mortality fPLLto life expectancy
: State ::
]
Rate Rank Rate : Rank Years Rank Years/dealh Rank .
Alabama 94 15 5.94 14 3.79 15 1354 14 133 17
Alaska 5 47 2.49 29 3.% 13 84 48 16.8 2
Arizona 30 29 2.11 37 139 35 414 29 13.8 13
Arkansas 20 36 2.18 34 134 37 283 35 143 8
California 459 2 3.96 23 2.75 23 5303 2 12.0 40
Colorado 22 33 1.71 43 1.27 40 309 33 14.0 9
Connecticut 66 19 4.98 19 2.87 22 797 21 12.1 39
Delaware 49 25 1835 1 13.08 1 727 23 14.8 4
District of Columbia 1 50 039 50 0.29 50 14 50 14.0 12
Florida 264 5 5.00 18 235 26 3387 5 123 32
Georgia 55 22 2.18 34 1.79 28 806 20 14.7 5
Hawaii 20 36 438 22 2.91 21 227 39 11.4 43
Idaho 22 33 5.88 15 3.72 17 279 36 12.7 29
Illinois 96 14 2.15 36 1.40 34 1388 13 13.4 16
Indiana 26 32 1.20 49 .0.73 49 316 32 123 37
Iowa 18 40 1.66 45 0.9! 47 232 38 12.9 20
Kansas 20 36 2.09 38 1.05 45 226 40 113 44
Kentucky 19 39 131 48 0.87 48 260 37 13.7 14
Louisiana 86 17 5.41 16 339 18 1,102 16 12.8 23
Maine S3 23 10.94 4 5.96 6 610 25 113 42
Maryland 136 10 7.16 12 530 8 1.825 10 13.4 15
Massachusetts 184 8 736 10 4.05 12 2,054 9 113 47
Michigan 66 19 1.83 41 132 38 987 19 15.0 3
Minnesota 47 26 2.78 26 1.78 29 585 26 12.4 33
Mississippi 98 13 10.05 6 6.22 4 1347 15 12.7 27
Missouri 52 24 239 28 1.44 31 635 24 123 36
Montana 22 33 730 11 437 10 309 33 14.0 9
Nebraska 12 43 1.98 39 0.94 46 127 43 10.6 49
Nevada 7 46 1.46 47 1.06 44 93 45 133 18
New Hampshire 17 41 3.90 24 2.74 24 214 41 12.6 30
New Jersey 473 1 15.21 2 8.88 2 5,821 1 123 34
New Mexico 13 42 2.29 32 137 30 167 42 12.8 21
New York 172 9 239 31 1.42 33 2,196 7 12.8 25
North Carolina 100 12 3.77 25 2.51 25 1320 12 133 19
North Dakota 4 49 1.63 46 136 36 87 47 21.8 1
Ohio 118 11 2.78 26 1.88 27 1,715 11 14.5 6
Oklahoma 30 29 2.46 30 1.43 32 376 30 12.5 31
Oregon 94 15 8.41 8 432 11 1,060 18 113 45
Pennsylvania 430 3 9.02 7 4.85 9 5,493 3 12.8 24
Rhode Island 29 31 7.14 13 3.86 14 351 31 12.1 38
South Carolina 64 21 4.70 21 3.11 19 784 22 123 35
South Dakota - - - - - - - - - -
Tennessee 35 28 1.81 42 136 41 500 28 143 7
Texas 335 4 5.18 17 3.79 15 4369 4 12.7 26
Utah 10 44 1.68 44 136 41 119 44 11.9 41
Vermont 5 47 236 33 132 43 50 49 10.0 50
Virginia 196 6 7.95 9 5.79 7 2316 6 12.8 22
Washington 195 7 10.25 5 6.10 5 2,191 8 113 46
West Virginia 86 17 12.03 3 633 3 1,091 17 12.7 28
Wisconsin 37 27 1.95 40 138 39 519 27 14.0 11
Wyoming 8 45 4.72 20 2.94 20 88 46 11.0 48
• indicates do deaths listed.
NOTE; Ranks are based oa «wounded *ah»e». SceAppendix Afar lowce description and Appendix B for methods and ICD-j and K3>-^ codes. 
SOURCE: National Center for Health Statistics Multiple cause of death data. Population estimates from US. Bureau of tbc Census.
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Table 1-6. Asbestosis: Most frequently recorded occupations on death certifícate,
selected states, U.S. residents age 15 and over, 1991-1992
COC Occupation Number Percebt
585 Plumbers, pipefitters, and steamfitters 46 8.0
575 Electricians 31 5.4
593 Insulation workers 29 5.0
567 Carpenters 25 4.3
889 Laborers, except construction 24 4.2
633 Supervisors, precision production occupations 18 3.1
643 Boilermakers 18 3.1
019 Managers and administrators, n.e.c. 17 2.9
783 Welders and cutters 17 2.9
453 Janitors and cleaners 15 2.6
All other occupations 322 55.7
Occupation not reported 16 2.8
. TOTAL 578 100.0
COC -1980 Census Occupation Code n.e.c. - not elsewhere classified
NOTE: See Appendix A for source description. Appendix B for methods and ICD-8 and ICD-9 codes, and Appendix C for list of 25 states reporting usual occupation and
years reporting. Data for 1985-1990 can be found in the Work-Related Lung Disease Surveillance Report, 1994, see Appendix E.
SOURCE: National Center for Health Statistics multiple cause of death data.
Table 1-7. Asbestosis: Most frequently recorded industries on death certifícate,
selected states, U.S. residents age 15 and over, 1991-1992
CIC • Industry Number Percent
060 Construction 149 25.8
360 Ship and boat building and repairing 50 8.7
192 Industrial and miscellaneous chemicals 23 4.0
262 Miscellaneous nonmetallic mineral stone products 23 4.0
400 Railroads 17 2.9
901 General government, n.e.c. 17 2.9
142 Yam, thread, and fabric mills 11 1.9
211 Other rubber products, and plastic footwear and belting 9 1.6
392 Not specified manufacturing industries 9 1.6
410 Trucking service 9 1.6
All other industries 244 42.2
Industry not reported 17 2.9
; TOTAL 578 100.0
C1C - 1980 Census Industry Code n.e.c. * not elsewhere classified
NOTE: See Appendix A for source description, Appendix B for methods and 1 0 8  and I CD-9 codes, and Appendix C for list of 25 states reporting usual industry and
years reporting. Data for 1985-1990 can be found in the Work-Related Lung Disease Surveillance Report, 1994, see Appendix E.
SOURCE: National Center for Health Statistics multiple cause of death data.
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Table 1-8. Asbestosis: Proportionate mortality ratio (PMR) by usual occupation, selected states 






593 Insulation workers 110 261.01 21220 317.53
643 Boilermakers 48 50.47 36.84 67.56
646 Lay-out workers 9 30.60 14.04 58.06
585 Plumbers, pipefitters, and steam fitters 153 19.06 16.03 22.50
653 Sheet metal workers 39 14.03 9.74 19.51
534 Heating, air conditioning, and refrigeration mechanics 11 11.20 5.60 20.04
584. Plasterers 6 10.61 3.89 23.12
575 Electricians 74 8.14 6.36 1029
759 Painting, paint spray machine operators 11 7.06 3.53 12.63
829 Sailors and deckhands 6 6.41 235 13.97
757 Separate, filter, clarify machine operators 8 6.01 2.59 11.83
547 Specified mechanics and repairers, n.e.c. 13 529 2.81 9.04
783 Welders and cutters 40 4.91 3.51 6.69
363 Production coordinators 5 4.68 1.51 10.93
518 Industrial machinery repairers 19 4.41 2.66 6.89
563 Brickmasons and stonemasons 19 4.36 2.63 6.81
544 Millwrights 11 421 2.10 7.53
516 Heavy equipment mechanics 9 420 1.93 7.97
056 Industrial engineer 6 3.89 1.42 8.47
756 Mixing, blending machine operators 5 3.64 1.18 8.50
558 Supervisors, construction, n.e.c. 26 330 2.16 4.84
696 Stationary engineers 14 3.13 1.71 525
549 Not specified mechanics and repairers 12 2.99 1.54 522
579 Painters, construction and maintenance 22 2.85 1.78 432
856 Industrial truck, tractor equipment operators 8 2.76 1.19 5.43
637 Machinists 47 2.65 1.93 3.55
777 Miscellaneous machine operators, n.e.c. 27 2.61 1.72 3.80
779 Machine operators, not specified 37 2.47 1.72 3.44
633 Supervisors, production occupations 47 235 1.72 3.15
567 Carpenters 51 233 1.73 3.07
869 Construction laborers 32 1.79 121 2.56
453 Janitors and cleaners 43 1.46 1.04 1.99
COC - 1980 Census Occupation Code a ^ c . • not elsewhere classified LCL-lower confidence limit UCL-upper confidence limit
NOTE: Sec Appendix A for source description. Appendix B for nediods a d  1CD-S and ICD-9 codes, and Appendix C far list of 25 Mates reporting usual occupation and
years reporting.
SOURCE: National Center Tor Health Statistics multiple cause of death (fata.
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Table 1-9. Asbestosis: Proportionate mortality ratio (PMR) by usual industry, selected states and 






360 Ship and boat building and repairing 164 43.01 36.60 50.19
262 Miscellaneous nonmetallic mineral and stone products 54 29.17 21.61 38.48
192 Industrial and miscellaneous chemicals 54 7.02 5.20 9.26
502 Lumber and construction materials 7 6.64 2.67 13.69
282 Fabricated structural metal products 29 6.22 4.17 8.94
462 Electric and gas, and other combinations 9 6.13 2.81 11.63
200 Petroleum refining 19 5.82 3.51 9.09
521 Hardware, plumbing and heating supplies 8 4.74 2.04 9.33
420 Water transportation 16 4.61 2.63 7.48
211 Other rubber products, and plastics footwear and belting 19 4.49 2.70 7.02
060 Construction 435 4.42 4.00 4.87
181 Drugs 8 4.38 1.89 8.62
881 Membership organizations 12 3.96 2.04 6.91
180 Plastics, synthetics, and resins 6 3.31 1.21 7.21
460 Electric light and power 25 3.29 2.12 4.85
210 Tires and inner tubes 10 2.95 1.42 5.42
272 Primary aluminum industries 7 2.88 1.16 5.94
400 Railroads 46 2.15 1.57 2.88
160 Pulp, paper, and paperboard mills 15 2.02 1.13 3.33
392 Not specified manufacturing industries 43 1.66 1.19 226
CIC - 1980 Census Industry Code LCL * lower confidence limit UCL - upper confidence limit
NOTE: See Appendix A for source description, Appendix B for methods and ICD-8 and I CD-9 codes, and Appendix C for list of 25 states reporting usual industry and
years reporting.
SOURCE: National Center for Health Statistics multiple cause of death data.
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Table 1-10. Asbestos: Number of MSHA and OSHA inspector samples, percent exceeding the
permissible exposure limit (PEL) and average severity level, by Industry, 1993-1994
CIC
Industries most frequently recorded on 
1991-1992 death certificates with asbestosis
Number of 
samples % > PEL
Average
severity
060 Construction 221 4.1 0,17
360 Ship and boat building and repairing 3 0.0 0.00
192 Industrial and miscellaneous chemicals 2 0.0 0.00
262 Miscellaneous nonmetaJIic mineral and stone products 65 10.8 0.43
400 Railroads 0 - -
90! General government, n.e.c. 20 0.0 0.05
142 Yam, thread, and fabric mills 1 0.0 0.00
211 Other rubber products, and plastics footwear and belts 6 0.0 0.03
392 Not specified manufacturing industries 0 - -
410 Trucking service 1 0.0 0.00
All other industries 483 0.8 0.08
Industry not reported 3 0.0 0.00
TOTAL 805 2.5 0.13
CIC - 1980 Census Industry Code uex . - act elsewhere classified * iodi cues incalculable field
NOTE: See Appendix A fbr source description. Appendix B for methods. Appendix C for list of 25 ttites reporting usual industry and y ew  reporting. and Appendix D tar
agents.
SOURCE: Bureau of Mines: Mine inspection M a  Analysis System. Occupational Safety Kid Health Administration: Integrated Management Information System.
National Center for Health Statistics: Multiple cause ai death data.
Table 1-11. Asbestos: Number of MSHA and OSHA inspector samples, percent exceeding the 
permissible exposure limit (PEL) and average severity level, by industry, 1993-1994_________
Number of Average •
CIC Industries most frequently sampled in 1993-1994 samples % >  PEL severity
060 Construction 221 4.1 0.17
262 Miscellaneous nonmetallic mineral and stone products 65 10.8 0.43
910 Justice, public order, and safety 43 0.0 0.02
831 Hospitals 22 0.0 0.00
050 Nonmetallic mining 21 0.0 0.04
901 General government, n.e.c. 20 0.0 0.05
842 Elementary and secondary schools 19 0.0 0.06
751 Automotive repair shops 18 0.0 0.03
591 Department stores 16 0.0 0.00
351 Motor vehicles and motor vehicle equipment 15 0.0 0.04
All other industries 342 \2 0.11
Industry not reported 3 0.0 0.00
TOTAL : 805 • 2.5 ' 0Á3
CIC - 1980 fj—toi« Industry Code ■ e.c. - not elsewhere classified
NOTE; Sec Appendix A for source description. Appendix B for methods. i d  Appendix D for agents.
SOURCE: Bureau of Mines: Mine Inspection Data Analysis System. Occupational Safety and Health Administration: Integrated Management Information System.
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UNITED STATES Asbestos: Exposure
Table 1-12 (page 1 of 2). Asbestos: Number of MSHA inspector samples, percent exceeding the permissible exposure limit (PEL) and average 
severity levels (Avg. Sev.), by state, 1974-1994_______
1974- Ï 9 â f : I t 1993-1994
Tptàl samples Sam pies'>  PEL < : Total samples Samples» PEL Total samples : Samples > PEL
Number
i l A y p  









Alabama 0 - - - 0 - 0
Alaska 0 - - - 0 . . 0
Arizona 86 0.94 14.0 4.78 0 . . 0
Arkansas 0 - - - 0 _ . 0
California 156 0.73 21.8 2.33 64 0.20 0.0 9 0.09 0.0
Colorado 25 0.19 0.0 - 20 0.03 0.0 0
Connecticut 0 - - - 0 - . 0
Delaware 0 - - ■ 0 • • 0 m
District of Columbia 0 - - - 0 . 0 m
Florida 4 0.03 0.0 - 0 • . 0 m
Georgia 16 1.79 25.0 5.45 4 0.00 0.0 0 m
Hawaii 0 - - - 1 0.00 0.0 1 0.00 0.0
Idaho 0 - - - 5 0.01 0.0 0 .
Illinois 55 0.05 0.0 - 2 0.00 0.0 1 0.00 0.0
Indiana 6 0.07 0.0 - 1 0.01 0.0 0
Iowa 0 - - - 0 - - 0 „
Kansas 0 - - - 0 . . 0
Kentucky 0 - - - 0 - - 0 -
Louisiana 4 0.00 0.0 - 32 0.00 0.0 5 0.00 0.0
Maine 0 - - - 0 ■ - 0 •
Maryland 91 0.27 3.3 1.58 12 0.00 0.0 0 •
Massachusetts 0 - - - 1 0.00 0.0 0 *
Michigan 2 0.00 0.0 - 5 0.01 0.0 5 0.01 0.0
Minnesota 208 0.10 0.5 1.20 31 0.02 0.0 2 0.05 0.0
Mississippi 0 - - - 0 - - 0 « -
Missouri 0 - - - 4 0.00 0.0 0 * • -
Montana 180 0.28 2.8 1.42 17 0.17 0.0 0 - - -
See footnotes at end of table.
UNITED STATES Asbestos: Exposure
Table 1-12 (page 2 of 2). Asbestos: Number of MSHA inspector samples, percent exceeding the permissible exposure limit (PEL) and average 
severity levels (Avg. Sev.), by state, 1974-1994__________________
State







Sev. % :;l:^SeV.::: Number
Avg.
Sev. ïïM M iïë Sev.
Nebraska 0 - - - 0 - - 0 _ _
Nevada 0 - - - 4 0.00 0.0 0 _ . _
New Hampshire 0 - - - 0 - - 0 ■ .
New Jersey 14 0.13 0.0 - 0 - - 0 - . .
New Mexico 96 0.18 2.1 3.30 2 0.44 0.0 0 - . .
New York 63 0.35 1.6 2.60 2 0.00 0.0 2 0.00 0.0 .
North Carolina 13 0.39 0.0 - 3 0.00 0.0 0 - . «
North Dakota 0 - - 0 - - 0 . . _
Ohio 1 0.01 0.0 - 0 - - 0 . . m
Oklahoma 21 0.17 0.0 - 0 - - 0 - . „
Oregon 0 - - - 0 - - 0 - . -
Pennsylvania 12 0.10 0.0 - 11 0.00 0.0 1 0.00 0.0 -
Rhode Island 0 - - » 0 - - 0 - at „
South Carolina 62 0.06 0.0 - 11 0.00 0.0 0 . a. _
South Dakota 27 0.27 0.0 - 43 0.09 0.0 0 - • .
Tennessee 0 - - - 0 - - 0 . a. .
Texas 72 1.12 1.4 75.63 5 0.00 0.0 4 0.00 0.0 .
Utah 0 - - - 2 0.00 0.0 0 - _ _
Vermont 221 0.62 14.9 2.07 34 0.55 17.6 1.96 0 . . .
Virginia 12 0.16 0.0 - 8 0.00 0.0 2 0.00 0.0 .
Washington 1 0.02 0.0 - 10 0.00 0.0 0 - - -
West Virginia 0 - - - 2 0.00 0.0 2 0.00 0.0 -
Wisconsin 35 0.13 0.0 - 1 0.00 0.0 0 - - _
Wyoming 0 - - - 7 0.00 0.0 0 - - •
TOTAL 1,483 0.41 6.5 3.38 344 0.12 34 0.03 0.0
• Indicates Incalculable field.
NOTE: Set Appendix A for lource description, Appendix B for methods, and Appendix 0  for agents,
SOURCE: Bureau of Mines: Mine Inspection Data Analysis System.
2̂iIE2=Ŝ Î£̂ =̂ ^̂ =̂ =̂=== ^ = a====_=:=======s=====3=_= =̂_Bai=1=̂ f£̂ i£fî £̂f̂ f
Table 1-13 (page 1 of 2). Asbestos: Number of OSHA inspector samples, percent exceeding the permissible exposure limit (PEL) and average 
severity levels (Avg. Sev.), by state, 1979-1994____________________
Total samples ; Samples > PEL Total samples Samples > PEL : Total samples Samples > PEL:




Sev. % Number l;ii:tiSeV.:;:; -i: III WM:
Alabama 91 0.73 9.9 6.53 82 0.06 2.4 1.71 1 0.00 0.0
Alaska 76 0.01 0.0 - no 0.14 2.7 4.52 4 0.00 0.0 •
Arizona 24 0.03 0.0 - 47 0.10 2.1 1.90 0 . •
Arkansas 44 0.07 0.0 - 212 0.66 7.5 7.62 67 0.40 10.4 1.90
California 23 0.14 4.3 1.27 153 0.55 6.5 7.13 6 0.01 0.0
Colorado 212 0.08 0.9 3.57 123 0.14 3.3 3.23 6 1.41 33.3 3.98
Connecticut 164 0.39 4.9 6.12 223 0.04 0.0 - 26 0.05 0.0
Delaware 20 0.13 0.0 - 4 0.01 0.0 - 0 .
District of Columbia 50 0.10 2.0 2.04 10 0.06 0.0 • 2 0.00 0.0
Florida 82 1.74 7.3 23.09 177 0,13 2.3 4.73 30 0.25 10.0 1.67
Georgia 197 0.45 12.2 3.01 147 0.09 2.7 1.91 5 0.00 0.0 _
Hawaii 9 0.01 0.0 - 14 0.00 0.0 - 3 0.00 0.0 .
Idaho 14 0.05 0.0 - 81 0.02 0.0 - 3 0.00 0.0 _
Illinois 222 0.06 1.8 1.73 434 0.03 0.2 1.20 65 0.02 0.0 _
Indiana 170 0.28 6.5 1.44 216 0.04 0.0 - 17 0.00 0.0 _
Iowa 87 0.24 6.9 2.72 209 0.03 0.5 1.15 3 0.00 0.0 _
Kansas 44 0.21 9.1 1.74 33 0.04 0.0 - 3 0.00 0.0 .
Kentucky 79 0.05 1.3 1.94 132 0.08 0.0 - 13 0.03 0.0 -
Louisiana 57 0.07 1.8 1.58 82 0.07 2.4 1.63 0 - . .
Maine 63 0.06 0.0 - 17 0.05 0.0 - 0 . . _
Maryland 20 0.03 0.0 - 51 0.31 9.8 2.64 4 0.08 0.0 _
Massachusetts 291 0.40 15.5 1.59 241 0.39 8.7 3.71 20 0.55 20.0 2.43
Michigan 0 - - - 342 0.10 2.0 3.36 61 0.04 0.0 _
Minnesota 8 0.31 25.0 1.15 23 0.00 0.0 - 0 ■ - _
Mississippi 17 0.08 0.0 - 105 0.06 1.0 1.05 16 0.09 0.0 -
Missouri 372 0.18 2.4 6.86 155 0.04 1.3 1.66 11 0.00 0.0 -
Montana 120 0.09 0.8 1.95 63 0.12 3.2 1.13 0 - - -
Sec footnotes at end of table.
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Table 1-13 (page 2 of 2). Asbestos: Number of OSHA inspector samples, percent exceeding the permissible exposure limit (PEL) and average 
severity levels (Avg. Sev.), by state, 1979-1994_______________________________________________________________
State
:li É; i'!  ̂ I 1993-1994













Nebraska 36 0.04 0.0 «• 109 0.01 0.0 - 3 0.14 0.0
Nevada 16 0.03 0.0 - 50 0.28 6.0 3.90 6 0.12 0.0
New Hampshire 100 0.82 12.0 5.84 70 0.05 1.4 1.50 5 0.00 0.0
New Jersey 268 0.23 3.4 3.39 307 0.81 14.7 5.13 13 0.02 0.0
New Mexico 2 0.00 0.0 - 22 0.02 0.0 - 6 0.02 0.0
New York 613 0.08 1.8 1.25 952 0.22 1.7 10.74 126 0.27 2.4 10.10
North Carolina 87 0.26 4.6 2.09 231 0.20 4.3 3.34 46 0.08 2.2 1.15
North Dakota 7 0.00 0.0 - 1 0.00 0.0 - 0 - .
Ohio 282 0.46 4.3 9.27 545 0.87 5.3 15,45 42 0.00 0.0
Oklahoma 91 0.12 2.2 4.35 78 0.14 6.4 1.83 3 0.00 0.0
Oregon 78 0.13 5.1 1.37 76 0.09 0.0 - 15 0.08 0.0
Pennsylvania 365 0.30 4.7 4.14 393 0.62 6.6 8.33 11 0.00 0.0
Rhode Island 46 0.38 13.0 2,43 56 1.01 16.1 6.17 0 - -
South Carolina 24 0.08 0.0 ■ 44 0.28 9.1 2.70 8 0.00 0.0
South Dakota 4 0.00 0.0 - 29 0.00 0.0 - 0 - .
Tennessee 12 0.00 0.0 - 111 4.59 0.9 500.00 29 0.07 0.0
Texas 317 0.05 0.6 1.30 434 0.30 4.6 5.42 41 0.01 0.0
Utah 2 0.02 0.0 - 2 0.00 0.0 - 0 - -
Vermont 0 - - - 1 0.00 0.0 - 0 - .
Virginia 106 0.38 11.3 2.41 125 0.57 16.8 2.43 0 - -
Washington 5 1.42 80.0 1.68 67 0.05 0.0 - 39 0.01 0.0
West Virginia 73 0.04 0.0 - 29 1.76 27.6 5.81 0 - -
Wisconsin 161 0.16 5.6 1.87 160 0.73 6.3 10.65 12 0.03 0.0
Wyoming 15 0.00 0.0 - 0 - - - 0 - -
ITOTALlf 5,266 0.24 4.0 8.10 mmm i iiM i' H i! w m itM l
• indicates Incalculable Held.
NOTE: See Appendix A for source description, Appendix B for methods, and Appendix D for ■genti.
SOURCE: Occupation*] Safety end Health Administration; Integrated Management Information System.
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ASBESTOS and OTHER FIBERS by PCM 7400
Various MW: Various CAS: Various RTECS: Various
METHOD: 7400, Issue 2 EVALUATION: FULL Issue 1: Rev. 3 on 15 May 1989
Issue 2: 15 August 1994
OSHA: 0.1 asbestos fiber (> 5 pm iong)/cc; PROPERTIES: solid, fibrous, crystalline, anisotropic
1 f/oo/30 mln excursion; cardnogen 
MSHA: 2 asbestos fibers/cc
NIOSH: 0.1 f/cc (Fibers > 5 pm iong)/400 L; cardnogen 
ACGIH: 02  croddolite; 0.5 emosrte; 2 chrysotile and other 
asbestos, fibers/cc; cardnogen
SYNONYMS [CAS#]: actinolite [77536-66-4] orforroactinolite [15669-07-5]; amostte [12172-73-5J; anthophylltte [77536-67-5]; 
chrysotile [12001-29-5]; serpentine [18786-24-8]; crocktoTit® [12001-28-4]; tremolite [77536-684]; amphibole asbestos [1332- 
21-4]; refractory ceramic fibers [142844-00-6]; fibrous glass.
SAMPLING MEASUREMENT
SAMPLER: FILTER
(0.45- to 1.2-pm cellulose ester 
membrane, 25-mm; conductive cowi on
TECHNIQUE: UGHT MICROSCOPY, PHASE 
CONTRAST
cassette) ANALYTE: fibers (manual count)
FLOW RATE*: 0.5 to 16 L/min SAMPLE
PREPARATION: acetone - collapse/triacetin - immersion
VOL-MIN*:
-MAX*:
400 L @ 0.1 fiber/cc 
(step 4, sampling)
•Adjust to give 100 to 1300 fiber/mm2 COUNTING
RULES:
method [2]
described in previous version of this
SHIPMENT: routine (pack to reduce shock) method as "Aa rules (1,3]
SAMPLE EQUIPMENT: 1. positive phase-contrast microscope
STABILITY: stable 2. Walton-Beckett graticule (100-pm 
field of view) Type G-22
BLANKS: 2 to 10 field blanks per set 3. phase-shift test slide (HSE/NPL)
ACCURACY CALIBRATION: HSE/NPL test slide
RANGE STUDIED: 80 to 100 fibers counted 
BIAS: see EVALUATION OF METHOD 
OVERALL PRECISION 0.115 to 0.13 [1]
RANGE:
ESTIMATED LOD:
100 to 1300 fibers/mm3 filter area 
7 fibers/mm2 filter area
ACCURACY: see EVALUATION OF METHOD PRECISION (S,): 0.10 to 0.12 [1]; see EVALUATION OF METHOD
APPLICABILITY: The quantitative working range is 0.04 to &5 fiber/cc for a 1000-L air sample. The LOO depends on sample 
volume and quantity of interfering dust, and is <0.01 fiber/cc for atmospheres free of interferences. The method gives an index 
of airborne fibers, it is primarily used for estimating asbestos concentrations, though PCM does not differentiate between 
asbestos and other fibers. Use this method in conjunction with electron microscopy (e.g., Method 7402) for assistance in 
identification of fibers. Fibers < ca. 0.25 pm diameter «rill not be detected by this method [4]. This method may be used for 
other materials such as fibrous glass by using alternate counting rules (see Appendix Q .
INTERFERENCES: If the method is used to detect a specific type of fiber, any other airborne fiber may interfere since all 
particles meeting the counting criteria are counted. Chaln-tike particles may appear fibrous. High levels of non-fibrous dust 
partides may obscure fibers in the field of view and increase the detection limit
OTHER METHODS: This revision replaces Method 7400, Revision #3 (dated 5/15/89).
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REAGENTS:
1. Acetone,* reagent grade.
2. Triacetin (glycerol triacetate), reagent grada
* See SPECIAL PRECAUTIONS.
EQUIPMENT:
1. Sampler field monitor, 25-mm, three-piece 
cassette with ca. 50-mm electrically conductive 
extension cowl and cellulose ester filter, 0.45- 
to pore size, and backup pad.
NOTE 1: Analyze representative filters for
fiber background before use to 
check for clarity and background. 
Discard the filter lot if mean Is ¿5  
fibers per 100 graticule fields. 
These are defined as laboratory 
blanks. Manufacturer-provided 
quality assurance checks on filter 
blanks are normally adequate as 
long as field blanks are analyzed 
as described below.
NOTE 2: The electrically conductive
extension cowl reduces  
electrostatic effects. Ground the 
cowl when possible during 
sampling.
NOTE 3: Use 0.8^im pore size filters for
personal sampling. The 0.45-pm 
filters are recommended for 
sampling when performing TEM 
analysis on the same samples. 
However, their higher pressure 
drop precludes their use with 
personal sampling pumps.
NOTE 4: Other cassettes have been
proposed that exhibit improved 
uniformity of fiber deposit on the 
fitter surface, &g., bellmouthed 
sam pler (E n v lro m e trlc s , 
Charleston, SC). These may be 
used If shown to give measured 
concentrations equivalent to 
sampler indicated above for the 
application.
2. Personal sampling pump, battery or line- 
powered vacuum, of sufficient capacity to 
meet flow-rate requirements (see step 4 for 
flow rate), with flexible connecting tubing.
3. Wire, multi-stranded, 22-gauge; 1“, hose damp 
to attach wire to cassette.
4. Tape, shrink- or adhesive-.
5. Slides, glass, frosted-end, pre-deaned, 25 x 
75-mm.
6. Cover slips, 22- x 22-mm, No. 1-1/2, unless 
otherwise specified by microscope 
manufacturer.
7. Lacquer or naQ polish.
8. Knife, #10 surgical steel, curved blade.
9. Tweezers.
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EQUIPMENT:
10. Acetone flash vaporization system for clearing 
filters on glass slides (see ref. [5] for 
specifications or see manufacturer's 
instructions for equivalent devices).
11. Micropipets or syringes, 5-#/L and 100- to 
50CM-
12. Microscope, positive phase (dark) contrast, 
with green or blue filter, adjustable field iris, 8 
to 10X eyepiece, and 40 to 45X phase 
objective (total magnification ca. 400X); 
numerical aperture = 0.65 to 0.75.
13. Graticule, Walton-Beckett type with 100-//m 
diameter circular field (area = 0.00785 mm2) at 
the specimen plane (Type G-22). Available 
from Optometries USA, P.O. Bax 699, Ayer, 
MA 01432 [phone (508)-772-1700J, and 
McCrone Accessories and Components, 850 
Pasqulnelli Drive, Westmont, IL 60559 [phone 
(312) 887-7100].
NOTE: The graticule is custom-made for each 
microscope, (see APPENDIX A for 
the custom-ordering procedure).
14. HSE/NPL phase contrast test slide, Mark II. 
Available from Optometries USA (address 
above).
15. Telescope, ocular phase-ring centering.
16. Stage micrometer (0.01-mm divisions).
SPECIAL PRECAUTIONS: Acetone is extremely flammable. Take precautions not to ignite It Heating 
of acetone in volumes greater than 1 mL must be done In a ventilated laboratory fume hood using a 
flameless, spark-free heat source.
SAMPUNG:
1. Calibrate each personal sampling pump with a representative sampler in line.
2. To reduce contamination and to hold the cassette tightly together, seal the crease between the 
cassette base and the cowl with a shrink band or light colored adhesive tape. For personal 
sampling, fasten the (uncapped) open-face cassette to the worker's lapel. The open face should 
be oriented downward.
NOTE: The cowl should be electrically grounded during area sampling, especially under
conditions of low relative humidity. Use a hose damp to secure one end of the wire 
(Equipment, Item 3) to the monitor's cowl. Connect the other end to an earth ground 
(I.e., cold water pipe).
3. Submit at least two field blanks (or 10% of the total samples, whichever is greater) for each set 
of samples. Handle field blanks In a manner representative of actual handling of associated 
samples in the set Open field blank cassettes at the same time as other cassettes just prior to 
sampling. Store top covers and cassettes in a dean area (e.g., a dosed bag or box) with the 
top covers from the sampling cassettes during the sampling period.
4. Sample at 0.5 L/mln or greater [6]. Adjust sampling flow rate, Q (L/min), and time, t (min), to 
produce a fiber density, E, of 100 to 1300 fibers/mm2 (3.85 • 104 to 5 • 10s fibers per 25-mm filter 
with effective collection area Ac= 385 mm2) for optimum accuracy. These variables are related
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to the action level (one-half the current standard), L (fibers/cc), of the fibrous aerosol being 
sampled by:
t = — —— , min.
Q • L - 10s
NOTE 1: The purpose of adjusting sampling times is to obtain optimum fiber loading on the
filter. The collection efficiency does not appear to be a function of flow rate In the 
range of 0.5 to 16 L/min for asbestos fibers [7]. Relatively large diameter fibers (>3  
pm) may exhibit significant aspiration loss and Inlet deposition. A sampling rate of 1 
to 4 L/min for 8 h Is appropriate In atmospheres containing ca. 0.1 fiber/cc in the 
absence of significant amounts of non-asbestos dust Dusty atmospheres require 
smaller sample volumes (£400 L) to obtain countable samples. In such cases take 
short, consecutive samples and average the results over the total collection time.
For documenting episodic exposures, use high flow rates (7 to 16 L/min) over 
shorter sampling times. In relatively dean atmospheres, where targeted fiber 
concentrations are much less than 0.1 fiber/cc, use larger sample volumes (3000 to 
10000 L) to achieve quantifiable loadings. Take care, however, not to overload the 
filter with background dust If & 50% of the filter surface Is covered with partides, 
the filter may be too overloaded to count and w3i bias the measured fiber 
concentration.
NOTE 2: OSHA regulations specify a minimum sampling volume of 48 L for an excursion
measurement, and a maximum sampling rate of 2.5 L/min [3].
5. At the end of sampling, replace top cover and end plugs.
6. Ship samples with conductive cowt attached In a rigid container with packing material to prevent
Jostling or damage.
NOTE: Do not use untreated polystyrene foam in shipping container because electrostatic 





NOTE 1: The object Is to produce samples with a smooth (non-grainy) background In a
medium with refractive Index £1.46. This method collapses the ffiter for easier 
focusing and produces permanent (1 -10 years) mounts which are useful for quality 
control and interlaboratory comparison. The aluminum "hot block" or similar flash 
vaporization techniques may be used outside the laboratory [2]. Other mounting 
techniques meeting the above criteria may also be used (e.g.p the laboratory fume 
hood procedure for generating acetone vapor as described in Method 7400 - 
revision of 5/15/85, or the non-permanent field mounting technique used in P&CAM 
239 [3,7,8,9]). Unless the effective filtration area Is known, determine the area and 
record the information referenced against the sample ID number [1,9,10,11].
NOTE 2: Excessive water in the acetone may slow the dearing of the filter, causing material
to be washed off the surface of the filter. Also, filters that have been exposed to 
high humidities prior to dearing may have a grainy background.
Ensure that the glass slides and cover slips are free of dust and fibers.
Adjust the rheostat to heat the "hot block* to ca 70 °C [2].
NOTE: If the "hot block" Is not used in a fume hood, It must rest on a ceramic plate and be 
isolated from any surface susceptible to heat damage.
Mount a wedge cut from the sample filter on a dean gass slide.
a. Cut wedges of ca. 25% of the filter area with a curved-blade surgical steel knife using a 
rocking motion to prevent tearing. Place wedge, dust side up, on slide.
NOTE: Static electricity wBI usually keep the wedge on the slide.
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b. Insert slide with wedge into the receiving slot at base of 'hot block”. Immediately place tip 
of a micropipet containing ca 250 pL acetone (use the minimum volume needed to 
consistently dear the filter sections) Into the Inlet port of the PTFE cap on top of the "hot 
block” and inject the acetone into the vaporization chamber with a slow, steady pressure on 
the plunger button whle holding pipet firmly in place. After waiting 3 to 5 sec for the filter to 
dear, remove pipet and slide from their ports.
CAUTION: Although the volume of acetone used is small, use safety precautions. Work in 
a well-ventilated area (e.g., laboratory fume hood). Take care not to ignite the 
acetone. Continuous use of this device in an unventilated space may produce 
explosive acetone vapor concentrations.
c. Using the 5-#/L micropipet, immediately place 3.0 to 3.5 ¿/L triacetin on the wedge. Gently 
lower a dean cover slip onto the wedge at a slight angle to reduce bubble formation. Avoid 
excess pressure and movement of the cover glass.
NOTE: if too many bubbles form or the amount of triacetin is insufficient, the cover slip may 
become detached within a few hours. If excessive triacetin remains at the edge of 
the filter under the cover slip, fiber migration may occur.
d. Mark the outline of the filter segment with a glass marking pen to aid in microscopic 
evaluation.
a  Glue the edges of the cover slip to the slide using lacquer or nail polish [12]. Counting may 
proceed immediately after dealing and mounting are completed.
NOTE: If dearing is slow, warm the slide on a hotplate (surface temperature 50 °C) for up 
to 15 min to hasten dealing. Heat carefully to prevent gas bubble formation.
CALIBRATION AND QUALITY CONTROL:
10. Microscope adjustments. Fdlow the manufacturers instructions. At least once daily use the 
telescope ocular (or Bertrand lens, for some microscopes) supplied by the manufacturer to 
ensure that the phase rings (annular diaphragm and phase-shifting elements) are concentric.
With each microscope, keep a logbook in which to record the dates of microscope deanings 
and major servicing.
a  Each time a sample is examined, do the following:
(1) Adjust the light source for even Humiliation across the field of view at the condenser iris.
Use Kohler Humiliation, If available. With some microscopes, the illumination may have 
to be set up with bright field optics rather than phase contract optics.
(2) Focus on the particulate materia] to be examined.
(3) Make sure that the field Iris is in focus, centered on the sample, and open only enough 
to fully Ilumínate the field of view.
b. Check the phase-shlft detection limit of the microscope periodically for each 
analyst/microscope combination:
(1) Center the HSE/NPL phase-contrast test slide under the phase objective.
(2) Bring the blocks of grooved lines into focus in the graticule area.
NOTE: The slide contains seven blocks of grooves (ca. 20 grooves per block) in
descending order of visibility. For asbestos counting the microscope optics 
must completely resolve the grooved lines in block 3 although they may appear 
somewhat faint, and the grooved lines in blocks 6 and 7 must be invisible when 
centered in the graticule area. Blocks 4 and 5 must be at least partially visible 
but may vary slightly in visibility between microscopes. A microscope which 
falls to meet these requirements has resolution either too low or too high for 
fiber counting.
(3) If Image quality deteriorates, dean the microscope optics. If the problem persists, 
considt the microscope manufacturer.
11. Document the laboratory's predsion for each counter for replicate fiber counts.
a  Maintain as part of the laboratory quality assurance program a set of reference slides to be 
used on a daily basis [13]. These slides should consist of filter preparations induding a 
range of loadings and background dust levels from a variety of sources induding both field
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and reference samples (e.g., PAT, AAR, commercial samples). The Quality Assurance 
Officer should maintain custody of the reference slides and should supply each counter with 
a minimum of one reference slide per workday. Change the labels on the reference slides 
periodically so that the counter does not become familiar with the samples,
b. From blind repeat counts on reference slides, estimate the laboratory intra- and intercounter 
precision. Obtain separate values of relative standard deviation (Sr) for each sample matrix 
analyzed in each of the following ranges: 5 to 20 fibers in 100 graticule fields, >20 to 50 
fibers in 100 graticule fields, and >50 to 100 fibers in 100 graticule fields. Maintain control 
charts for each of these data files.
NOTE: Certain sample matrices (e.g., asbestos cement) have been shown to give poor 
precision [9]
12. Prepare and count field blanks along with the field samples. Report counts on each field blank. 
NOTE 1: The identity of blank filters should be unknown to the counter until all counts have
been completed.
NOTE 2: if a field blank yields greater than 7 fibers per 100 graticule fields, report possible
contamination of the samples.
13. Perform blind recounts by the same counter on 10% of filters counted (slides relabeled by a 
person other than the counter). Use the following test to determine whether a pair of counts by 
the same counter on the same fitter should be rejected because of possible bias: Discard the 
sample If the absolute value of the difference between the square roots of the two counts (in 
fiber/mm2) exceeds 2.77 (X)Sp where X = average of the square roots of the two fiber counts
(in fiber/mm2) and S'= ^  , where Sr is the intracounter relative standard deviation for the
appropriate count range On fibers) determined in step 11. For more complete discussions see 
reference [13].
NOTE 1: Since fiber counting Is the measurement of randomly placed fibers which may be
described by a Poisson distribution, a square root transformation of the fiber count 
data wfll result in approximately normally distributed data [13].
NOTE 2: If a pair of counts is rejected by this test, recount the remaining samples in the set
and test the new counts against the first counts. Discard all rejected paired counts. 
It is not necessary to use this statistic on blank counts.
14. The analyst is a critical part of this analytical procedure. Care must be taken to provide a non- 
stressftf and comfortable environment for fiber counting. An ergonomically designed chair 
should be used, with the microscope eyepiece situated at a comfortable height for viewing. 
External lighting should be set at a level similar to the II umination level In the microscope to 
reduce eye fatigue. In addition, counters shodd take 10-to-20 minute breaks from the 
microscope every one or two hours to limit fatigue [14]. During these breaks, both eye and 
upper back/neck exercises should be performed to relieve strain.
15. All laboratories engaged in asbestos counting shodd participate in a proficiency testing program 
such as the AIHA-NIOSH Proficiency Analytical Testing (PAT) Program for asbestos and 
routinely exchange field samples with other laboratories to compare performance of counters.
MEASUREMENT:
16. Center the slide on the stage of the calibrated microscope under the objective lens. Focus the 
microscope on the plane of the filter.
17. Adjust the microscope (Step 10).
NOTE: Calibration with the HSE/NPL test slide determines the minimum detectable fiber 
diameter (ca. 0.25 pm) [4].
18. Counting rules: (same as P&CAM 239 rules [1,10,11]: see examples in APPENDIX B).
a. Count any fiber longer than 5 pm which lies entirely within the graticule area.
(1) Count only fibers longer than 5 pm. Measure length of curved fibers along the curve.
(2) Count only fibers with a length-to-width ratio equal to or greater than 3:1.
b. For fibers which cross the boundary of the graticule field:
138 NIOSH Manual of Analytical Methods (NMAM), Fourth Edition, 8/15/94
AS8ESTQS and OTHER RBERS by PCM: METHOD 7400, Issue 2, dated 15 August 1994 - Pape 7 of 15
(1) Count as 1/2 fiber any fiber with only one end lying within the graticule area, provided 
that the fiber meets the criteria of rule a above.
(2) Do not count any fiber which crosses the graticule boundary more than once.
(3) Reject and do not count all other fibers.
c. Count bundles of fibers as one fiber unless individual fibers can be identified by observing 
both ends of a fiber.
d. Count enough graticule fields to yield 100 fibers. Count a minimum of 20 fields. Stop at 100 
graticule fields regardless of count
19. Start counting from the tip of the filter wedge and progress along a radial line to the outer edge. 
Shift up or down on the filter, and continue in the reverse direction. Select graticule fields 
randomly by looking away from the eyepiece briefly while advancing the mechanical stage. 
Ensure that, as a minimum, each analysis covers one radial line from the filter center to the outer 
edge of the filter. When an agglomerate or bubble covers ca. 1/6 or more of the graticule field, 
reject the graticule field and select another. Do not report rejected graticule fields In the total 
number counted.
NOTE 1: When counting a graticule field, continuously scan a range of focal planes by
moving the fine focus knob to detect very fine fibers which have become embedded 
in the filter. The small-diameter fibers will be very faint but are an important 
contribution to the total count A minimum counting time of 15 seconds per field Is 
appropriate for accurate counting.
NOTE 2: This method does not allow for differentiation of fibers based on morphology.
Although some experienced counters are capable of selectively counting only fibers 
which appear to be asbestiform, there is presently no accepted method for ensuring 
uniformity of judgment between laboratories. It is, therefore, incumbent upon all 
laboratories using this method to report total fiber counts. If serious contamination 
from non-asbestos fibers occurs in samples, other techniques such as transmission 
electron microscopy must be used to identify the asbestos fiber fraction present In 
the sample (see NIOSH Method 7402). In some cases (i.e., for fibers with diameters 
> 1 pm), polarized light microscopy (as In NIOSH Method 7403) may be used to 
identify and eliminate interfering non-crystalline fibers [15].
NOTE 3: Do not count at edges where filter was cut. Move in at least 1 mm from the edge.
NOTE 4: Under certain conditions, electrostatic charge may affect the sampling of fibers.
These electrostatic effects are most likely to occur when the relative humidity is low 
(below 20%), and when sampling is performed near the source of aerosol. The 
result is that deposition of fibers on the filter is reduced, especially near the edge of 
the filter. If such a pattern is noted during fiber counting, choose fields as dose to 
the center of the filter as possible [5].
NOTE 5: Counts are to be recorded on a data sheet that provides, as a minimum, spaces on
which to record the counts for each field, filter identification number, analyst's name, 
date, total fibers counted, total fields counted, average count, fiber density, and 
commentary. Average count is calculated by dividing the total fiber count by the 
number of fields observed. Fiber density (fibers/mm^ is defined as the average 
count (fibers/field) divided by the field (graticule) area (mm2/fie!d).
CALCULATIONS AND REPORTING OF RESULTS
20. Calculate and report fiber density on the filter, E (fibers/mm2), by dividing the average fiber
count per graticule field, F/rif, minus the mean field blank count per graticule field, B/nb, by the 
graticule field area, Af (approx. 0.00785 mm2):
E = fiber^/mm2.
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NOTE: Fiber counts above 1300 fibers/mm2 and fiber counts from samples with >50% of fiter 
area covered with particulate stolid be reported as “uncountable" or 'probably biased.' 
Other fiber counts outside the 100-1300 fiber/mm2 range should be reported as having 
'greater than optimal variability” and as being “probably biased.”
21. Calctiate and report the concentration, C (fibers/cc), of fibers in the air volume sampled, V (L), 
using the effective collection area of the filter, A,, (approx. 385 mm2 for a 25-mm filter):
c  ( E ) ( A . )
V ■ 103
NOTE: Periodically check and adjust the value of Ac ff necessary.
22. Report intralaboratory and interiaboratory relative standard deviations (from Step 11) with each 
set of results.
NOTE: Precision depends on the total number of fibers counted [1,16]. Relative standard
deviation Is documented in references [1,15-17] for fiber counts up to 100 fibers In 100 
graticule fields. Comparability of (nteriaboratory results is discussed below. As a first 
approximation, use 213% above and 49% below the count as the upper and lower 
confidence limits for fiber counts greater than 20 (Fig. 1).
EVALUATION OF METHOD:
A. This method is a revision of P&CAM 239 [10]. A summary of the revisions is as follows:
1. Sampling:
The change from a 37-mm to a 25-mm fitter improves sensitivity for similar air volumes. The 
change in flew rates allows for 2-m3 fiil-shift samples to be taken, providing that the fitter is not 
overloaded with norvfibrous particulates. The collection efficiency of the sampler is not a 
function of flow rate in the range 0.5 to 16 L/min [10].
2. Sample Preparation Technique:
The acetone vapor-triacetin preparation technique is a faster, more permanent mounting 
technique than the dimethyl phthalate/diethyi oxalate method of P&CAM 239 [2,4,10]. The 
aluminum "hot block” technique minimizes the amount of acetone needed to prepare each 
sample.
3. Measurement:
a. The Walton-Beckett gratictie standardizes the area observed [14,18,19].
b. The HSE/NPL test slide standardizes microscope optics for sensitivity to fiber diameter 
[4.14].
c. Because of past inaccuracies associated with low fiber counts, the minimum recommended 
loading has been increased to 100 fibers/mm2 fitter area (a total of 78.5 fibers counted in 
100 fields, each with field area = .00785 mm2.) Lower levels generally result in an 
overestimate of the fiber count when compared to results in the recommended analytical 
range [20]. The recommended loadings should yield intracounter S, in the range of 0.10 to
0.17 [21,22¿3].
B. Interiaboratory comparaba ity:
An International collaborative study Evolved 16 laboratories using prepared slides from the asbestos
cement, milling, mining, textile, and friction material industries [9]. This relative standard deviations
(SJ varied with sample type and laboratory. The ranges were:
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Intralaboratorv Sf Intertaboratofv Sf Overall S.
AIA (NIOSH A Rules)*
Modified CRS (NfOSH B Rules)**
0.12 to 0.40 
0.11 to 0.29




* Under AIA rules, only fibers having a diameter less than 3 pm are counted and fibers attached to 
particles larger than 3 pm are not counted. NIOSH A Rules are otherwise similar to the AIA rules.
* *  See Appendix C.
A NIOSH study conducted using field samples of asbestos gave intralaboratory Sr in the range 0.17 to
0.25 and an interlaboratory Sr of 0.45 [21]. This agrees well with other recent studies [9,14,16].
At this time, there is no independent means for assessing the overall accuracy of this method. One 
measure of reliability is to estimate how well the count for a single sample agrees with the mean count 
from a large number of laboratories. The following discussion Indicates how this estimation can be 
carried out based on measurements of the intertaboratory variability, as well as showing how the results 
of this method relate to the theoretically attainable counting precision and to measured intra- and 
intertaboratory Sr (NOTE: The following discussion does not include bias estimates and should not be 
taken to Indicated that lightly loaded samples are as accurate as property loaded ones).
Theoretically, the process of counting randomly (Poisson) distributed fibers on a filter surface will give an 
Sr that depends on the number, N, of fibers counted:
Thus Sr is 0.1 for 100 fibers and 0.32 for 10 fibers counted. The actual Sr found in a number of studies is 
greater than these theoretical numbers [17,19,20,21].
An additional component of variability comes primarily from subjective interlaboratory differences. In a 
study of ten counters in a continuing sample exchange program, Ogden [15] found this subjective 
component of intralaboratory Sr to be approximately 0.2 and estimated the overall Sr by the term:
Ogden found that the 90% confidence interval of the individual Intralaboratory counts in relation to the 
means were +2 Sr and -1.5 Sr In this program, one sample out of ten was a quality control sample.
For laboratories not engaged in an intensive quality assurance program, the subjective component of 
variability can be higher.
In a study of field sample results in 46 laboratories, the Asbestos Information Association also found that 
the variability had both a constant component and one that depended on the fiber count [14]. These 
results gave a subjective intertaboratory component of Sr (on the same basis as Ogden's) for field 
samples of ca 0.45. A similar value was obtained for 12 laboratories analyzing a set of 24 field samples
[21]. This value falls slightly above the range of Sr (0.25 to 0.42 for 1984-85) found for 80 reference 
laboratories In the NIOSH PAT program for laboratory-generated samples [17].
A number of factors influence Sr for a given laboratory, such as that laboratory’s actual counting 
performance and the type of samples being analyzed. In the absence of other information, such as from 
an intertaboratory quality assurance program using field samples, the value for the subjective component 
of variability Is chosen as 0.45. It Is hoped that the laboratories wSI carry out the recommended 
Interlaboratory quality assurance programs to improve their performance and thus reduce the Sr
Sr = 1/( N )1* (i)
I N ■> ( 0.2 • N t2 ]1B 
N
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The above relative standard deviations apply when the population mean has been determined It Is 
more usefid, however, for laboratories to estimate the 90% confidence interval on the mean count from a 
single sample fiber count (Figure 1). These curves assume similar shapes of the count distribution for 
interiaboratory and intralaboratory results [16].
For example, if a sample yields a count of 24 fibers, Figure 1 indicates that the mean Interiaboratory 
count will fall within the range of 227% above and 52% below that value 90% of the time. We can apply 
these percentages directly to the air concentrations as well. If, for instance, this sample (24 fibers 
counted) represented a 500-L volume, then the measured concentration Is 0.02 fibers/mL (assuming 100 
fields counted, 25-mm filter, 0.00785 mm2 counting field area). If this same sample were counted by a 
group of laboratories, there Is a 90% probability that the mean would fall between 0.01 and 0.08 
fiber/mL These limits should be reported in any comparison of results between laboratories.
Note that the S, of 0.45 used to derive Figure 1 1s used as an estimate for a random group of 
laboratories. If several laboratories belonging to a quality assurance group can show that their 
Interiaboratory S, Is smaller, then it is more correct to use that smaller Sr However, the estimated S, of
0.45 Is to be used in the absence of such information. Note also that it has been found that Sr can be 
higher for certain types of samples, such as asbestos cement [9].
Quite often the estimated airborne concentration from an asbestos analysis is used to compare to a 
regulatory standard. For instance, if one is trying to show compliance with an 0.5 fiber/mL standard 
using a single sample on which 100 fibers have been counted, then Figure 1 indicates that the 0.5 
fiber/mL standard must be 213% higher than the measured air concentration. This indicates that if one 
measures a fiber concentration of 0.16 fiber/mL (100 fibers counted), then the mean fiber count by a 
group of laboratories (of which the compliance laboratory might be one) has a 95% chance of being less 
than 0.5 fibers/mL; Le.. 0.16 + 2.13 x 0.16 = 0.5.
It can be seen from Figure 1 that the Poisson component of the variability Is not very important unless 
the number of fibers counted is small. Therefore, a further approximation is to simply use +213% and 
-49% as the upper and lower confidence values of the mean for a 100-fiber count.
500
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Figure 1. Interiaboratory Precision of Fiber Counts
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The curves In Figures 1 are defined by the following equations:
UCL » 2 X ♦ &25 * 1(235 ♦ 2 X f  -  4 ( 1 -  Z2S S?) X*]™ 
2 ( 1 -  Z2S S *)
LCL ■ 2 X » 4 - | ( 4  + 2 X ) * - 4 ( 1  - 4 S,1 ) X* J1*
2 (1  - 4 8 , * )
where Sr = subjective interlaboratory relative standard deviation, which is dose to the total 
interlaboratory Sr when approximately 100 fibers are counted.
X = total fibers counted on sample 
LCL -  lower 95% confidence limit 
UCL = upper 95% confidence limit 
Note that the range between these two limits represents 90% of the total range.
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APPENDIX A: CALIBRATION OF THE WALTON-BECKETT GRATICULE:
Before ordering the Walton-Beckett gratictie, the following calibration must be done to obtain a counting
area (D) 100 pm in diameter at the Image plane. The diameter, dc (mm), of the circular counting area
and the disc diameter must be specffied when ordering the graticule.
1. Insert any available graticule Into the eyepiece and focus so that the graticiie lines are sharp and 
dear.
2. Set the appropriate interpupBIary distance and, If applicable, reset the binocular head adjustment 
so that the magnification remains constant
3. Install the 40 to 45X phase objective.
4. Place a stage micrometer on the microscope object stage and focus the microscope on the
graduated lines.
5. Measure the magnified grid length of the graticule, L* fy/m), using the stage micrometer.
6. Remove the gratioie from the microscope and measure Its actual grid length, L, (mm). This can
best be accomplished by using a stage fitted with verniers.
7. Calctiate the drde diameter, d« (mm), for the Walton-Beckett graticule:
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de = 7* x D. (5)
K
Example: If = 112 ##m, L, = 4.5 mm and D = 100 pm, then d* = 4.02 mm.
8. Check the field diameter, D (acceptable range 100 pm ± 2 pm) with a stage micrometer upon 
receipt of the graticule from the manufacturer. Determine field area (acceptable range 0.00754 
mm2 to 0.00817 mm2).
APPENDIX B: COMPARISON OF COUNTING RULES:
Figure 2 shows a Walton-Beckett graticule as seen through the microscope. The rules wQl be discussed 
as they apply to the labeled objects in the figure.
Figure 2. Walton-Beckett graticule with fibers.
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These rules are sometimes referred to as the "A“ rules.
FIBER COUNT
DISCUSSION
1 1 fiber Optically observable asbestos fibers are actually bundles of fine fibrls. If the 
fibrils seem to be from the same bundle the object is counted as a single 
fiber. Note, however, that all objects meeting length and aspect ratio criteria 
are counted whether or not they appear to be asbestos.
2 2 fiber If fibers meeting the length and aspect ratio criteria (length >5 pm and 
lengtfrto-width ratio >3 to 1) overlap, but do not seem to be part of the 
same bundle, they are counted as separate fibers.
3 1 fiber Although the object has a relatively large diameter (>3 /mi), it is counted as 
fiber wider the rules. There is no upper limit on the fiber diameter in the 
counting nies. Note that fiber width is measured at the widest compact 
section of the object
4 1 fiber Although long fine fibrils may extend from the body of a fiber, these fibrils 
are considered part of the fiber if they seem to have originally been part of 
the bundle.
5 Do not 
count
If the object is ¿5 pm long, it is not counted.
6 1 fiber A fiber partially obscured by a particle is counted as one fiber. If the fiber 
ends emanating from a particle do not seem to be from the same fiber and 
each end meets the length and aspect ratio criteria, they are counted as 
separate fibers.
7 1/2 fiber A fiber which crosses into the graticule area one time is counted as 1/2 
fiber.
8 Do not 
count
Ignore fibers that cross the graticiiate boundary more than once, 
count
9 Do not 
count
Ignore fibers that lie outside the graticule boundary.
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APPENDIX C. ALTERNATE COUNTING RULES FOR NON-ASBESTOS FIBERS
Other counting rules may be more appropriate for measurement of specific non-asbestos fiber types, 
such as fibrous glass. These include the "B” rules given below (from NIOSH Method 7400, Revision #2, 
dated 8/15/87), the World Health Organization reference method for man-made mineral fiber [24], and 
the NIOSH fibrous glass criteria document method [25]. The upper diameter limit in these methods 
prevents measurements of non-thoracic fibers. It is important to note that the aspect ratio limits 
included in these methods vary. NIOSH recommends the use of the 3:1 aspect ratio in counting fibers.
It is emphasized that hybridization of different sets of counting rules is not permitted. Report specifically 
which set of counting rules are used with the analytical results.
"B" COUNTING RULES:
1. Count only ends of fibers. Each fiber must be longer than 5 pm and less than 3 pm diameter.
2. Count only ends of fibers with a length-to-width ratio equal to or greater than 5:1.
3. Count each fiber end which falls within the graticule area as one end, provided that the fiber meets 
rules 1 and 2 above. Add split ends to the count as appropriate if the split fiber segment also meets 
the criteria of rules 1 and 2 above.
4. Count visibly free ends which meet rules 1 and 2 above when the fiber appears to be attached to 
another particle, regardless of the size of the other particle. Count the end of a fiber obscured by 
another particle if the partide covering the fiber end is less than 3 /mi in diameter.
5. Count free ends of fibers emanating from large dumps and bundles up to a maximum of 10 ends (5 
fibers), provided that each segment meets rules 1 and 2 above.
& Count enough graticule fields to yield 200 ends. Count a minimum of 20 graticule fields. Stop at 
100 graticule fields, regardless of count
7. Divide total end count by 2 to yield fiber count
APPENDIX D. EQUIVALENT LIMITS OF DETECTION AND QUANTITATION
fiber density on filter* fiber concentration In air, f/cc
fibers 400-Lair 1000-Lair
Der 100 fields fibers/mm2 sample sarnie
200 255 0.25 0.10
100 127 0.125 0.05
LOQ....80....... ......102............ .....0.10............ .0.04
50 64 0.0625 0.025
25 32 0.03 0.0125
20 25 0.025 0.010
10 12.7 0.0125 0.005
8 10.2 0.010 0.004
LOD.....5.5..... ..........7............ .....0.00675...... , ...0.0027
*  Assumes 385 mm2 effective filter collection area, and field area = 0.00785 mm2, for relatively "dean" 
(little particulate aside from fibers) filters.
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ASBESTOS by TEM 7402
FORMULA: Various MW: Various CAS: Various RTECS: Various
METHOD; 7402 EVALUATION: PARTIAL Issue 1: 15 May 1989
Issue 2: 15 August 1994
OS HA: 0.1 asbestos fibers (>5 $xn long)/oc;
1 f/oc/30 min excursion; carcinogen 
MSHA: 2 asbestos fibers/cc
NIOSH: 0.1 f/cc (libers > 5 pm long)/400 U carcinogen 
ACGIH: 02  croddolite; 05 amoslte; 2 chrysotile 
and cither asbestos, fibers/cc; carcinogen
PROPERTIES: solid, fibrous, crystalline, 
anistropic
SYNONYMS [CAS#]: actinofite [77538-66-4] or ferroactinolite [1566WÏ7-5]; amosite 112172-73-5]; mnthophyllfte [77536-67-5]; 
chrysotile [12001-29-5]; serpentine [18786-24-8]; croddofite [12001-28-4]; tremolite [77536-68-6]; amphibole asbestos [1332-21-4].
SAMPUNG MEASUREMENT
SAMPLER: FILTER
(0.45- to 1^-^m cellulose ester membrane, 
25-mm diameter; conductive cassette)
FLOW RATE: 0-5 to 16 L/min
VOL-MIN*: 400 L @ a i fiber/cc 
-MAX*: (step 4, sampling)
♦Adjust for 100 to 1300 fibers/mm2
SHIPMENT: routine (pack to reduce shock)
SAMPLE
STABILITY: stable
BLANKS: 2 to 10 field blanks per set




PREPARATION; modified Jaffe wick
EQUIPMENT: transmission electron microscope; energy 
dispersive X-ray system (EDX) analyzer
CALIBRATION: qualitative electron diffraction; calibration 
of TEM magnification and EDX system
RANGE: 100 to 1300 fibers/mm2 filter area [1]
ESTIMATED LOD: 1 confirmed asbestos fiber above 95% of
ACCURACY
expected mean blank value
PRECISION (S^: 0.28 when 65% of fibers are asbestos;
0.20 when adjusted fiber oount is applied 
to PCM count [2].
RANGE STUDIED: 80 to IX  fibers counted 
BIAS: not determined
OVERALL PRECISION see EVALUATION OF METHOD
ACCURACY: not determined
APPLICABILITY: The quantitative working range is 0.04 to 0.5 fiber/cc for a 1000-L air sample. The LOD depends on sample 
volume and quantity of Interfering dust, and Is <0.01 fiber/cc for atmospheres free of Interferences. This method Is used to 
determine asbestos fibers In the optically visible range and is intended to complement the results obtained by phase contrast 
microscopy (Method 7400).
INTERFERENCES: Other amphibole particles that have aspect ratios greater than 3:1 and elemental compositions similar to 
the asbestos minerals may Interfere In the TEM analysis. Some norvamphlbole minerals may give electron diffraction patterns 
similar to amphiboles. Hfigh concentrations of background dust interfere with fiber identification. Some non-asbestos amphibole 
minerals may give electron diffraction patterns similar to asbestos amphiboles.
OTHER METHODS: This method is designed for use with Method 7400 (phase contrast microscopy).
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REAGENTS:
1. Acetone. (See SPECIAL PRECAUTIONS.)
EQUIPMENT:
1. Sampler field monitor, 25-mm, three-piece cassette with ca. 50-mm eiectrically-conductive extension 
cowl, cellulose ester membrane filter. 0.45- to 1.2-pm pore size, and backup pad.
NOTE 1: Analyze representative filters for fiber background before use. Discard the filter lot if
mean count Is >5 fibers/100 fields. These are defined as laboratory blanks.
NOTE 2: Use an electrically-conductive extension cowl to reduce electrostatic effects on fiber
sampling and during sample shipment Ground the cowl when possible during 
sampling.
NOTE 3: 0.8-//m pore size filters are recommended for personal sampling. 0.45-pm fitters are
recommended for sampling when performing TEM analysis on the samples because the 
particles deposit closer to the filter surface. However, the higher pressure drop through 
these filters normally preclude their use with personal sampling pumps.
2. Personal sampling pump, 0.5 to 16 L/min, with flexible connecting tubing.
3. Microscope, transmission electron, operated at ca. 100 kV, with electron diffraction and 
energy-dispersive X-ray capabilities, and having a fluorescent screen with inscribed or overlaid 
calibrated scale (Step 15).
NOTE: The scale is most efficient if It consists of a series of lines inscribed on the screen or partial 
circles every 2 cm distant from the center.
4. Diffraction grating replica with known number of lines/mm.
5. Slides, glass, pre-deaned, 25- x 75-mm.
6. Knife, surgical steel, curved-blade.
7. Tweezers.
8. Grids, 200-mesh TEM copper, (optional: carbon-coated).
9. Petri dishes, 15-mm depth. The top and bottom of the petri dish must fit snugly together. To assure 
a tight fit, grind the top and bottom pieces together with an abrasive such as carborundum to 
produce a ground-glass contact surface.
10. Foam, dean polyurethane, spongy, 12-mm thick.
11. Filters. Whatman No. 1 qualitative paper or equivalent, or lens paper.
12. Vacuum evaporator.
13. Cork borer, (about 8-mm).
14. Pen, waterproof, marking.
15. Reinforcement, page, gummed.
16. Asbestos standard bulk materials for reference; e.g. SRM #1866, available from the National Institute 
of Standards and Technology.
17. Carbon rods, sharpened to 1 mm x 8 mm.
18. Microscope, light, phase contrast (PCM), with Walton-Beckett graticule (see method 7400).
19. Grounding wire, 22-gauge, multi-strand.
20. Tape, shrink- or adhesive*.
SPECIAL PRECAUTIONS: Acetone Is extremely flammable (Hash point = 0 °F). Take precautions not 
to Ignite ft. Heating of acetone must be done in a fume hood using a flameless, spark-free heat source. 
Asbestos Is a confirmed human carcinogen. Handle only In a well-ventilated fume hood.
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SAMPUNG:
1. Calibrate each personal sampling pump with a representative sampler in line.
2. For personal sampling, fasten sampler to worker’s lapel near worker’s mouth. Remove the top 
cover from cowl extension ("open-face") and orient sampler face down. Wrap joint between 
extender and monitor body with tape to help hold the cassette together and provide a marking 
surface to identify the cassette. Where possible, especially at low %RH, attach sampler to 
electrical ground to reduce electrostatic effects during sampling.
3. Submit at least two field blanks (or 10% of the total samples, whichever Is greater) for each set 
of samples. Remove top covers from the field Wank cassettes and store top covers and 
cassettes in a dean area (e.g., dosed bag or box) during sampling. Replace top covers when 
sampling is completed.
4. Sample at 0.5 to 16 L/min [3]. Adjust sampling rate, Q (L/min), and time, t (min), to produce 
fiber density. E, of 100 to 1300 fibers/mm2 [3.85 • 104 to 5 ■ 10* fibers per 25-mm filter with 
effective collection area (Ac= 385 mm2)] for optimum accuracy. Do not exceed ca. 0.5 mg total 
dust loading on the filter. These variables are related to the action level (one-half the current 
standard), L (fibers/cc), of the fibrous aerosol being sampled by:
t = — —— , min. 
Q • L • 103
NOTE: The purpose of adjusting sampling times is to obtain optimum fiber loading on the filter. 
A sampling rate of 1 to 4 L/min for 8 h (700 to 2800 L) is appropriate in atmospheres 
containing ca. 0.1 fiber/cc in the absence of significant amounts of non-asbestos dust 
Dusty atmospheres require smaller sample volumes (¿400 L) to obtain countable 
samples. In such cases take short, consecutive samples and average the results over 
the total collection time. For documenting episodic exposures, use high rates (7  to 16 
L/min) over shorter sampling times. In relatively dean atmospheres, where targeted 
fiber concentrations are much less than 0.1 fiber/cc, use larger sample vdumes (3000 to 
10000 L) to achieve quantifiable loadings. Take care, however, not to overload the filter 
with background dust [3].
5. At the end of sampling, replace top cover and small end caps.
6. Ship samples upright with conductive cowl attached in a rigid container with packing material to 
prevent jostling or damage.
NOTE: Do not use untreated polystyrene foam in the shipping container because electrostatic 
forces may cause fiber loss from sample filter.
SAMPLE PREPARATION:
7. Remove circular sections from any of three quadrants of each sample and blank filter using a 
cork borer [4]. The use of three grid preparations reduces the effect of local variations in dust 
deposit on the filter.
8. Affix the circular filter sections to a dean glass slide with a gummed page reinforcement Label 
the slide with a waterproof marking pen.
NOTE: Up to eight filter sections m?y be attached to the same slide.
9. Place the slide in a petri dish which contains several paper ffiters soaked with 2 to 3 mL 
acetone. Cover the dish. Wait 2 to 4 min for the sample fflter(s) to fuse and dear.
NOTE: The "hot block” dealing technique [5] of Method 7400 or the DMF dearing technique [6] 
may be used instead of steps 8 and 9.
10. Transfer the slide to a rotating stage inside the bell jar of a vacuum evaporator. Evaporate a 1- 
by 5-mm section of a graphite rod onto the deared filter(s). Remove the slide to a dean, dry, 
covered petri dish [4].
11. Prepare a second petri dish as a Jaffe wick washer with the wicking substrate prepared from 
filter or lens paper placed on top of a 12-mm thick disk of dean, spongy polyurethane foam [7].
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Cut a V-notch on the edge of the foam and filter paper. Use the V-notch as a reservoir for 
adding solvent
NOTE: The wicking substrate should be thin enough to fit into the petri dish without touching 
the lid.
12. Place the TEM grid on the fitter or lens paper. Label the grids by marking with a pencil on the 
filter paper or by putting registration marks on the petri dish halves and marking with a 
waterproof marker on the dish lid. In a fume hood, fill the dish with acetone untQ the wicking 
substrate is saturated.
NOTE: The level of acetone should be just high enough to saturate the filter paper without 
creating puddles.
13. Remove about a quarter section of the carbon-coated filter from the glass slide using a surgical 
knife and tweezers. Carefully place the excised filter, carbon side down, on the 
appropriately-labeled grid in the acetone-saturated petri dish. When all fitter sections have been 
transferred, slowly add more solvent to the wedge-shaped trough to raise the acetone level as 
high as possible without disturbing the sample preparations. Cover the petri dish. Elevate one 
side of the petri dish by placing a slide under it (allowing drops of condensed acetone to form 
near the edge rather than in the center where they would drip onto the grid preparation).
CALIBRATION AND QUALITY CONTROL:
14. Determine the TEM magnification on the fluorescent screen:
a. Define a field of view on the fluorescent screen either by markings or physical boundaries. 
NOTE: The field of view must be measurable or previously inscribed with a scale or
concentric circles (all scales should be metric) [7].
b. Insert a diffraction grating replica Into the specimen holder and place into the microscope. 
Orient the replica so that the grating lines fall perpendicular to the scale on the TEM 
fluorescent screen. Ensure that goniometer stage tût Is zero.
c. Adjust microscope magnification to 10.000X. Measure the distance (mm) between the same 
relative positions (e.g., between left edges) of two widely-separated lines on the grating 
replica. Count the number of spaces between the lines.
NOTE: On most microscopes the magnification is substantially constant only within the 
central 8- to 10-cm diameter region of the fluorescent screen.
d. Calculate the true magnification (M) on the fluorescent screen:
where: X = total distance (mm) between the two grating lines;
G = calibration constant of the grating replica (Jines/mm);
Y = number of grating replica spaces counted
e. After calibration, note the apparent sizes of 0.25 and 5.0 //m on the fluorescent screen. 
(These dimensions are the boundary limits for counting asbestos fibers by phase contrast 
microscopy.)
15. Measure 20 grid openings at random on a 200-mesh copper grid by placing a grid on a glass 
slide and examining it under the PCM. Use the Walton-Beckett graticule to measure the grid 
opening dimensions. Calculate an average graticule field dimension from the data and use this 
number to calculate the gratictfe field area for an average grid opening.
NOTE: A grid opening is considered as one graticule field.
16. Obtain reference selected area electron diffraction (SAED) or microdiffraction patterns from 
standard asbestos materials prepared for TEM analysis.
NOTE: This is a visual reference technique. No quantitative SAED analysis is required [7]. 
Microdiffraction may produce dearer patterns on very small fibers or fibers partially 
obscured by other material,
a. Set the specimen holder at zero tilt
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b. Center a fiber, focus, and center the smallest field-limiting aperture on the fiber. Obtain a 
diffraction pattern. Photograph each distinctive pattern and keep the photo for comparison 
to unknowns.
NOTE: Not all fibers will present diffraction patterns. The objective lens current may need 
adjustment to give optimum pattern visibility. There are many more amphiboles 
which give diffraction patterns similar to the analytes named on p. 7402-1. Some, 
but not all, of these can be eliminated by chemical separations. Also, some 
non-amphiboles (e.g., pyroxenes, some talc fibers) may interfere.
17. Acquire energy-dispersive X-ray (EDX) spectra on approximately 5 fibers having diameters
between 0.25 and 0.5 //m of each asbestos variety obtained from standard reference materials 
[7].
NOTE: The sample may require tilting to obtain adequate signal. Use same tilt angle for all 
spectra.
a. Prepare TEM grids of all asbestos varieties.
b. Use acquisition times (at least 100 sec) sufficient to show a silicon peak at least 75% of the 
monitor screen height at a vertical scale of ¿500 counts per channel.
c. Estimate the elemental peak heights visually as follows:
(1) Normalize all peaks to silicon (assigned an arbitrary value of 10).
(2) Visually interpret all other peaks present and assign values relative to the silicon peak.
(3) Determine an elemental profile for the fiber using the elements Na, Mg, Si, Ca, and Fe. 
Example: 0-4-10-3-<1 [7].
NOTE: In fibers other than asbestos, determination of Al, K, Ti, S, P, and F may also be 
required for fiber characterization.
(4) Determine a typical range of profiles for each asbestos variety and record the profiles for 
comparison to unknowns.
MEASUREMENT:
18. Perform a diffraction pattern inspection on all sample fibers counted under the TEM, using the
procedures given in step 17. Assign the diffraction pattern to one of the following structures:
a. chrysotfle;
b. am phi bole;
c. ambiguous;
d. none.
NOTE: There are some crystalline substances which exhibit diffraction patterns similar to those 
of asbestos fibers. Many of these, (brucite, halloysite, etc.) can be eliminated from 
consideration by chemistry. There are, however, several minerals (e.g., pyroxenes, 
massive amphiboles, and talc fibers) which are chemically similar to asbestos and can 
be considered interferences. The presence of these substances may warrant the use of 
more powerful diffraction pattern analysis before positive identification can be made.' If 
interferences are suspected, morphology can play an important role in making positive 
identification.
19. Obtain EDX spectra in either the TEM or STEM modes from fibers on field samples using the
procedure of step 18. Using the diffraction pattern and EDX spectrum, classify the fiber
a. For a chrysotfle structure, obtain EDX spectra on the first five fibers and one out of ten 
thereafter. Label the range profiles from 0-5-10-0-0 to 0-10-10-0-0 as "chrysotfle."
b. For an amphiboie structure, obtain EDX spectra on the first 10 fibers and one out of ten 
thereafter. Label profiles ca. 0-2-10-0-7 as "possible amosite"; profiles ca. 1-1-10-0-6 as 
"possible crocidoiite"; profiles ca. 0-4-10-3-<1 as "possible tremolite"; and profiles ca.
0-3-10-0-1 as "possible arrthophyliite."
NOTE: The range of profiles for the amphiboles will vary up to ±  1 unit for each of the 
elements present according to the relative detector efficiency of the spectrometer.
c. For an ambiguous structure, obtain EDX spectra on all fibers. Label profiles similar to the 
chrysotile profile as "possible chrysotfle." Label profiles similar to the various amphiboles as 
"possible amphiboles." Label all others as "unknown" or “non-asbestos."
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20. Counting and Sizing:
a. insert the sample grid into the specimen grid holder and scan the grid at zero tot at low 
magnification (ca. 300 to 500X). Ensure that the carbon film is intact and unbroken over ca. 
75% of the grid openings.
b. In order to determine how the grids should be sampled, estimate the number of fibers per 
grid opening during a low-magnification scan (500 to 1000X). This will allow the analyst to 
cover most of the area of the grids during the fiber count and analysis. Use the following 
rules when picking grid openings to count [7,8]:
(1) Light loading (<5 fibers per grid opening): count total of 40 grid openings.
(2) Moderate loading (5 to 25 fibers per grid opening): count minimum of 40 grid openings 
or 100 fibers.
(3) Heavy loading (>25 fibers per opening): count a minimum of 100 fibers and at least 6 
grid openings.
Note that these grid openings should be selected approximately equally among the three 
grid preparations and as randomly as possible from each grid.
c. Count only grid openings that have the carbon film intact At 500 to 1000X magnification, 
begin counting at one end of the grid and systematically traverse the grid by rows, reversing 
direction at row ends. Select the number of fields per traverse based on the loading 
indicated in the initial scan. Count at least 2 field blanks per sample set to document 
possible contamination of the samples. Count fibers using the following rules:
(1) Count all particles with diameter greater than 0.25 pm that meet the definition of a fiber 
(aspect ratio ^3:1, longer than 5 /mi). Use the guideline of counting all fibers that 
would have been counted under phase contrast light microscopy (Method 7400). Use 
higher magnification (10000X) to determine fiber dimensions and countability under the 
acceptance criteria. Analyze a minimum of 10% of the fibers, and at least 3 asbestos 
fibers, by EDX and SAED to confirm the presence of asbestos. Fibers of similar 
morphology under high magnification can be identified as asbestos without SAED. 
Particles which are of questionable morphology should be analyzed by SAED and EDX 
to aid in identification.
(2) Count fibers which are partially obscured by the grid as half fibers.
NOTE: If a fiber is partially obscured by the grid bar at the edge of the field of view, 
count it as a half fiber only if more than 2.5 pm of fiber is visible.
(3) Size each fiber as it is counted and record the diameter and length:
(a) Move the fiber to the center of the screen. Read the length of the fiber directly from 
the scale on the screen.
NOTE 1: Data can be recorded directly off the screen in pm and later converted
to pm by computer.
NOTE 2: For fibers which extend beyond the field of view, the fiber must be
moved and superimposed upon the scale until its entire length has been 
measured.
(b) When a fiber has been sized, return to the lower magnification and continue the 
traverse of the grid area to the next fiber.
d. Record the following fiber counts:
(1) f$< fb = number of asbestos fibers in the grid openings analyzed on the sample filter and 
corresponding field blank, respectively.
(2) Fs, Fb = number of fibers, regardless of identification, in the grid openings analyzed on 
the sample filter and corresponding field blank, respectively.
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CALCULATIONS:
21. Calculate and report the fraction of optically visible asbestos fibers on the filter,
(fs - y /(F # - Fb). Apply this fraction to fiber counts obtained by PCM on the same filter or on other 
filters for which the TEM sample is representative. The final result is an asbestos fiber count. The 
type of asbestos present should also be reported.
22. As an integral part of the report, give the model and manufacturer of the TEM as well as the model 
and manufacturer of the EDX system.
EVALUATION OF METHOD:
The TEM method, using the direct count of asbestos fibers, has been shown to have a precision of 0.275 
(sr) in an evaluation of mixed amosite and wollastonite fibers. The estimate of the asbestos fraction, 
however, had a precision of 0.11 (sr). When this fraction was applied to the PCM count, the overall 
precision of the combined analysis was 0.20 [2].
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ASBESTOS, CHRYSOTILE by XRD 9000
Mg3S¡20 5(0H)4 MW: ca. 283 CAS: 12001-29-5 RTECS: CI6478500
METHOD: 9000, issu« 2 EVALUATION: FUU. Issuel: 15 May 1989
Issue 2: 15 August 1994
EPA Standard (Bulk): 1% by weight PROPERTIES: solid, fibrous mineral; conversion to 
Forsterite at 580 °C; attacked by acids; 
loses water above 300 °C
SYNONYMS: Chrysotile
SAMPLING MEASUREMENT
BULK SAMPLE: 1 to 10 grams TECHNIQUE: X-RAY POWDER DIFFRACTION
SHIPMENT: seal securely to prevent escape of asbestos ANALYTE: chrysotile
SAMPLE
STABILITY: indefinitely
PREPARATION: grind under liquid Na; wet-sieve through 
10-*/m sieve
BLANKS: none required DEPOSIT: 5 mg dust on 0.45^m Ag membrane filter
XRD: Cu target X-ray tube; Optimize for 
intensity; 1 ° slit; Integrated intensity with 
background subtraction
CALIBRATION: suspensions of asbestos in 2-propanol
ACCURACY RANGE: 1 to 100% (w/w) asbestos
RANGE STUDIED: 1 to 100% in talc [1]
BIAS: negligible if standards and samples are 
matched in particle size [1]
OVERALL PRECISION (ê^): unknown; depends on
matrix and concentration
ACCURACY: ± 14% to ± 25%
ESTIMATED LOD: 0.2% asbestos in talc and caicite; 0.4% in 
heavy X-ray absorbers such as Fe20 3
PRECISION (§,): 0.07 (5 to 100%); 0.10 (@ 3%); 0.125 
(@1%)
APPLICABILITY: Analysis of percent chrysotile asbestos in bulk samples.
INTERFERENCES: Antigorite (massive serpentine), Chlorite, Kaolinrte, Bementite, and Brushite interfere. X-ray fluorescence 
and absorption is a problem with some elements; fluorescence can be circumvented with a diffracted beam monochromator, 
and absorption is corrected for in this method.
OTHER METHODS: This is P&CAM 309 [2] applied to bulk samples only, since the sensitivity is not adequate for personal air 
samples. The EPATest Method for the determination of asbestos in bulk insulation samples is similar to this one [3]. Method 
7400is an optical counting procedure for airborne fibers in personal samples. Methods 7402 (Asbestos by Transmission Electron 
Microscopy) and 9002 (Asbestos by Polarized Ught Microscopy) are also useful for positive identification of asbestos.
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REAGENTS:
1. Chrysotfle*. available from: Analytical 
Reference Minerals, Measurements Research 
Branch, DPSE, NIOSH, 4676 Columbia 
Parkway, Cincinnati, OH 45226; or UICC 
Asbestos Reference Sample Set, UICC MRC 
Pneumoconiosis Unit Uandough Hospital, 
Penarth, Glamorgan, CF6 1XW, UK.2.
2. 2-Propanol*
3. DesiccanL
4. Glue or tape for securing Ag filters to XRD 
holders.
*  See SPECIAL PRECAUTIONS.
EQUIPMENT:
1. Vials, plastic (for bulk sample).
2. Freezer mill, liquid ^-cooled, (Spex Model 
6700 or equivalent), grinding vials (Spex6701), 
extractor (Spex 6704).
3. Ultrasonic bath.
4. Sieve, 10-pm, for wet-sieving.
5. FBters, polycarbonate, 1.0-^m, 37-mm 
(Nudepore or equivalent).
6. FBtration apparatus and side-arm vacuum flask 
with 25- and 37-mm filter holders.
7. Oven, drying, 110 °C.
8. Analytical balance, readable to 0.01 mg.
9. Beaker, Griffin, 50-mL, with watchglass cover.
10. Filters, silver membrane, 25-mm diameter,
0.45-//m pore size (MBIipore Corp., Poretics 
Corp., or equivalent).
11. Desiccator.
12. Bottles, glass, 1-L, with ground glass stoppers.
13. Wash bottle, polyethylene.
14. Magnetic stirrer.
15. X-ray powder diffractometer with copper target 
x-ray tube and scintillation detector.
16. Reference specimen (mica, Arkansas stone or 
other stable standard) for data normalization.
17. Volumetric pipettes and flasks.
SPECIAL PRECAUTIONS: Asbestos, a human carcinogen, should be handled In a hood [4]. 
2-Propanol is flammable.
SAMPUNG:
1. Place several grams of the dust to be analyzed in a plastic vial, seal the vial securely and ship in 
a padded carton.
SAMPLE PREPARATION:
2. Place ca. 0.5 g of sample dust in a grinding vial and grind in a liquid nitrogen-cooled mill for 2 to 
10 min.
3. Wet sieve the ground dust using a 10-//m sieve and 2-propanol. Place the dust on the sieve and 
place the sieve directly in an ultrasonic bath or in a wide dish in the bath. Use enough 
2-propanol to cover the dust (put water in the bath if a dish is used to contain the 2-propanol). 
Apply ultrasonic power to sieve the dust
NOTE: ft may take some time to obtain several mg of dust Heating of the 2-propanol is likely 
and cooling periods may be required.
4. Recover the sieved sample dust from the 2-propanol by filtering the suspension through a 
non-fibrous filter (polycarbonate) or by driving off the 2-propanol on a hot plate. Dry the sieved 
sample in 110 °C  oven for 4 h or more.
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9 5. Weigh out ca. 5 mg of the sieved material onto a small square of tared weighing paper. Record 
the actual weight, W, to the nearest 0.01 mg. Transfer the dust to a 50-mL beaker, washing the 
weighing paper with several mL of 2-propanol. Add 10 to 15 mL 2-propanol to the beaker.
6. Cover the beaker with a watchglass. Agitate in an ultrasonic bath at least 3 min until all 
agglomerated particles are dispersed. Wash the underside of the watchglass with 2-propanol, 
collecting the washings in the beaker.
7. Place a silver filter in the filtration apparatus. Attach the funnel securely over the entire filter 
circumference. With no vacuum, pour 2 to 3 mL 2-propanol onto the filter. Pour the sample 
suspension from the beaker into the funnel and apply vacuum. During filtration, rinse the beaker 
several times and add rinsings to the funnel.
NOTE: Control the filtration rate to keep the liquid level in the funnel near the top during rinsing. 
Do not wash the walls or add 2-propanol to the funnel when the liquid level is lower than 
4 cm above the filter. Leave the vacuum on after filtration for sufficient time to produce 
a dry filter.
8. Remove the filter with forceps and attach it to the sample holder for XRD analysis.
CALIBRATION AND QUALITY CONTROL:
9. Prepare and analyze working standard filters:
a. Prepare two suspensions of chrysotile asbestos in 2-propanol by weighing 10 and 100 mg of 
the dry powder to the nearest 0.01 mg. Quantitatively transfer each to a 1-L glass-stoppered 
bottle using 1.00 L 2-propanol.
NOTE: Depending on the partide size of the standard, it may need to be ground and wet 
sieved (step 3). Dry the standards in a 110 °C oven for 4 h or more. Store in a 
desiccator.
b. Suspend the powder in the 2-propanol with an ultrasonic probe or bath for 20 min. 
Immediately move the flask to a magnetic stirrer with thermally-insulated top and add a 
stirring bar to the suspension. Cool the solution to room temperature before withdrawing 
aliquots.
c. Mount a filter on the filtration apparatus. Place several mL 2-propanol on the filter surface. 
Turn off the stirrer and shake vigorously by hand. Within a few seconds of setting the bottle 
down, remove the lid and withdraw an aliquot from the center of the 10 or 100 mg/L 
suspension. Do not adjust the volume in the pipet by expelling part of the suspension. If 
more than the desired aliquot is withdrawn, return all of the suspension to the bottle, rinse 
and dry the pipet, and take a new aliquot. Transfer the aliquot from the pipet to the filter. 
Keep the tip of the pipet near the surface but not submerged in the delivered suspension.
d. Rinse the pipet with several mL 2-propanol, draining the rinse into the funnel. Repeat the 
rinse several more times. Prepare working standard filters, in triplicate, by this technique, at
e.g., 0, 20, 30, 50 100, 200 and 500 pq.
e. Apply vacuum and rapidly filter the suspension. Leave vacuum on until filter is dry. Do not 
wash down the sides of the funnel after the deposit is in place since this will rearrange the 
material on the filter. Transfer the filter to the sample holder.
f. Analyze by XRD (step 12). The XRD intensities (12.d.) are designated lx° and are then
normalized (12.e.) to obtain \ The intensities for standards greater than 200 mg should be 
corrected for matrix absorption (12.f. and 13).
g. Prepare a calibration graph by plotting lx°, as a function of //g of each standard.
NOTE: Poor repeatability (greater than 10% above 0.04 mg chrysotile) indicates that new
standards should be made. The data should lie along a straight line. It is preferable 
to use a weighted least squares with 1 /a 2 weighing, where o2 is the variance of the 
data at a given loading.
h. Determine the slope, m, of the calibration curve in counts///g. The intercept on the abscissa 
should be within ±5 //g of zero.
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NOTE: A large intercept Indicates an error in determining the background, Le., an Incorrect 
baseline has been calculated or interference by another phase.
10. Select six sliver membrane filters as media blanks (for determination of sample self-absorption, 
step 13) randomly from the same box of filters to be used for depositing the samples. Mount 
each of the media blanks on the filtration apparatus and apply vacuum to draw 5 to 10 mL of 
2-propanol through the filter. Remove, let dry and mount on sample holders. Determine the net
normalized count for the silver peak, !>£, for each media blank (step 12). Obtain an average 
value for the six media blanks.
MEASUREMENT:
11. Obtain a qualitative X-ray diffraction scan (e.g., 10 to 60 degrees 2-theta) of the sample to






12. Mount the filter (sample, standard or blank) in the XRD instrument and:
a. Determine the net intensity, l„ of the reference specimen before each filter is scanned.
Select a convenient normalization scale factor, N, which is approximately equivalent to the 
net count for the reference specimen peak, and use this value of N for all analyses.
b. Measure the diffraction peak area of a chrysotile peak that is free of interference. Scan 
times should be long, e.g., 15 min.
c. Measure the background on each side of the peak for one-half the time used for peak 
scanning. The sum of these two counts is the average background. Determine the position 
of the background for each sample.
d. Calculate the net intensity, I* (the difference between the peak integrated count and the total 
background count).
e. Calculate and record the normalized intensity, îx, for the sample peak on each sample and 
standard:
NOTE: Normalizing to the reference specimen intensity compensates for long-term drift in X-ray 
tube intensity. If intensity measurements are stable, the reference specimen may be run 
less frequently; net intensities should be normalized to the most recently measured 
reference intensity.
f. Determine the net count, 1 ,̂ of an interference-free silver peak on the sample fQter following the 
same procedure. Use a short scan time for the silver peak (e.g., 5% of scan time for analyte 
peaks) throughout the method.
g. Scan each field blank over the same 2-theta range used for the analyte and silver peaks. These 
analyses serve only to verify that contamination of the filters has not occurred. The analyte peak 
shodd be absent The normalized intensity of the silver peak should match that of the media 
blanks.
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CALCULATIONS:
13. Calculate the percentage of chrysotile in the bulk dust sample:
0 : 1 m J L b l l ioo 
m • W
where: Tx = normalized intensity for sample peak
b = intercept of calibration graph (Ix° vs. W) 
m = slope of calibration graph (counts/pg)
f(T) = = absorption correction factor (Table 1)
R = sin (0^  )/sln (6J
T = ^/(average 1^) = transmittance of sample 
= normalized silver peak intensity from sample
average = normalized silver peak intensity from media blanks (average of six values) 
W = mass of deposited sample in //g.
NOTE: For a more detailed discussion of the absorption correction procedure, see references
[5] to [8].
EVALUATION OF METHOD:
This method is based on the work of B A  Lange in developing P&CAM 309 [1,2]. Samples in the range 
of 1 to 100% chrysotile in talc were studied to establish the feasibility of an XRD method for airborne 
asbestos. Analytical precision was as follows:
% Chrysotile







This work also showed that bias of results after absorption corrections are made is negligible.
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METHOD REVISED BY: 
M. T. Abell, NIOSH/DPSE
TABLE 1. ABSORPTION CORRECTION FACTOR AS A FUNCTION OF TRANSMITTANCE FOR 
SOME CHRYSOTILE-SILVER PEAK COMBINATIONS.
m    m
Transmittance Chrvsotile 12.09 24.3? Transmittance 12.08 24.38
T Silver 38.12 99-12 T _38.12 9912
1.00 1.0000 1.0000 0.69 1.6839 1.3142
0.99 1.0157 1.0078 0.68 1.7151 1.3277
0.98 1.0317 1.0157 0.67 1.7470 1.3414
0.97 1.0480 1.0237 0.66 1.7797 1.3555
0.96 1.0647 1.0319 0.65 1.8132 1.3698
0.95 1.0817 1.0402 0.64 1.8475 1.3845
0.94 1.0991 1.0486 0.63 1.8827 1.3995
0.93 1.1168 1.0572 0.62 1.9188 1.4148
0.92 1.1350 1.0659 0.61 1.9558 1.4305
0.91 1.1535 1.0747 0.60 1.9938 1.4465
0.90 1.1724 1.0837 0.59 2.0328 1.4629
0.89 1.1917 1.0928 0.58 2.0728 1.4797
0.88 1.2114 1.1021 0.57 2.1139 1.4969
0.87 1.2316 1.1115 0.56 2.1560 1.5145
0.86 1.2522 1.1212 0.55 2.1993 1.5325
0.85 1.2733 1.1309 0.54 2.2438 1.5510
0.84 1.2948 1.1409 0.53 2.2895 1.5700
0.83 1.3168 1.1510 0.52 2.3365 1.5895
0.82 1.3394 1.1613 0.51 2.3848 1.6095
0.81 1.3624 1.1718 0.50 2.4344 1.6300
0.80 1.3859 1.1825 0.49 2.4855 1.6510
0.79 1.4100 1.1933 0.48 2.5380 1.6727
0.78 1.4346 1.2044 0.47 2.5921 1.6950
0.77 1.4598 1.2157 0.46 2.6478 1.7179
0.76 1.4856 1.2272 0.45 2.7051 1.7414
0.75 1.5120 1.2389 0.44 2.7642 1.7657
0.74 1.5390 1.2508 0.43 2.8251 1.7907
0.73 1.5666 1.2630 0.42 2.8879 1.8165
0.72 1.5949 1.2754 0.41 2.9526 1.8431
0.71 1.6239 1.2881 0.40 3.0195 1.8705
0.70 1.6536 1.3010
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ASBESTOS (bulk) by PLM 9002
various MW: various CAS: 1332-21-4 RTECS: CI6475000
METHOD: 9002, Issue 2 EVALUATION: PARTIAL Issue 1: 15 May 1989
Issue 2: 15 August 1994
EPA Standard (Bulk): 1% PROPERTIES: solid, fibrous, crystalline, anisotropic
SYNONYMS ICAS #]: actinolite [77536-66-4], or ferroactinolite [15669-07-5]; amosite [12172-73-5]; anthophytlrte [77536^7-5]; 






1 to 10 grams





MICROSCOPY. STEREO AND 
POLARIZED LIGHT, WITH DISPERSION 
STAINING
actinolite asbestos, amosite, anthophyllite 
asbestos, chrysotile, croddolite, tramollte 
asbestos
BLANKS: none required EQUIPMENT:
RANGE:
microscope, polarized light; 100-400X 
dispersion staining objective, stereo 
microscope: 10-45X
1% to 100% asbestos
ESTIMATED LOD: <1% asbestos [1]
PRECISION: not determined
ACCURACY





APPLICABILITY: this method is useful for the qualitative identification of asbestos and the &emi-quantitative determination of 
asbestos content of bulk samples. The method measures percent asbestos as perceived by the analyst in comparison to 
standard area projections, photos, and drawings, or trained experience. The method is not applicable to samples containing 
large amounts of fine fibers below the resolution of the light microscope.
INTERFERENCES: Other fibers «nth optical properties similar to the asbestos minerals may give positive interferences. Optical 
properties of asbestos may be obscured by coating on the fibers. Fibers finer than the resolving power of the microscope (ca. 
0.3 ¿m) will not be detected. Heat and acid treatment may alter the index of refraction of asbestos and change its color.
OTHER METHODS: This method (originally designated as method 7403) is designed for use with NIOSH Methods 7400 (phase 
contrast microscopy) and 7402 (electron microscopy/EDS). The method is similar to the EPA bulk asbestos method [1].
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REAGENTS: EQUIPMENT:
1. Sample containers: screw-top plastic vials of 
10- to 50-mL capacity.
2. Microscope, polarized light, with polarizer, 
analyzer, port for retardation plate, 360° 
graduated rotating stage, substage condenser 
with iris, lamp, lamp iris, and:
a. Objective lenses: 10X, 20X, and 40X or 
near equivalent
b. Ocular iense: 10X minimum.
c. Eyepiece reticle: crosshair.
d. Dispersion staining objective lens or 
equivalent
e. Compensator plate: ca 550 nm± 20 nm, 
retardation: "first order red" compensator.
3. Microscope slides: 75 mm x 25 mm.
4. Cover slips.
5. Ventilated hood or negative-pressure glove 
box.
6. Mortar and pestle: agate or porcelain.
7. Stereomicroscope, ca. 10 to 45X
8. Light source: incandescent or fluorescent
9. Tweezers, dissecting needles, spatulas, 
probes, and scalpeis.
10. Glassine paper or dean glass plate.
11. Low-speed hand drill with coarse burr bit 
(optional).
SPECIAL PRECAUTIONS: Asbestos, a human carcinogen, should be handled only in an exhaust hood 
(equipped with a HEPA filter) [2]. Precautions should be taken when collecting unknown samples, which 
may be asbestos, to preclude exposure to the person collecting the sample and minimize the disruption 
to the parent material [3]. Disposal of asbestos-containing materials should follow EPA Guidelines [4].
SAMPLING:
1. Place 1 to 10 g of the material to be analyzed in a sample container.
NOTE: For large samples (i.e., whole ceiling tiles) that are fairly homogenous, a representative 
small portion should be submitted for analysis. Sample size should be adjusted to 
ensure that it is representative of the parent material.
2. Make sure that sample containers are taped so they wDI not open in transit
3. Ship the samples in a rigid container with sufficient packing material to prevent damage or 
sample loss.
SAMPLE PREPARATION:
4. Visually examine samples in the container and with a low-magnification stereomicroscope in a 
hood. (If necessary, a sample may be carefully removed from the container and placed on 
glassine transfer paper or dean glass plate for examination). Break off a portion of the sample 
and examine the edges for emergent fibers. Note the homogeneity of the sample. Some hard 
tiles can be broken, and the edges examined for emergent fibers. K fibers are found, make an 
estimate of the amount and type of fibers present, confirm fiber type (step 14) and quantify (step 
15).
1. Refractive index (Rl) liquids for Dispersion 
Staining: high-dispersion (HD) series, 1.550, 
1.605, 1.620.
2. Refractive index liquids: l.oA), 1.680, and 
1.700.
3. Asbestos reference samples such as SRM 
#1866, available from the National Institute of 
Standards and Technology.*
4. Distilled Water (optional).
5. Concentrated HQ: ACS reagent grade.
* See SPECIAL PRECAUTIONS.
NIOSH Manual of Analytical Methods (NMAM), Fourth Edition, 6/15/94
ASBESTOS (bulk): METHOD 9002, Issue 2, dated 15 August 1994 - Page 3 of 9
5. In a hood, open sample container and with tweezers remove small, representative portions of 
the sample.
a. If there are obvious separable layers, sample and analyze each layer separately.
b. If the sample appears to be slightly inhomogeneous, mix it in the sample container with 
tweezers or a spatula before taking the portion of analysis. Alternatively, take small 
representative portions of each type of material and place on a glass slide.
c. On hard tiles that may have thin, inseparable layers, use a scalpel to cut through all the 
layers for a representative sample. Then cut it into smaller pieces after placing Rl liquid on it 
before trying to reduce the thickness. Alternatively, use a low-speed hand drill equipped 
with a burr bit to remove material from hard tiles. Avoid excessive heating of the sample 
which may alter the optical properties of the material.
NOTE: This type of sample often requires ashing or other specialized preparation, and may 
require transmission electron microscopy for detection of the short asbestos fibers 
which are characteristic of floor tiles.
d. If the sample has large, hard particles, grind it in a mortar. Do not grind so fine that fiber 
characteristics are destroyed.
e. If necessary, treat a portion of the sample in a hood with an appropriate solvent to remove 
binders, tars, and other interfering materials which may be present in the sample. Make 
corrections for the non-asbestos material removed by this process.
NOTE: Other methods of sample preparation such as acid washing and sodium
metaphosphate treatment and ashing may be necessary, especially to detect low 
concentrations of asbestos. If needed, use as described in Reference [1J.
6. After placing a few drops of Rl liquid on the slide, put a small portion of sample in the liquid. 
Tease apart with a needle or smash small clumps with the flat end of a spatula or probe, 
producing a uniform thickness or particles so that better estimates of projected area 
percentages can be made. Mix the fibers and particles on the slide so that they are as 
homogeneous as possible.
NOTE: An even dispersion of sample should cover the entire area under the cover slip, some 
practice will be necessary to judge the right amount of material to place on the slide.
Too little sample may not give sufficient information and too much sample cannot be 
easily analyzed.
CALIBRATION AND QUALITY CONTROL:
7. Check for contamination each day of operation. Wipe microscope slides and cover slips with 
lens paper before using Check refractive index liquids. Record results In a separate logbook.
8. Verify the refractive Indices of the refractive index liquids used once per week of operation. 
Record these checks in a separate logbook.
9. Follow the manufacturer’s instructions for illumination, condenser alignment and other 
microscope adjustments. Perform these adjustments prior to each sample set.
10. Determine percent of each identified asbestos species by comparison to standard projections 
(Figure 1) [1]. If no fibers are detected in a homogeneous sample, examine at least two 
additional preparations before concluding that no asbestos is present.
11. If it appears that the preparation technique might not be able to produce a homogeneous or 
representative sample on the slide, prepare a duplicate slide and average the results. 
Occasionally, when the duplicate results vary greatly, it will be necessary to prepare additional 
replicate slides and average all the replicate results. Prepare duplicate slides of at least 10% of 
the samples analyzed. Average the results for reporting.
12. Analyze about 5% blind samples of known asbestos content
13. Laboratories performing this analytical method should participate in the National Voluntary 
Laboratory Accreditation Program [5] or a similar interlaboratory quality control program. Each 
analyst should have complete formal training in polarized light microscopy and its application to 
crystalline materials. In lieu of formal training, laboratory training In asbestos bulk analysis under 
the direction of a trained asbestos bulk analyst may be substituted. Owing to the subjective 
nature of the method, frequent practice is essential in order to remain proficient in estimating 
projected area percentages.
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QUALITATIVE ASSESSMENT:
14. Scan the slide to identify any asbestos minerals using the optical properties of morphology,
refracth/e indices, color, pleochroism, birefringence, extinction characteristics, sign of elongation,
and dispersion staining characteristics.
NOTE: Identification of asbestos using polarized light microscopy is unlike most other analytical 
methods. The quality of the results is dependent on the skill and Judgment of the 
analyst This method does not lend itself easily to a stepwise approach. Various 
procedures devised by different analysts may yield equivalent results- The following 
step-wise procedure repeatedly utilizes the sample preparation procedure previously 
outlined.
a. Prepare a slide using 1.550 HD Rl liquid. Adjust the polarizing filter such that the polars are 
partially crossed, with ca. 15° offset Scan the preparation, examining the morphology for 
the presence of fibers. If no fibers are found, scan the additional preparations. If no fibers 
are found in any of the preparations, report that the sample does not contain asbestos, and 
stop the analysis at this point
b. If fibers are found, adjust the polarizing filter such that the polars are fully crossed. If all of 
the fibers are isotropic (disappear at all angles of rotation) then those fibers are not 
asbestos. Fibrous glass and mineral wool, which are common components of suspect 
samples, are isotropic. If only isotropic fibers are found in the additional preparations, report 
no asbestos fibers detected, and stop the analysis.
c. If anisotropic fibers are found, rotate the stage to determine the angle of extinction. Except 
for tremol ite-actinolite asbestos which has oblique extinction at 10-20°, the other forms of 
asbestos exhibit parallel extinction (Table 1). Tremol ite may show both parallel and oblique 
extinction.
d. Insert the first order red compensator plate in the microscope and determine the sign of 
elongation. All forms of asbestos have a positive sign of elongation except for crocidolite. If 
the sign of elongation observed Is negative, go to step *g."
NOTE: To determine the direction of the sign of elongation on a particular microscope
configuration, examine a known chrysotile sample and note the direction (NE-SW or 
NW-SE) of the blue coloration. Chrysotile has a positive sign of elongation.
e. Remove the first-order red compensator and uncross the polarizer. Examine under plane
polarized light for blue and gold-brown Becke colors at the fiber-on interface (Le.p index of
refraction match). Becke colors are not always evident Examine fiber morphology for 
twisted, wavy bundles of fibers which are characteristic of chrysotile. Twisted, ribbon-like 
morphology with cellular internal features may indicate cellulose fibers. It may be necessary 
to cross the polars partially in order to see the fibers if the index of refraction is an exact 
match at 1.550. If the fibers appear to have higher index of refraction, go to step "h,” 
otherwise continue.
f. Identification of chrysotile. insert the dispersion staining objective. Observation of
dispersion staining colors of blue and blue-magerrta confirms chrysotile. Cellulose, which is
a common interfering fiber at the 1.550 index of refraction, will not exhibit these dispersion 
staining colors. If chrysotile is found, go to step 15 for quantitative estimation.
g. Identification of crocidolite. Prepare a slide in 1.700 Rl liquid. Examine under plane- 
polarized light (uncrossed polars); check for morphology of crocidolite. Fibers will be 
straight, with rigid appearance, and may appear blue or purple-blue. Crocidolite is 
pleochroic, Le., it will appear to change its color (blue or gray) as it is rotated through plane 
polarized light Insert the dispersion staining objective. The central stop dispersion staining 
color are red magenta and blue magenta, however, these colors are sometimes difficult to 
impossible to see because of the opacity of the dark blue fibers. If observations above 
indicate crocidolite, go to step 15 for quantitative estimation.
h. Identification of amosite. Prepare a slide in 1.680 Ri liquid. Observed the fiber morphology 
for amosite characteristics: straight fibers and fiber bundles with broom-like or splayed 
ends, if the morphology matches amosite, examine the fibers using the dispersion staining 
objective. Blue and pale blue colors indicate the cummingtonite form of amosite, and gold 
and blue colors indicate the gruñente form of amosite. If amosite is confirmed by this test,
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go to step 15 for quantitative estimation, otherwise continue.
L Identification of anthophyilite-tremolite-actinolite. Prepare a slide in 1.605 HD Rl liquid. 
Examine morphology for comparison to anthophyllite-tremolite-actinolite asbestos. The 
refractive indices for these forms of asbestos vary naturally within the species. Anthophyllite 
can be distinguished from actinolite and tremolite by its nearly parallel extinction. Actinolite 
has a light to dark green color under plane-polarized light and exhibits some pleochroism. 
For all three, fibers will be straight, single fibers possibly with some larger composite fibers. 
Cleavage fragments may also be present Examine using the central stop dispersion 
staining objective. Anthophyllite will exhibit central stop colors of blue and gold/gold- 
magenta; tremolite will exhibit pale blue and yellow; and actinolite will exhibit magenta and 
golden-yellow colors.
NOTE: In this refractive index range, wollastonite is a common interfering mineral with 
similar morphology including the presence of cleavage fragments. It has both 
positive and negative sign of elongation, parallel extinction, and central stop 
dispersion staining colors of pale yellow and pale yellow to magenta. If further 
confirmation of wollastonite versus anthophyllite is needed, go to step Bja. If any of 
the above forms of asbestos were confirmed above, go to step 15 for quantitative 
estimation. If none of the tests above confirmed asbestos fibers, examine the 
additional preparations and if the same result occurs, report the absence of 
asbestos in this sample, 
j. Wash a small portion of the sample in a drop of concentrated hydrochloric acid on a slide. 
Place the slide, with cover slip in place, on a warm hot plate until dry. By capiltary action, 
place 1.620 Rl liquid under the cover dip and examine the slide. Wollastonite fibers will 
have a "cross-hatched" appearance across the length of the fibers and will not show central 
stop dispersion colors. Anthophyllite and tremolite will still show their original dispersion 
colors.
NOTE: There are alternative analysis procedures to the step-wise approach outlined above 
which wQI yield equivalent results. Some of these alternatives are:
L Perform the initial scan for the presence of asbestos using crossed polars as 
well as the first-order red compensator. This allows for simultaneous viewing of 
birefringent and amorphous materials as well as determine their sign of 
elongation. Some fibers which are covered with mortar may best be observed 
using this configuration,
ii. Some analysts prefer to mount their first preparation in a Rl liquid different than 
any asbestos materials and conduct their initial examination under plane- 
polarized light
Hi. If alternative Rl liquids are used from those specified, dispersion staining colors 
observed wOl also change. Refer to an appropriate reference for the specific 
colors associated with asbestos in the Rl liquids actually used.
QUANTITATIVE ASSESSMENT:
15. Estimate the content of the asbestos type present in the sample using the 1.550 Rl preparation. 
Express the estimate as an area percent of all material present, taking into account the loading 
and distribution of all sample material on the slide. Use Figure 1 as an aid in arriving at your 
estimate. If additional unidentified fibers are present in the sample, continue with the qualitative 
measurement (step 14).
NOTE: Point-counting techniques to determine percentages of the asbestos minerals are not 
generally recommended. The point-counting method oniy produces accurate 
quantitative data when the material on the slide is homogeneous and has a uniform 
thickness, which is difficult to obtain [6]. The point-counting technique is, recommended 
by the EPA to determine the amount of asbestos in bulk [1]; however, in the more 
recent Asbestos Hazard Emergency Response Act (AHERA) regulations, asbestos 
quantification may be performed by a point-counting or equivalent estimation 
method 17].
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16. Make a quantitative estimate of the asbestos content of the sample from the appropriate
combination of the estimates from both the gross and microscopic examinations. If asbestos 
fibers are identified, report the material as "asbestos-containing*. Asbestos content should be 
reported as a range of percent content The range reported should be indicative of the analyst’s 
precision in estimating asbestos content For greater quantities use Figure 1 in arriving at your 
estimate.
EVALUATION OF METHOD:
The method Is compiled from standard techniques used in mineralogy [8-13], and from standard 
laboratory procedures for bulk asbestos analysis which have been utilized for several years. These 
techniques have been successfully applied to the analysis of EPA Bulk Sample Analysis Quality 
Assurance Program samples since 1982 [1,5]. However, no formal evaluation of this method, as written, 
has been performed.
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Table 1. Optical Properties of Asbestos Fibers |
Refractive index 
{Aooroximate Values)





Chrysotile Wavy fibers with kinks. 
Splayed ends on larger 
bundles. Colorless to 
light brown upon being 
heated. Nonpleochroic. 
Aspect ratio typically 
>10:1.




Straight fibers and fiber 
bundles. Bundle ends 
appear broom-like or 
splayed. Colodessto 
brawn upon heating. 
May be wealdy 
pleochroic. Aspect ratio 
typical Jy >10:1.
1.67 1.70 a02 - 0.03
Croddolite
(Hebeckite)
Straight fibers and fiber 
bundles. Longer fibers 
show curvature. Splayed 
ends on bundles. 
Characteristic blue color. 
Pleochroic. Aspect ratio 
typically >10:1.
1.71 1.70 0014 - 0.016 
Interference colors 
maybe masked by 
blue color.
Anthophyflhe Straight fibers and fiber 
bundles. Cleavage 
fragments maybe 
present Colorless to 
light brown.
Nonpleochroic to wealdy 
pleochroic. Aspect ratio 
generally <10:1.
1.61 1.63 a o i9 -a o 2 4
Tremolite-
Actinolite
Straight and curved 
fibers. Cleavage 
fragments common. 
Large fiber bundles show 
splayed ends. Tremolite 
is colorless. Actinolite is 
green and wealdy to 
moderately pleochroic. 






1.62 - 1j64 
(tremolite)
1*64 - 1.68 
(actinolite)
0jQ2 - 0.03 
— --- - ----------
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Table 1. Optical Properties of Asbestos Fibers (Continued)








Chrysolite Parallel to fiber 
length






Parallel to fiber 
length

















Parallel to fiber 
length






AnthophyHite Parallel to fiber 
length























HO = high-dispersion RI liquid series.
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DISCLAIMER
This document has been 
reviewed in accordance 
with policies at the U.S.' 
Environmental Protection 
Agency and the National 
‘ Institute for Occupational 
Safety and Health. Infor­
mation provided is based 
upon current scientific and 
technical understanding 
of the issues presented. 
Following the advice given . 
will not necessarily provide 
complete protection in all 
situations or against all ’ 
health hazards that may be 
caused byindoorair poll­
ution. Mention of any trade 
names or commercial prod­




bestos” describes six naturally 
occurring fibrous minerals found in certain 
types of rock formations. When mined 
and processed, asbestos is typically sepa­
rated into very thin fibers that are normally 
invisible to die naked eye. They may 
remain in the air for many hours if re­
leased from asbestos-containing material 
(ACM) and may be inhaled during this 
time. Three specific diseases — asbestos is 
(a fibrous scarring of the lungs), lung 
cancer, and mesothelioma (a cancer of the 
lining of the chest or abdominal cavity) — 
have been linked to asbestos exposure. It 
may be 20 years or more after exposure 
before symptoms of these diseases appear; 
however, high levels of exposure can re­
sult in respiratory diseases within a shorter 
period of time.
Most of the health problems resulting 
from asbestos exposure have been experi­
enced by workers whose jobs exposed 
them to asbestos in the air over a pro­
longed period without the worker protec­
tion that is now required Asbestos fibers 
can be found nearly everywhere in our 
environment, usually at very low levels. 
While the risk to occupants is likely to be 
small, health concerns remain, particularly 
for the custodial and maintenance workers 
in a building. Their jobs are likely to bring 
them into proximity to ACM and may 
sometimes require them to disturb the 
ACM in the performance of maintenance 
activities.
EPA estimates that “friable** (easily 
crumbled) ACM can be found in an esti­
mated 700,000 public and commercial 
buildings. About 500,000 of those build­
ings are believed to contain at least some 
damaged asbestos. Significantly damaged 
ACM is found primarily in building areas
not generally accessible to the public, such 
as boiler and mechanical rooms, where 
asbestos exposures generally would be 
limited to service and maintenance work­
ers. However, if friable ACM is present in 
air plenums, it can be distributed through­
out the building, thereby possibly exposing 
building occupants.
When is asbestos a problem? Intact and 
undisturbed asbestos materials do not 
pose a health risk. The mere presence of 
asbestos in a building does not mean that 
the health of building occupants is endan­
gered. ACM which is in good condition, 
and is not damaged or disturbed, is not 
likely to release asbestos fibers into the air. 
When ACM is properly managed, release 
of asbestos fibers into the air is reduced, 
and the risk of asbestos-related disease is 
thereby correspondingly reduced.
There are a number of guidelines and 
regulations that govern asbestos exposure. 
Occupational standards for preventing 
asbestos-related diseases are recommended 
by NIOSH and promulgated by OS HA. 
NIOSH guidance contains Recommended 
Exposure Limits (RELs) and OSHA 
standards set Permissible Exposure Limits 
(PELs). The standards also contain many 
other measures, such as surveillance, 
medical screening, analytical methods, and 
methods of control. OSHA regulations 
and the EPA Worker Protection Rule also 
provide guidance on day-to-day activities 
that may bring workers in contact with 
ACM. EPA National Emission Standards 
for Hazardous Air Pollutants (NESHAP) 
define acceptable practices for renovation 
and demolition activities that involve as­
bestos-containing materials. In addition, 
many States have set exposure standards 
and other regulations concerning asbestos.
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OSHA requires that signs 
be posted around areas 
where work is being done 
that involves damaged 
asbestos-containing 
materials. These signs 
must communicate specific 
types of information.
EPA and NIOSH recommend a practical 
approach that protects public health by 
emphasizing that ACM in buildings should 
be identified and appropriately managed, 
and that those workers who might disturb 
it should be properly trained and protected.
EPA AND NIOSH 
POSITIONS ON ASBESTOS
In an effort to calm unwarranted fears that 
a number of people seem to have about the 
mere presence of asbestos in their build­
ings and to discourage die decisions by 
some building owners to remove all ACM 
regardless of its condition, the EPA Ad­
ministrator issued an Advisory to the Pub­
lic on Asbestos in Buildings in 1991. This 
advisory summarized EPA’s policies for 
asbestos control in the presentation of the 
following “five facts”:
■ Although asbestos is hazardous, die risk 
of asbestos-related disease depends upon 
exposure to airborne asbestos fibers.
■ Based upon available data, the average 
airborne asbestos levels in buildings 
seem to be very low. Accordingly, the 
health risk to most building occupants 
also appears to be very low.
■ Removal is often not a building owner’s
Asbestos 
Cancer and Lung Disease Hazard 
Authorized Personnel Only 
Respirators and Protective 
Clothing Are Required in This Area
best course of action to reduce asbestos 
exposure. In fact, an improper removal 
can create a dangerous situation where 
none previously existed.
■ EPA only requires asbestos removal in 
order to prevent significant public expo-* 
sure to airborne asbestos fibers during 
building demolition or renovation 
activities.
■ EPA does recommend a pro-active, in- 
place management program whenever 
asbestos-containing material is 
discovered.
NIOSH’s position on asbestos exposure 
has been expressed in NIOSH policy state­
ments and internal reports and at OSHA 
public hearings:
■ NIOSH recommends the goal of elimi­
nating asbestos exposure in the work­
place. Where exposures cannot be elimi­
nated, exposures should be limited to the 
lowest concentration possible.
■ NIOSH contends that there is no safe 
airborne fiber concentration for asbestos. 
NIOSH therefore believes that any de­
tectable concentration of asbestos in die 
workplace warrants further evaluation 
and, if necessary, the implementation of 
measures to reduce exposures.
■ NIOSH contends that there is no scien­
tific basis to support differentiating 
health risks between types of asbestos 
fibers for regulatory purposes.
Copies of the EPA and NIOSH policy 
statements and public advisories are avail­
able, respectively, from those agencies.
See the last section in this appendix and 
Appendix G for information on how to 
obtain them.
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PROGRAMS FOR MANAGING 
ASBESTOS IN-PLACE
In some cases, an asbestos operations and 
maintenance program is more appropriate 
than other asbestos control strategies, in­
cluding removal. Proper asbestos manage­
ment is neither to rip it all out in a panic nor 
to ignore the problem under the false pre­
sumption that asbestos is “risk free.”
Health concerns remain, particularly for 
custodial and maintenance workers.
In-place management does not mean “do 
nothing.” It means having a program to 
ensure that the day-to-day management of 
the building is carried out in a manner that 
minimizes release of asbestos fibers into the 
air, and that ensures that when asbestos 
fibers are released, either accidentally or 
intentionally, proper control and clean-up 
procedures are implemented. Such a pro­
gram may be all that is necessary to control 
the release of asbestos fibers until the as­
bestos-containing material in a building is 
scheduled to be disturbed by renovation or 
demolition activities.
The first responsibility of a building 
owner or manager is to identify asbestos- 
containing materials, through a building- 
wide inventory or on a case-by-case basis, 
before suspect materials are disturbed by 
renovations or other actions. The Asbestos 
Hazard Emergency Response Act 
(AHERA) program requires that in schools 
an inventory of asbestos materials be done 
by properly accredited individuals. Starting 
in late 1991 or 1992, there will also be a 
requirement that if an inventory of asbestos 
materials is done in public and commercial 
buildings, the inventory must be done by 
properly accredited individuals. In public 
and commercial buildings facing major 
renovations or demolition, inspections for 
the presence of ACM are required, accord­
ing to the 1990 revision of the EPA Asbes­
tos NESHAP. A carefully designed air 
monitoring program can be used as an ad­
junct to visual and physical evaluations of 
the asbestos-containing materials.
After the material is identified, the build­
ing management and staff can then insti­
tute controls to ensure that the day-to-day 
management of the building is carried out 
in a manner that prevents or minimizes die 
release of asbestos fibers into the air.
These controls will ensure that when as­
bestos fibers are released, either acciden­
tally or intentionally, proper management 
and clean-up procedures are implemented.
Another concern of EPA, NIOSH, and 
other Federal, State, and local agencies that 
are concerned with asbestos and public 
health is to ensure proper worker training 
and protection. In the course of their daily 
activities, maintenance and service work­
ers in buildings may disturb materials and 
thereby elevate asbestos fiber levels and 
asbestos exposure, especially for them­
selves, if they are not properly trained and 
protected. For these persons, risk may be 
significantly higher than for other building 
occupants. Proper worker training and 
protection, as part of an active in-place 
management program, can reduce any 
unnecessary asbestos exposure for these 
workers and others. AHERA requires this 
training for school employees whose job 
activities may result in asbestos distur­
bances.
In addition to the steps outlined above, 
an in-place management program will 
usually include notification to workers and 
occupants of the existence of asbestos in 
their building, periodic surveillance of the 
material, and proper recordkeeping. EPA 
requires all of these activities for schools 
and strongly recommends that other build­
ing owners also establish comprehensive 
asbestos management programs. Without 
such programs, asbestos materials could be 
damaged or could deteriorate, which might 
result in elevated levels of airborne asbes­
tos fibers. While the management costs of 
all the above activities will depend upon 
the amount, condition, and location of the 
materials, such a program need not be 
expensive.
Asbestos
WHERE TO GO FOR 
ADDITIONAL INFORMATION
For guidance on asbestos, building owners 
and managers aie urged to become familiar 
with two EPA documents: Managing 
Asbestos in Place (published in 1990 and 
also known as the “Green Book”) and 
Guidance for Controlling Asbestos-Con­
taining Materials in Buildings (published 
in 1985 and also known as the “Purple 
Book”).
To obtain copies of the guidance publi­
cations and other materials mentioned 
above, or to get additional information on 
technical issues, call or write:
Environmental Assistance Division 
Office of Toxic Substances 
U.S. EPA (TS-799)
401 M Street SW
Washington, DC 20460
Telephone (TSCA Information Hotline):
202-554-1404
National Institute for Occupational 
Safety and Health
Technical Information Branch 
4676 Columbia Parkway 
Cincinnati, OH 45226 
Telephone: 1-800-35-NIQSH or 
1-800-356-4674
Contact State air pollution control or health 
agencies for information on pertinent State 
activities and regulations. To find an as­
bestos contact in State agencies, consult 
the EPA Directory of State Indoor Air 
Contacts. For a more complete listing of 
publications concerning asbestos, refer to 
Appendix G.
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Working on brakes? Think about this
»Asbestos can cause fatal diseases years after exposure. 
Asbestos is used in clutches and brakes. 
•Anyone working on brakes needs protection from asbestos.
We can't see it, smell it, taste it, or feel it, but we know that asbestos can cause debilitating and often fatal diseases. 
We also know that these diseases take as long as 20 years to develop. What we don’t know is how much-or how 
little-exposure to asbestos can cause them.
There is no known safe level of exposure. Anyone who works with any quantity of asbestos for any length of time 
risks developing serious disease later in life. And that person puts others at risk. Invisible asbestos fibers cling to 
clothes, hair, and skin. When they become airborne, as they do in natural movement, anyone near that person 
can inhale them.
Since asbestos is used in clutches and brakes, you may be exposing yourself and your loved ones to that risk.
Yet protection from asbestos exposure can be simple and inexpensive. This bulletin will give you the facts about 
asbestos and how to take care of yourself when working with it.
What is 
asbestos?
Asbestos is a mined mineral. It is a 
needle-like fiber that is very resis­
tant to pressure and heat, which is 
why it is used in brakes and clutches.
It is very brittle, and it fractures length­
wise, creating smaller and smaller 
fibers with sharp, needle-like edges.
You cant see these fibers in the 
air—some asbestos particles 
are so small that nearly 200 of 
them would have to be bundled 
together to equal the diameter of 
one human hair.
These invisible particles are in 
brake dust and you can inhale 
them right through unapproved 
protective dust masks. They can 
then travel through the respiratory 
system and lodge in the lungs, 
where they become permanently 
embedded in lung tissue.
LUNG CANCER DEATHS*






who work with asbestos
How dangerous is asbestos exposure?
Asbestos fibers are often found at 
tumor sites in the lung, and exposure 
to asbestos causes deadly lung dis­
eases. Among these are:
•Lung cancer: About 95% of
lung cancer victims die quickly — by 
the time the disease is detectable by 
x-ray, it is often widespread. Lung 
cancer accounts for the largest num­
ber of deaths attributed to asbestos 
exposure, and asbestos is almost as 
deadly as smoking as a cause of this 
disease. In fact, a smoker who works 
with asbestos is 10 times more likely
to contract and die from lung cancer 
than than a non-smoker who works 
with asbestos.
•Mesothelioma: This deadly
cancer is 100% fatal, usually within 
one year of diagnosis — and asbestos 
is the major cause of this disease. No 
one knows how little it takes. Even 
indirect exposure is deadly. Wives, 
children, and pets of people who work 
with asbestos have died just from 
exposure to the clothes of the worker. 
This disease damages the lining of the 
chest and abdominal cavities.
Dangers continued on side 2
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Doing a Brake Job? It's Easy to Do it Right!
If you can recognize hazards and 
know how to control them, you are 
better equipped to protect yourself. 
Therefore, the National Institute for 
Occupational Safety and Health 
(NIOSH) recommends a few basic 
rules for doing brake jobs. They 
include:
•Don't Blow It! Asbestos dust 
that doesn't get into the air will never 
get into your lungs. So never use an 
air hose, dry brush, rag, or ordinary 
shop-vac. They all stir up deadly 
dust. And for the same reason, 
don't grind brake linings. Slow 
lathe-turning will reduce dust 
significantly.
•Keep It Clean! Clean 
spills by vacuuming with 
HEP A (High Efficiency Particulate 
Air) systems or wet mopping 
immediately. (Dry sweeping and air 
hoses will blow dust into the air, and 
into your lungs.) Dispose of waste 
in sealed, labelled containers. And 
if you use a HEPA vacuum system, 
vacuum each component as you 
remove it.
Remember:
•Keepbrake dust out o f the air!
•Keep work areas free of food and drink.
• Dispose o f a il spills, contami­nated solutionsf and ragsin accordance with state and local regulations.
• Keep work clothing separate from street clothing—and launder work clothing after 
each sh ift
• Wash hands after working, but never with the same rags used to clean brakes.
•Wet It Down! When using a wet 
brush, thoroughly wet the wheel hub 
and back of the assembly first. After 
removing the drum, wash all compo­
nents with the brush. If using aerosol 
spray, remember to keep the nozzle far 
enough away from the surface to keep 
fibers from splashing back at you in the 
liquid. Also, if you must hammer 
drums, place a pan with water beneath 
the wheel to catch the dust
•Seal It Tight! Enclosure systems 
should fit completely around the brake 
drum backing plate and should provide 
a tight seal around the axle. Turn on 
the HEPA vacuum before positioning 
enclosure over wheel, and 
P J P TI leave it on while removing the 
j- enclosure.
•Check It Out! Make sure you have 
enough light to see and space to work. 
Respect the hazards and know how to 
control them. And if you have ques­
tions about safety practices, call:
The Ohio Industrial Commission 
1-800-282-3045 or 
The National Institute for 
Occupational Safety and Health 
1-800-35-NI05H
•Masks do BS21 filter asbestos fibers. Respirators equipped with HEPA filters are the only approved protection.
•New substitute friction mate­rials have DQl been tested for safety over time. Use these safety precautions even when you believe the brake shoes do not contain asbestos.
Dangers, continued
•Other Cancers: Cancer of
the voice box has been linked to 
asbestos exposure. Asbestos 
also appears to cause cancers of 
the stomach and large intestine.
•Asbestosis: When micro­
scopic asbestos fibers get caught 
in lung tissue, they cause scars. 
When this scarring spreads, the 
lungs cant expand and contract 
as easily as they should — and 
the victim finds it harder and 
harder to breathe. The condition 
is permanent, and studies suggest 
that if you work with asbestos for 
many years without protecting 
yourself, you stand about a 50-50 
chance of developing this debilitat­
ing disease.
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How do you know 
you have asbestos- 
related disease?
Unfortunately, you probably won’t  
Asbestos, like radiation, seems harm­
less —  and no one has ever itched, 
sneezed, wheezed, or scratched 
because of it, even after asbestos 
particles have penetrated the lungs.
The victim often feels fine for years 
and may no longer even be working 
with asbestos when symptoms begin.
Usually symptoms take between 15 
and 30 years to become troublesome. 
By that time, as we have seen, 
disease can suddenly make it impos­
sible to work. And in the case of lung 
cancer and mesothelioma, which are 
not curable, actually threaten life.
The danger is deadly serious.
This bulletin was produced at the 
Ohio State University office of the 
Ohio Technology Transfer Organi­
zation (OSU/OTTO) under a 
cooperative agreement with the 
National institute for Occupational 
Safety and Health, Centers for 
Disease Control.
Sources for some of the informa­
tion indude:
•National Institute for Occupational 
Safety and Health 
•United States Environmental 
Protection Agency 
•Ohio Industrial Commission 
•Ohio Department of Education 
Ohio Automotive Wholesalers 
Association
•Ohio Automotive Service 
Association 
•Clayton Associates 
•The Ohio State University
For more information about the Ohio 
Technology Transfer Organization, 
œ il 614-466-42B6
PART II
NIOSH BIBLIOGRAPHY ON ASBESTOS

A. NIOSH-AUTHORED DOCUMENTS
NIOSH numbered publications document the results of 
NIOSH research. Included in this category are Criteria 
Documents, Current Intelligence Bulletins, Alerts, 
Health and Safety Guides, technical reports of scientific 
investigations, compilations of data, work-related 
booklets, symposium and conference proceedings, and 
NIOSH administrative and management reports. The 
following publications on asbestos are listed 
alphabetically by title.
1. NUMBERED PUBLICATIONS
Building Air Quality. A Guide for Building Owners and 
Facility Managers, 1991. (Joint NIOSH-EPA 
Publication)
NIOSH PUB NO: 91-114. 253 pp.
GPO NO: 055-000-00390-4 $25.00
(A copy of the section on asbestos is contained in Part I 
of this Bibliography.)
Control of Asbestos Exposure During Brake Drum 
Service, 1989.
NIOSH PUB NO: 89-121. 79 pp.
NTISNO: PB90-168501 $31.50
Criteria for a Recommended Standard: Occupational 
Exposure to Asbestos, 1972. (Revised: See next entry.) 
NIOSH PUB NO: 72-10267. 129 pp.
NTIS NO: PB-209510 $39.00
Criteria for a Recommended Standard: Occupational 
Exposure to Asbestos (Revised), 1976.
NIOSH PUB NO: 77-169. 100 pp.
NTISNO: PB-273965 $31.50
(An abstract of this recommended standard is contained 
in Part I one of this Bibliography.)
Current Intelligence Bulletin 5 - Asbestos Exposure 
During Servicing of Motor Vehicle Brake and Clutch 
Assemblies, 1975.
NIOSH PUB NO: 78-127. 125 pp. (This publication is 
a compendium of Current Intelligence Bulletins 1-18.) 
NTISNO: PB83-105080 $35.00
Estimates of Pulmonary and Gastrointestinal Deposition 
for Occupational Fiber Exposures, 1979.
NIOSH PUB NO: 79-135. 84 pp.
NTISNO: PB80-149644 $31.50
An Evaluation of Glove Bag Containment in Asbestos 
Removal, 1990.
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Subcommittee on Toxic Substances, Environmental 
Oversight, Research and Development, Committee on 
Environment and Public Works. 6 pp.
NTIS NO: PB91-132852 $10.00
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Environmental Protection Agency on their notice of 
proposed rule revision, including disposal of asbestos 
containing materials removed from schools. 6 pp. 
NTISNO: PB90-129404 $10.00
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This fact sheet answers the most frequently asked health questions about asbestos. For more 
information, you may call 404-639-6000. This fact sheet is one in a series of summaries about 
hazardous substances and their health effects. This information is important because this substance 
may harm you. The effects of exposure to any hazardous substance depend on the dose, the 
duration, how you are exposed, personal traits and habits, and whether other chemicals are present
SUMMARY: Exposure to asbestos usually occurs by breathing contaminated air in 
workplaces that make or use asbestos. Asbestos is also found in the air of buildings 
containing asbestos that are J>eing tom ¿own or renoyated̂ Âsbestos exposure can 
cause cancer and other serious lung problems* Thissubstancehasbeen found in 
at least 58 of the 1,430 National Priorities List sites identified by the Environmental 
Protection Agency (EPA). ;
What is asbestos?
(Pronounced Ss-bSs'tas)
Asbestos is the name that’s used for a group of six 
different fibrous minerals (amosite, chrysotile, crocidolite, 
and the fibrous varieties of tremolite, actinolite, and 
anthophyllite) that occur naturally in soil and rocks in some 
areas. Asbestos fibers vary in length and may be straight or 
curled.
Asbestos fibers are resistant to heat and most chemicals. 
Because of this, asbestos fibers are used for a wide range of 
manufactured goods, mostly roofing shingles, ceiling and 
floor tiles, paper products, asbestos cement products, friction 
products (automobile clutch, brake, and transmission parts), 
textiles, packaging, gaskets, and coatings.
What happens to asbestos when It enters the 
environment?
□  Asbestos can enter the air and water from the weather­
ing of natural deposits and the wearing down of manu­
factured asbestos products, such as brake pads.
□  Small fibers may remain suspended in the air for a long 
time before settling. Larger fibers tend to settle more 
quickly.
□  Asbestos fibers aren’t able to move through soil and they 
aren’t broken down to other compounds in the environ­
ment Therefore, they can remain in the environment for 
decades or longer.
□  Asbestos fibers may build up in animals.
How might I  be exposed to asbestos?
□  Breathing low levels in air.
□  Breathing higher levels in air while working in industries 
that make or use asbestos products or near a building that 
contains asbestos products and is being tom down or 
renovated.
□  Breathing higher levels in air near an asbestos-related 
industry or near an asbestos-containing waste site.
□  Drinking water containing asbestos from natural sources 
or from asbestos-containing cement pipes in drinking 
water distribution systems.
How can asbestos affect my health?
Asbestos mainly affects the lungs. Changes in the mem­
brane surrounding the lung are quite common in workers 
exposed to asbestos. These are also sometimes found in 
people living in areas with high levels of asbestos in the air, 
but effects on breathing usually aren’t serious.
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Breathing very high levels of asbestos may result in a 
slow buildup of scar-like tissue in the lungs and in the mem­
brane that surrounds the lungs. This disease is called asbesto- 
sis« and is usually found in asbestos workers and not in the 
genera] public. People with asbestosis have shortness of 
breath, often along with a cough and sometimes heart enlarge­
ment. This is a serious disease and can eventually lead to dis­
ability or death.
How likely is asbestos to cause cancer?
The Department of Health and Human Services 
(DHHS) has determined that asbestos is a known carcinogen.
It is known that asbestos causes cancer in people. There 
are two types of cancer caused by exposure to high levels of 
asbestos: cancer of the lung tissue itself and mesothelioma, a 
cancer of the membrane that surrounds the lung and other 
internal organs. Both of these are usually fatal. These dis­
eases don’t develop immediately, but show up only after 
many years.
Interactions between cigarette smoke and asbestos in­
crease your chances of getting lung cancer. Studies of work­
ers suggest that breathing asbestos can increase the chances 
of getting cancer in other parts of the body (stomach, intes­
tines. esophagus, pancreas, kidneys), but this is not certain.
People who are exposed to lower levels of asbestos may 
also have an increased risk of developing cancer, but the 
risks are usually small and are difficult to measure.
It is not known whether ingesting asbestos causes cancer. 
Some people who had been exposed to asbestos fibers in 
their drinking water had higher-than-average death rates 
from cancer of the esophagus, stomach, and intestines. How­
ever, it isn't known whether this was caused by asbestos or 
by something else.
Is there a medical test to show whether I’ve 
been exposed to asbestos?
Chest X-rays cannot detect asbestos fibers, but can detect 
early signs of lung disease caused by asbestos. Other tests 
(lung and CAT scans), are also useful in detecting changes in 
the lungs.
Tests exist to measure asbestos fibers in urine, feces, 
mucus, or material rinsed out of the lung. However, low lev­
els of asbestos fibers are found in these body fluids in nearly 
all people, so higher-than-average levels can only show that 
you have been exposed to asbestos, not whether you will ex­
perience any health effects.
Has the federal government made 
recommendations to protect human health?
In 1989, the EPA banned all new uses of asbestos; uses es­
tablished before this date are still allowed. The EPA has estab­
lished regulations that require school systems to inspect for 
damaged asbestos and to eliminate or reduce the exposure by 
removing the asbestos or by covering it up. The EPA has set a 
limit of 7 million fibers per liter (MFL) as the concentration of 
long asbestos fibers that may be present in drinking water.
Glossary
Carcinogen: A substance that can cause cancer.
CAS: Chemical Abstract Service.
MFL: Million fibers per liter.
CAT scan: A medical test in which a computer makes a 
3-dimensional image of a body organ.
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Where can I get more information? ATSDR can tell you where to find occupational and environmental health 
clinics. Their specialists can recognize, evaluate, and treat illnesses resulting from exposure to hazardous substances. You 
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Questions and Answers About Asbestos Exposure
1. What Is asbestos?
"Asbestos" is the name given to a group of minerals that occur naturally as masses of 
strong, flexible fibers that can be separated into thin threads and woven. These fibers 
are not affected by heat or chemicals and do not conduct electricity. For these 
reasons, asbestos has been widely used in many industries. Four types of asbestos 
have been commonly used:
• Chrysotile, or white asbestos (curly, flexible white fibers), which accounts 
for about 90 percent of the asbestos currently used in industry;
• Amosite (straight, brittle fibers that are light gray to pale brown in color);
• Crocidolite, or blue asbestos (straight blue fibers); and
• Anthophyllite (brittle white fibers).
Chiysotile asbestos, with its curly fibers, is in the serpentine family of minerals. The 
other types of asbestos, which all have needle-like fibers, are known as amphiboles.
Asbestos fiber masses tend to break easily into a dust composed of tiny particles that 
can float in the air and stick to clothes. The fibers may be easily inhaled or swallowed 
and can cause serious health problems.
2. How Is asbestos used?
Asbestos has been mined and used commercially in North America since the late 
1800s, but its use increased greatly during World War n. Since then, it has been used 
in many industries. For example, the building and construction industry uses it for 
strengthening cement and plastics as well as for insulation, fireproofing, and sound 
absorption. The shipbuilding industry has used asbestos to insulate boilers, steampipes, 
hot water pipes, and nuclear reactors in ships. The automotive industry uses asbestos 
in vehicle brakeshoes and clutch pads. More than 5,000 products contain or have 
contained asbestos, some of which are listed below:




• Asbestos cement sheet and pipe products used for water supply and sewage 
piping, roofing and siding, casings for electrical wires, fire protection 
material, chemical tanks, electrical switchboards and components, and 
residential and industrial building materials;
• Friction products, such as clutch facings; brake linings for automobiles, 
railroad cars, and airplanes; and industrial friction materials;
• Products containing asbestos paper, such as table pads and heat-protective 
mats, heat and electrical wire insulation, industrial filters for beverages, small 
appliance components, and underlying material for sheet flooring;
• Asbestos textile products, such as packing components, roofing materials, 
heat- and fire-resistant clothing, and fireproof draperies; and
• Other products, including ceiling and floor tile; gaskets and packings; paints, 
coatings, and sealants; caulking and patching tape; and plastics.
In the late 1970s, the U.S. Consumer Product Safety Commission banned the use of 
asbestos in wallboard patching compounds and gas fireplaces because these products 
released excessive amounts of asbestos fibers into the environment. In addition, 
asbestos was voluntarily withdrawn by manufacturers of electric hair dryers. These 
and other regulatory actions, coupled with widespread public concern about the hazards 
of asbestos, have resulted in a significant annual decline in U.S. use of asbestos: 
Domestic use of asbestos amounted to about 560,000 metric tons in 1979, but it had 
dropped to about 55,000 metric tons by 1989.
What are the health hazards of exposure to asbestos?
Exposure to asbestos may increase the risk of several serious diseases:
• Asbestosis—a chronic lung ailment that can produce shortness of breath and 
permanent lung damage and increase the risk of dangerous lung infections;
• Lung cancer;
• Mesothelioma—a relatively rare cancer of the thin membranes that line the 
chest and abdomen; and




Since the early 1940s, millions of American workers have been exposed to asbestos 
dust, including many of the 4.5 million men and women who worked in shipyards 
during the peak shipbuilding years of World War n . Health hazards from asbestos 
dust have been recognized in workers exposed in shipbuilding trades, asbestos mining 
and milling, manufacturing of asbestos textiles and other asbestos products, insulation 
work in the construction and building trades, brake repair, and a variety of other 
trades. Demolition workers, drywall removers, and firefighters also may be exposed 
to asbestos dust. As a result of Government regulations and improved work practices, 
today's workers (those without previous exposure) are likely to face smaller risks than 
did those exposed in the past.
Although it is known that the risk to workers increases with heavier exposure and 
longer exposure time, investigators have found asbestos-related diseases in some 
shipyard workers exposed to high levels of asbestos fibers for only brief periods 
(as little as 1 or 2 months). Even workers who may not have worked directly with 
asbestos but whose jobs were located near contaminated areas have developed 
asbestosis, mesothelioma, and other cancers associated with asbestos exposure.
Generally, workers who develop asbestos-related diseases show no signs of illness until 
many years after first exposure. For example, the time between first exposure to 
asbestos and the appearance of lung cancer is generally 15 yean or more; a lag of 30 
to 35 years is not unusual. The lag period for development of mesothelioma and 
asbestosis is even greater, often as long as 40 to 45 years.
There is also some evidence that family members of workers heavily exposed to 
asbestos face an increased risk of developing mesothelioma and perhaps other asbestos- 
related diseases. This risk is thought to result from exposure to asbestos dust brought 
into the home on the shoes, clothing, skin, and hair of workers.
How great Is the risk?
Not all workers exposed to asbestos will develop diseases related to their exposure. In 
fact, many will experience no ill effects.
Asbestos that is bonded into finished products such as walls, tiles, and pipes poses no 
risk to health as long as it is not damaged or disturbed (for example, by sawing or 
drilling) in such a way as to release fibers into the air. When asbestos particles are set 
free and inhaled, however, exposed individuals are at risk of developing an asbestos- 
related disease. Once these nearly indestructible fibers work their way into body 
tissues, they tend to stay there indefinitely.
The risk of developing asbestos-related diseases varies with the type of industry in 
which the exposure occurred and with the extent of the exposure. In addition, different
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types of asbestos fibers may be associated with different health risks. For example, 
results of several studies suggest that croddolite and amosite are more likely than 
chrysotile to cause lung cancer, asbestosis, and, in particular, mesothelioma. Even so, 
no fiber type can be considered harmless, and proper safety precautions should always 
be taken by people working with asbestos.
6. How does smoking affect risk?
Many studies have shown that the combination of smoking and asbestos exposure is 
particularly hazardous. Cigarette smokers, on the average, are 10 times as likely to 
develop lung cancer as are nonsmokers. For nonsmokers who work with asbestos, the 
risk is about five times greater than for those in the general population. By contrast, 
smokers who also are heavily exposed to asbestos are as much as 90 times more likely 
to develop lung cancer than are nonexposed individuals who do not smoke. Smoking 
does not appear to increase the risk of mesothelioma, however.
There is evidence that quitting smoking will reduce the risk of lung cancer among 
asbestos-exposed workers, perhaps by as much as half or more after at least 5 years 
without smoking. People who were exposed to asbestos on the job at any time during 
their life or who suspect they may have been exposed should not smoke. If they 
smoke, they should stop.
7. Who needs to be examined?
Individuals who have been exposed (or suspect they have been exposed) to asbestos 
dust on the job or at home via a family contact should inform their physician of their 
exposure history and any symptoms. A thorough physical examination, including a 
chest x-ray and lung function tests, may be recommended. Interpretation of the chest 
x-ray may require die help of a specialist who is experienced in reading x-rays for 
asbestos-related diseases. Other tests also may be necessary.
As noted earlier, the symptoms of asbestos-related diseases may not become apparent 
for many decades after exposure. If any of the following symptoms develop, a 
physical examination should be scheduled without delay:
• Shortness of breath;
• A cough or a change in cough pattern;
• Blood in the sputum (fluid) coughed up from the lungs;





• Difficulty in swallowing or prolonged hoarseness; and/or
• Significant weight loss.
8. What are the treatments for asbestos-related diseases?
The key to successful treatment of asbestos-related diseases lies in early detection. 
The health problems caused by asbestosis are due mainly to lung infections, like 
pneumonia, that attack weakened lungs. Early medical attention and prompt, 
aggressive treatment offer the best chance of success in controlling such infections. 
Depending on the situation, doctors may give a vaccine against influenza or 
pneumococcal pneumonia as a protective measure.
Treatment of cancer is tailored to the individual patient and may include surgery, 
anticancer drugs, radiation, or combinations of these therapies. Information about 
cancer treatment is available from the National Cancer Institute-supported Cancer 
Information Service, whose toll-free telephone number is 1-800-4-CANCER.
9. How can workers protect themselves?
Employers are required to follow regulations dealing with asbestos exposure on the job 
that have been issued by the Occupational Safety and Health Administration (OSHA), 
the Federal agency responsible for health and safety regulations in the workplace. 
Regulations related to mine safety are enforced by the Mine Safety and Health 
Administration (MSHA). Workers should use all protective equipment provided by 
their employers and follow recommended work practices and safety procedures. 
Workers who are or who have been exposed to asbestos should not smoke cigarettes.
Workers who are concerned about asbestos exposure in the workplace should discuss 
the situation with other employees, their union, and their employers. If necessary, 
OSHA can provide more information or make an inspection. Area offices of OSHA 
are listed in the "United States Government'' section of telephone directories’ blue 
pages (under "Department of Labor”). If no listing is found, workers may call or 
write to one of the OSHA regional offices listed on page 9. Mine workers may contact 
MSHA’s Office of Standards, Variances, and Regulation at Room 627, 4015 Wilson 
Boulevard, Arlington, VA 22203; the telephone number is 703-235-1910.
Hie National Institute for Occupational Safety and Health (NIOSH) is another Federal 
agency that is concerned with asbestos exposure in the workplace. The Institute 
conducts asbestos-related research, evaluates work sites for possible health hazards, 
and makes safety recommendations. In addition, NIOSH distributes publications on the 
health effects of asbestos exposure and can suggest additional sources of information. 




Health, 4676 Columbia Paikway/Mailstop C-19, Cincinnati, OH 45226. The toll-free 
telephone number is 1-8QO-35-NIOSH (1-800-356-4674).
10« What should people who have been exposed to asbestos do?
It is important for exposed individuals to:
• Stop smoking;
• Get regular health checkups;
• Get prompt medical attention for any respiratory illness; and
• Use all protective equipment, work practices, and safety procedures designed 
for working around asbestos.
11. Will the Government provide examinations and treatment or pay for such 
services? What about insurance coverage?
Medical services related to asbestos exposure are available through the Government 
only for certain groups of eligible individuals. In general, exposed individuals must 
pay for their own medical services unless they are covered by private or Government 
health insurance. Medicare may reimburse people with symptoms of asbestos-related 
diseases for the costs of diagnosis and treatment (following review of medical 
procedures for appropriateness). General and specific information about benefits is 
available from the Medicare office serving each state; for the telephone number of the 
nearest office, call 1-800-772-1213.
People with asbestos-related diseases also may qualify for financial help, including 
medical payments, under state workers’ compensation laws. Because eligibility 
requirements vary from state to state, workers should contact the workers’ 
compensation program in the state where the last exposure occurred. (The telephone 
number may be found in the blue pages of a local telephone directory.)
If exposure occurred during employment with a Federal agency (military or civilian), 
medical expenses and other compensation may be covered by the Federal Employees’ 
Compensation Act. Workers who are or were employed in a shipyard by a private 
employer may be covered under the Longshoremen and Harbor Workers’ 
Compensation Act Information about eligibility or how to file a claim is available 
from the U.S. Department of Labor, Office of Workers’ Compensation Programs, 





Retired military personnel and their eligible dependents may receive health care at any 
Department of Defense medical facility, Department of Veterans Affairs (VA) hospital, 
or Public Health Service hospital. Where no Federal facility is available, civilian 
facilities may be used under the Civilian Health and Medical Program for the 
Uniformed Services. Those over age 65 may be covered by Medicare. Former 
members of the military who believe they may have a service-related medical problem 
may inquire about care at a VA facility or telephone the local VA office.
Workers also may wish to contact their international union for information on other 
sources of medical help and insurance matters. One organization, the Asbestos Victims 
Special Fund Trust, provides financial assistance to asbestos victims who have not 
received workers’ compensation or compensation through legal avenues. Information 
is available from the Trust at Suite M -ll, 1500 Walnut Street, Philadelphia, PA 19102; 
die telephone number is 1-800-447-7590.
12. Is there a danger of nonoccupational exposure from products contaminated with 
asbestos particles?
Asbestos is so widely used that the entire population has been exposed to some degree. 
Air, beverages, drinking water, food, drug and dental preparations, and a variety of 
consumer products all may contain small amounts of asbestos. In addition, asbestos 
fibers are released into the environment from natural deposits in the earth and as a 
result of wear and deterioration of asbestos products.
The U.S. Environmental Protection Agency (EPA) regulates the general public’s 
exposure to asbestos in buildings, drinking water, and the environment. The EPA’s 
Toxic Substances Control Act (TSCA) Assistance Office can answer questions about 
toxic substances, including asbestos. Printed material is available on a number of 
topics, particularly on controlling asbestos exposure in schools and other buildings.
The TSCA office can provide information about accredited laboratories for asbestos 
testing and can refer inquirers to other resources on asbestos. Questions may be 
directed to the TSCA Assistance Office, U.S. Environmental Protection Agency,
7408 M Street SW, Washington, DC 20024; the telephone number is 202-554-1404.
The Consumer Product Safety Commission (CPSC) is responsible for the regulation of 
asbestos in consumer products. The CPSC maintains a toll-free information line on the 
potential hazards of commercial products; the telephone number is 1-800-638-2772. In 
addition, CPSC provides information about laboratories for asbestos testing, guidelines 
for repairing and removing asbestos, and general information about asbestos in the 
home. Publications are available from the Office of Public Affairs, Consumer Product 





The U.S. Food and Drug Administration is concerned with asbestos contamination of 
foods, drugs, and cosmetics and will answer questions on these topics. The address is 
Office of Consumer Affairs, Food and Drug Administration, HFE-88, 5600 Fishers 
Lane, Rockville, MD 20857; the telephone number is 301-443-3170.
13. What other organizations offer information related to asbestos exposure?
The American Lung Association and the American Cancer Society can provide 
information about lung disease, cancer, and smoking. Local chapters of these 
organizations are listed in telephone directories. Material about cancer and how to quit 
smoking is available by calling the National Cancer Institute-supported Cancer 
Information Service (CIS). The CIS, a program of the National Cancer Institute, 
provides a nationwide telephone service for cancer patients and their families, the 
public, and health care professionals. CIS information specialists have extensive 
training in providing up-to-date and understandable information about cancer and 
cancer research. They can answer questions in English and Spanish and can send free 
printed material. In addition, CIS offices serve specific geographic areas and have 
information about cancer-related services and resources in their region. The toll-free 
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U.S. Department of Labor 
Program Highlights
Fact Sheet No. OSHA 93-06
BETTER PROTECTION AGAINST ASBESTOS IN THE WORKPLACE
What Is Asbestos?
Asbestos is a widely used, mineral-based material that is 
resistant to heat and corrosive chemicals. Typical fy, asbestos 
appears as a whitish, fibrous material which may release 
fibers that range in texture from coarse to silky; however, 
airborne fibers that can cause health damage may be too 
small to see with the naked eye.
Who Is Exposed?
An estimated 1.3 million employees in construction and 
general industry face significant asbestos exposure on the 
job. Heaviest exposures occur in the construction industry, 
particularly during the removal of asbestos during renovation 
or demolition. Employees are also likely to be »posed 
during the manufacture of asbestos products (such as 
textiles, friction products, insulation, and other building 
materials) and during automotive brake and clutch repair 
work.
What Are the Dangers of Asbestos Exposure?
Exposure to asbestos can cause asbestosis (scarring of the 
lungs resulting in loss of lung function that often progresses 
to disability and to death); mesothelioma (cancer affecting the 
membranes lining the lungs and abdomen); lung cancer, and 
cancers of the esophagus, stomach, colon, and rectum.
What Protections Are Mandatory?
The U.S. Occupational Safety and Health Administration 
(OSHA) has issued revised regulations covering asbestos 
exposure in general industry and construction. Both 
standards set a maximum exposure limit and include 
provisions for engineering controls and respirators, protective 
clothing, exposure monitoring, hygiene facilities and practices, 
warning signs, labeling, recordkeeping, and medical exams.
Nonasbestiform tremol'rte, anthophyllite, and actinofjte were 
excluded from coverage under the asbestos standard in May 
1992.
Here are some of the highlights of the revised rules, published 
in the Federal Register June 20,1986; and on Sept 14,1988:
— Permissible Exposure Limit: In both general 
industry and construction, workplace exposure must be 
limited to 0.2 fibers per cubic centimeter of air (0.2 f/cc), 
averaged over an eight-hour work shift The excursion or 
short-term limit is one fiber per cubic centimeter of air (1 f/cc) 
averaged over a sampling period of 30 minutes.
— Exposure Monitoring: In general industry, 
employers must do initial monitoring for workers who may be 
exposed above the ‘action level* of 0.1 f/cc. Subsequent 
monitoring must be conducted at reasonable intervals, in no 
case longer than six months for employees exposed above 
the action level.
In construction, daily monitoring must be continued 
until exposure drops below the action level (0.1 f/cc). Daily 
monitoring is not required where employees are using 
supplied-air respirators operated in the positive pressure 
mode.
— Methods of Compliance: In both general industry 
and construction, employers must control exposures using 
engineering controls, to the extent feasible. Where 
engineering controls are not feasible to meet the exposure 
limit, they must be used to reduce employee exposures to the 
lowest levels attainable and must be supplemented by the use 
of respiratory protection.
— Respirators: In general industry and construction, 
the level of exposure determines what type of respirator is 
required; the standards specify the respirator to be used.
— Regulated Areas: In general industry and 
construction, regulated areas must be established where the 
8-hour TWA or 30-minute excursion values for airborne 
asbestos exceed the prescribed permissible exposure limits. 
Only authorized persons wearing appropriate respirators can 
enter a regulated area. In regulated areas, eating, smoking, 
drinking, chewing tobacco or gum, and applying cosmetics 
are prohibited.
Warning signs must be displayed at each regulated 
area and must be posted at all approaches to regulated 
areas.
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— Labels: Caution labels must be placed on all raw 
materials, mixtures, scrap, waste, debris, and other products 
containing asbestos fibers.
— Recordkeeping: The employer must keep an 
accurate record of all measurements taken to monitor 
employee exposure to asbestos. This record is to include: 
the date of measurement, operation involving exposure, 
sampling and analytical methods used, and evidence of their 
accuracy; number, duration, and results of samples taken; 
type of respiratory protective devices worn; name, social 
security number, and the results of all employee exposure 
measurements. This record must be kept for 30 years.
— Protective Clothing: For any employee exposed to 
airborne concentrations of asbestos that exceed the PEL, the 
employer must provide and require the use of protective 
clothing such as coveralls or similar fulLbody clothing, head 
coverings, gloves, and foot covering. Wherever the possibility 
of eye irritation exists, face shields, vented goggles, or other 
appropriate protective equipment must be provided and worn.
in construction, there are special regulated-area 
requirements for asbestos removal, renovation, and 
demolition operations. These provisions include a negative 
pressure area, decontamination procedures for workers, and 
a "competent person* with the authority to identify and control 
asbestos hazards. The standard includes an exemption from 
the negative pressure enclosure requirements for certain small 
scale, short duration operations provided special work 
practices prescribed in an appendix to the standard are 
followed.
— Hygiene Facilities and Practices: Clean change 
rooms must be furnished by employers for employees who 
work in areas where exposure is above the TWA and/or 
excursion Emit Two lockers or storage facilities must be 
furnished and separated to prevent contamination of the 
employee’s street clothes from protective work clothing and 
equipment Showers must be furnished so that employees 
may shower at the end of the work shift Employees must 
enter and exit the regulated area through the decontamination 
area.
The equipment room must be supplied with 
impermeable, labeled bags and containers for the 
containment and disposal of contaminated protective clothing 
and equipment
Lunchroom facilities for those employees must have a 
positive pressure, filtered air supply and be readily accessible 
to employees. Employees must wash their hands and face 
prior to eating, drinking or smoking. The employer must 
ensure that employees do not enter lunchroom facilities with 
protective work clothing or equipment unless surface fibers
have been removed from the clothing or equipment
Employees may not smoke in work areas where they 
are occupationally exposed to asbestos.
— Medical Exams: In general industry, exposed 
employees must have a preplacement physical examination 
before being assigned to an occupation exposed to airborne 
concentrations of asbestos at or above the action level or the 
excursion leveL The physical examination must include chest 
X-ray, medical and work history, and pulmonary function 
tests. Subsequent exams must be given annually and upon 
termination of employment, though chest X-rays are required 
annually only for 45 and over workers whose first asbestos 
exposure occurred more than 10 years ago.
In construction, examinations must be made available 
annually for workers exposed above the action level or 
excursion limit for 30 or more days per year or who are 
required to wear negative pressure respirators; chest X-rays 
are at the discretion of the physician.
Where Can I Get More Information?
Copies of the general industry asbestos standard Part II, 
Health Standards, Stock Number 869-017-00110-4, $16.00) 
and the construction industry standard (Stock Number 869- 
017-00112-1, $14.00) are available from the Superintendent of 
Documents, Government Printing Office, Washington, DC 
20402-9325, or telephone 202-783-3238. These standards are 
also available on CO-ROM (Stock Number 729-013-00000-5, 
$88.00) by subscription for four updates per year or a single 
disk for $28.00.
Two pamphlets summarizing the rule are also available: (in 
single copies) 'Asbestos Standard for General Industry" and 
'Asbestos Standard for Construction Industry," and can be 
obtained by sending a self-addressed mailing label to the 
OSHA Publications Office, Room N-3101, Washington, D.C. 
20210, telephone 202-219-4667 or from any local OSHA 
office.
Questions about the standards can be answered by any local 
OSHA office or by OSHA regional offices located in Boston, 
New York, Philadelphia, Atlanta, Chicago, Dallas, Kansas City, 
Denver, San Francisco, and Seattle.
AO local OSHA offices have available for loan slide programs 
on the general industry and construction asbestos standards. 
Training on asbestos and other safety and health hazards is 
conducted at the OSHA Training Institute. 1555 Times Or.,
Des Plaines. IL 60018, telephone 708-297-4810; tuition is 
charged.
# #  #
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